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Abstract
Inositol  hexakisphosphate  (InsP6)  is  the  main  storage  form  of  phosphorous  in 
animal feeds. Phytases are enzymes (myo-inositol hexakisphosphate phosphohydrolases) 
that break down InsP6 by hydrolysis to release inorganic phosphate. Non-ruminant animals 
do  not  produce  phytases  needed  to  digest  dietary  InsP6,  instead  relying  on  enzymes 
produced by their gut microbiota. A similar situation is found in humans where several 
members  of  the  commensal  bacteria  have  been  found  to  produce  multiple  inositol 
polyphosphate phosphatases (Minpp) which display phytase activity.
In this study, high resolution X-ray crystal structures of Minpps from two human 
commensal  gut  bacteria,  Bacteroides  thetaiotaomicron (BtMinpp)  and  Bifidobacterium 
longum (BlMinpp), were solved and refined.  High performance liquid chromatography 
was employed to analyse the products of InsP6 hydrolysis, revealing that Minpps attack 
InsP6 with high positional promiscuity, unlike bacterial and fungal phytases which display 
high catalytic specificity.
Site-directed  mutagenesis  was  employed  to  further  investigate  the  catalytic 
promiscuity of BtMinpp, mutagenizing its active site to mimic that of PhyA, a specific 3-
phytase from Aspergillus niger. Further experiments introduced active site residues from 
human Minpp. The results of these studies reveal that by altering key active site residues, 
the positional specificity and the ratios of the InsP5 products generated by BtMinpp action 
can be altered,  opening the possibility of engineering catalytic flexibility into phytases 
used as commercial animal feed additives.
Disulfide bridges  were engineered into  BtMinpp with the aim of enhancing its 
thermostability – an attractive characteristic for animal feed enzymes. Sites for potential 
disulfide  bridges  were  identified  and a  one  such  mutant  was  produced.  However,  the 
engineered protein did not show a significant enhancement in thermostability. 
 The results of experiments described in this thesis provide novel insights into the 
hydrolysis of InsP6 by Minpps that suggest a role as precursors for a new generation of 
phytases for the animal feed industry.
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Chapter 1. Introduction
1.1 Inositol polyphosphates
Inositols are polyols of cyclohexane, with  cis-1,2,3,5-trans-4,6-cyclohexanehexol 
or myo-inositol (figure 1.1.0.1) being the most prominent form in nature. In its low energy 
state,  myo-inositol has its 2-hydroxyl in the axial position while the other hydroxyls are 
equatorial.  By  itself,  myo-inositol  is  achiral  due  to  a  plane  of  reflection  within  the 
molecule but substitution of certain hydroxyl groups can make it optically active. Inositol 
polyphosphates (InsP), as the name suggests, are polyphosphorylated inositols (of the D-
myo- variant). There are 63 (i.e. 26 – 1) possible InsPs (excluding inositol pyrophosphates 
in which phosphate groups are replaced with pyrophosphates) and most of them exist 
biologically, though only a few have been extensively studied  (Irvine et al. 2001). InsPs 
are ubiquitous in cells and their levels are regulated by InsP phosphatases (Majerus et al. 
1999) and kinases (Shears 2004).
Figure  1.1.0.1.  Chemical  structure  of  myo-inositol. Notice  that  in  the  low  energy  chair 
conformation only the hydroxyl group at position 2 is in the axial conformation, while all others 
are equatorial. Reproduced from http://en.wikipedia.org/wiki/Inositol.
1.1.1 Inositol hexakisphosphate
Phosphorus  is  an  important  element  in  all  living  organisms.  Phosphates  are 
components  of  important  biomolecules  such as  adenosine  triphosphate  (ATP)  and  the 
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nucleic acids (both DNA and RNA). myo-inositol hexakisphosphate, also known as phytic 
acid or InsP6, is the main storage form of phosphorus in plants, especially in seeds (Raboy 
2003).  It chelates to minerals such as calcium and magnesium, which are released along 
with  free  phosphates  during  the  germination  of  seeds  when  phytate  is  hydrolysed 
(Schlemmer et al. 2009). InsP6 cannot be digested by non-ruminant animals such as pigs 
and poultry, and cause further problems such as eutrophication of the aquatic environment 
after InsP6 is excreted  (Brinch-Pedersen et al. 2002). Phytic acid has been viewed as an 
anti-nutrient for some time, since it also chelates other essential minerals such as iron and 
zinc which may cause deficiencies of said minerals (Schlemmer et al. 2009). However, in 
recent decades studies have suggested that InsP6 possesses antioxidant (Graf et al. 1987) 
and anticancer  (Shamsuddin 1995) activities. Other than its nutritional properties, InsP6 
has also been shown to be involved in diverse cellular processes. It facilitates DNA repair 
by binding to DNA protein kinase (DNA-PK), a protein involved in non-homologous end 
joining (NHEJ)  (Hanakahi et al. 2000). It is found in the core of ADAR2, an RNA editing 
enzyme,  and  is  required  for  its  activity  (Macbeth et  al. 2005). It  is  required  for  the 
function of yeast GLE1, a protein essential to mRNA export in heat shocked cells (York et  
al. 1999).  In  a  more  recent  study,  InsP6 has  been  reported  to  stimulate  tumor  cell 
proliferation at low concentrations (Windhorst et al. 2013).
1.1.2 Inositol triphosphates
Inositol 1,4,5-triphosphate (Ins(1,4,5)P3), which is most commonly referred to as 
the IP3, is a second messenger along with Ca2+. Described as early as 1983 (Streb et al. 
1983), it is responsible for many different signalling mechanisms in cells (Berridge 2009), 
such as fertilization (Cuthbertson et al. 1985) and cell death (Hanson et al. 2004). When 
IP3 binds to IP3 receptors, a release of Ca2+ from internal store is induced, thus generating a 
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calcium flux in cells (Tsui et al. 2010). Rather than obtaining IP3 by dephosphorylation of 
higher InsPs, eukaryotes generally obtain IP3 by metabolising phosphatidylinositol  4,5-
bisphosphate  (PIP2)  into  IP3 and  1,2-diacylglycerol  (DAG)  with  phospholipase  C 
(Berridge 2009). Interestingly, DAG is an important signalling lipid responsible for a wide 
range of biological responses (Gómez-Fernández et al. 2007). Inositol phosphate kinases 
then turn IP3 into higher InsPs, including InsP4s, InsP5s, InsP6 and inositol pyrophosphates 
(Tsui et al. 2010).
Another  inositol  triphosphate,  inositol  1,2,6-triphosphate  (Ins(1,2,6)P3),  also 
known as α-trinositol  or pp56, does not  occur naturally  in mammals,  and is  produced 
commercially by partial degradation of InsP6 with phytase (Bell et al. 1998). It can act as 
an analgesic and has antinociceptive effect towards both acute and prolonged nociceptive 
behaviour (Malmberg et al. 1995).  pp56 also exhibits anti-inflammatory effects and the 
ability to prevent or reduce the severity of edema formation (Bell et al. 1998).
1.1.3 Inositol tetrakis- and pentakis-phosphates
Inositol-1,3,4,5-tetrakisphosphate  (Ins(1,3,4,5)P4)  is  synthesized  from  IP3 by 
inositol 1,4,5-triphosphate 3-kinase (IP3K) in animals (Irvine et al. 1986). It has the ability 
to modulate the level of cellular calcium ions. It has long been known that Ins(1,3,4,5)P4 
has a protective effect on IP3, since an inositol polyphosphate 5-phosphatase has a 10-fold 
higher affinity and an 100-fold lower Vmax for Ins(1,3,4,5)P4 than IP3, thus increasing the 
effectiveness  of  IP3 (Connolly et  al. 1987).  With  IP3 metabolism  inhibited  by 
Ins(1,3,4,5)P4,  the  activation  of  Ca2+-release-activated  Ca2+ channel  (ICRAC),  a  store 
operated  Ca2+ channel  (SOC),  is  also  facilitated  (Hermosura et  al. 2000).  In  addition, 
Ins(1,3,4,5)P4 may bind to IP3 receptor, and either mimics IP3 to active Ca2+ release or act 
as  an  inhibitor,  depending  on  the  isoform  (Irvine et  al. 2001).  Furthermore,  there  is 
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evidence that Ins(1,3,4,5)P4 can activate voltage-gated Ca2+ channels (in contrast to IP3 
receptor operated Ca2+ channels) in the plasma membrane of endothelial cells (Lückhoff et  
al. 1992) and neurons (Tsubokawa et al. 1996), allowing the entry of Ca2+ into cells.
Inositol-3,4,5,6-tetrakisphosphate (Ins(3,4,5,6)P4) has a role in regulating Cl- level 
in cells.  When Ca2+ level is elevated, Cl- release is triggered through Ca2+-regulated Cl- 
channels. However, the effect of Cl- secretion is short-lived due to the inhibition of the 
channels by Ins(3,4,5,6)P4 (Ho et al. 1997). 
The  level  of  another  InsP4,  inositol-1,4,5,6-tetrakisphosphate  (Ins(1,4,5,6)P4)  is 
elevated  when cells  are  infected  with  Salmonella  dublin.  The  protein  SopB from the 
bacterium  is  an  inositol  polyphosphate  phosphatase  that  hydrolyses  inositol-1,3,4,5,6-
pentakisphosphate, and the virulence of the bacteria is linked to the disruption of inositol 
phosphate  signalling  pathways  (Norris et  al. 1998).  Ins(1,4,5,6)P4 also  acts  as  a 
“intermolecular  glue”  between  histone  deacetylase  enzyme  3  (HDAC3)  and  nuclear 
receptor co-repressor 2 (NCOR2), a complex that regulates gene expression by chromatin 
condensation, which makes it a good cancer drug target (Watson et al. 2012).
Inositol-1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5) is one of the most abundant 
InsPs besides InsP6 in mammalian cells, with concentrations generally maintained between 
concentrations  of  10  to  100  μM  (Sasakawa et  al. 1995). In  avian  erythrocytes, 
Ins(1,3,4,5,6)P5 is believed to decrease the affinity of haemoglobin for O2 (Johnson et al. 
1969), a function similar to 2,3-bisphosphoglycerate (2,3-BPG) or adenosine triphosphate 
(ATP) in most vertebrates (Coates 1975). In other animal cells, Ins(1,3,4,5,6)P5 serve as a 
'hub' in higher inositol polyphosphate metabolism (Irvine et al. 2001). Ins(1,3,4,5,6)P5 is 
also shown to be involved in viral assembly by binding to HIV-1 Gag protein (Campbell 
et al. 2001), and in regulation of calcium channels by stimulating vascular L-type Ca2+ 
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channels  (Quignard et  al. 2003). Furthermore,  by  interacting  with  PTEN,  a  tumour 
suppressor, Ins(1,3,4,5,6)P5 is demonstrated to have a role in cell proliferation (Orchiston 
et al. 2004) and apoptosis (Piccolo et al. 2004), as well as possessing antiangiogenic and 
antitumour effects (Maffucci et al. 2005).
1.1.4 Inositol pyrophosphates
Pyrophosphoric  acid,  also  known  as  diphosphoric  acid,  is  formed  by  the 
dehydration reaction of two phosphoric acids, and the salt is called a pyrophosphate or 
diphosphate. Inositol pyrophosphates or diphosphoinositol polyphosphate (PP-InsPs) are 
produced in organisms when a phosphate group on an inositol polyphosphate is further 
phosphorylated. There  are  two  groups  of  enzymes  involved  in  making  of  PP-InsPs; 
inositol  hexakisphosphate  kinases  (IP6Ks)  (Saiardi et  al. 2001) and  diphosphoinositol 
pentakisphosphate  kinases  (PPIP5Ks)  (Fridy et  al. 2007).   IP6Ks  and  PPIP5Ks,  also 
known  as  Kcs1  and  VIP  respectively  in  yeast,  phosphorylate  InsP6 with  different 
positional specificity to generate InsP7, and collectively generate InsP8 (Tsui et al. 2010). 
Knockout of the Kcs1 gene from yeast resulted in impaired vacuole biogenesis, suggesting 
a role for PP-IPs in endocytic trafficking (Saiardi et al. 2000). Overexpression of IP6K2 
enhances interferon induced apoptosis in tumour cells, linking PP-InsPs with apoptosis 
(Morrison et al. 2002). PP-InsPs have also been implicated in other cellular functions such 
as osmotic stress response and telomere length regulation (Barker et al. 2009).
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1.2 Inositol polyphosphate phosphatases and phytases
Inositol polyphosphate phosphatases are enzymes that remove phosphate groups 
from inositol  polyphosphates  to  form a  free  phosphate  and  a  hydroxyl  group  on  the 
inositol  ring.  Phytases  are  the  best  structurally  characterized  group  of  inositol 
polyphosphate phosphatases. Another group of inositol  polyphosphate phosphatase that 
has been structurally characterized is the family of inositol polyphosphate 5-phosphatase 
(INPP5).
Phytase is a generic term given to an enzyme that hydrolyses phosphomonoester 
bonds  from phytic  acid,  thus  releasing  orthophosphates  (Mullaney et  al. 2003).  Four 
classes of phytases have been reported in the literature; histidine acid phosphatases,  β-
propeller phytases, purple acid phosphatases (Mullaney et al. 2003) and protein tyrosine 
phosphatase-like phytases (Puhl et al. 2007).
1.2.1 HAP phytases and related phosphatases
Many of  the  phytases  for  which  crystal  structures  are  available  belong  to  the 
histidine acid phosphatase (HAP) family. The histidine phosphatase superfamily is a large 
functionally-diverse  group  of  enzymes,  sharing  a  conserved  catalytic  site  involving  a 
histidine  residue  which  became  phosphorylated  during  the  mechanistic  cycle  (Rigden 
2008). Histidine phosphatases have a conserved active site RHG motif (with the exception 
of glucose-1-phosphatase, which has RHN). As shown in  figure 1.2.1.1, the active site 
histidine  is  phosphorylated,  and  the  phosphate  is  then  removed  through hydrolysis  to 
allow new substrate to bind.
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Figure 1.2.1.1.  Catalytic mechanism of enzymes of the histidine phosphatase superfamily. 
The catalytic  histidine from the RHG motif  and a  proton donor (usually  an aspartate,  though 
sometime a  glutamate  in  branch 1  HAPs)  are  shown in  the  basic/positively-charged catalytic  
pocket. The lone pair of atom Nε2 of the catalytic histidine initiates a nucleophilic attack on the 
phospho group, which leads to the formation of a phosphohistidine intermediate. The negatively 
charged residue then attacks a water molecule, which in turn attacks the phospho group of the  
phosphohistidine to generate a free phosphate. Adapted from (Rigden 2008).
The histidine phosphatases can be separated into two branches, where branch 2 
includes fungal and bacterial phytases (Rigden 2008).  The crystal structures of phytases 
from E. coli (Lim et al. 2000), A. ficuum (niger) (Kostrewa et al. 1997) and A. fumigatus 
(Liu et al. 2004) were the earliest to be solved, each comprising an α/β domain and an α-
helix only domain, as shown in figure 1.2.1.2. More recently, structures of other bacterial 
HAP phytases with 49 – 64% sequence identity to E. coli phytase have also been solved, 
including those from Hafnia alvei  (Ariza et al. 2013) and Citrobacter braakii  (Sanchez-
Romero et al. 2013). A fungal phytase from A. niger is sold as Natuphos™ (BASF animal 
nutrition)  to  be  added  to  animal  feedstock.  As  a  phytase,  the  protein  mobilizes 
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phosphorous in the form of phosphate liberated from dietary phytic acid.
Figure 1.2.1.2. Overall fold of A. fumigatus phytase, representative of the HAP phytases. The 
structure consists of two domains; an α/β domain (top) and an α-helix only domain (bottom). The 
catalytic residues His 59 and Asp 339 are shown as spheres. PDB code: 1SKA (Liu et al. 2004).
The HAP phytases and the other branch 2 histidine phosphatases have a conserved 
catalytic core which consists of an RHGXRXP catalytic motif (branch 1 enzymes only 
have the RHG component conserved) and an HD proton donor motif  (Liu et al. 2004). 
Fungal phytases have a broader substrate specificity compared to other branch 2 histidine 
phosphatases, and are able to hydrolyse a range of phosphate-containing compounds such 
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as phytate, ATP, glucose 6-phosphate and fructose 6-phosphate, while  E. coli phytase is 
more specific and only hydrolyses phytate (Wyss et al. 1999). A closer inspection of the 
crystal  structures  showed that  helix  209-228 in  E.  coli phytase  is  much closer  to  the 
catalytic pocket compared to its counterpart in A. fumigatus phytase, thus decreasing the 
active  site  volume  and  increasing  its  specificity  (Liu et  al. 2004).  E. coli glucose-1-
phosphatase (G1Pase), a branch 2 HAP, is structurally very similar to E. coli phytase, but 
has the RHG part of the first catalytic motif replaced by RHN. As the name suggests, E. 
coli  G1Pase hydrolyses glucose-1-phosphate, but it also shows activity towards phytate, 
glucose-6-phosphate, fructose-1-phosphate and ribose-5-phosphate  (Cottrill et al. 2002). 
However,  E.  coli G1Pase  can  only  remove  one  phosphate  from  InsP6 to  form 
Ins(1,2,4,5,6)P5,  while  E. coli  phytase can sequentially remove phosphates to produce 
InsP2 (Greiner et al. 2001).
Multiple  inositol  polyphosphate  phosphatase  1  (Minpp1),  initially  known  as 
inositol (1,2,4,5)-tetrakisphosphate 3-phosphatase  (Nogimori et al. 1991), is a branch 2 
HAP found in human, rat (Caffrey et al. 1999) and mouse (Chi et al. 2000). A homologue 
of the enzyme was also found in chicken, where it was annotated as HiPER1 (Histidine 
Phosphatase  of  the  Endoplasmic  Reticulum-1)  (Romano et  al. 1998).  Homologues  of 
Minpp1 have also appeared in various genome projects for eukaryotes, including many 
animals and plants, as well as slime mould  (Eichinger et  al. 2005).  The expression of 
Minpp1 is up-regulated during chondrocyte hypertrophy, and since InsP6 inhibits calcium 
phosphate crystal growth, it has been proposed that Minpp1 aids bone mineralization by 
increasing  InsP6 hydrolysis  (Caffrey et  al. 1999).  Its  in  vivo activity  as  an  inositol 
phosphate phosphatase is sometimes questioned because it is compartmentalized in the 
endoplasmic  reticulum,  where  no  inositol  polyphosphates  are  found  (Ali et  al. 1993). 
However, with the recent discovery of ABC transporters in plants that bind to InsP6, it is 
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possible that inositol polyphosphates may not be exclusively cytosolic after all  (Nagy et  
al. 2009).
Minpp1 has also been shown to display activity towards 2,3-bisphosphoglycerate 
(2,3-BPG)  as  substrate,  removing  the  phosphate  at  the  3-position  (Cho et  al. 2008). 
Minpp1 is also found in erythrocytes, and as 2,3-BPG aids oxygen release by decreasing 
haemoglobin  oxygen  affinity,  Minpp1  is  suggested  to  act  as  an  oxygen  regulator  in 
animals  (Cho et  al. 2008).  Because  of  the  activity  towards  2,3-BPG,  Minpp1 is  also 
suggested to be responsible for an alternative pathway for glycolysis, as shown in Figure 
1.2.1.4.  Interestingly,  although  the  Minpp1s  share  the  RHGXRXP motif  in  branch  2 
histidine phosphatases, the HD substrate binding/leaving motif is replaced by HA. So far, 
no structures of Minpp1 have been reported.
Figure  1.2.1.3.  Alternative  pathway  for glycolysis  with  Minpp1  and  2,3-BPG. The  upper 
pathway shows the relevant part of the original pathway, and the alternative pathway suggested by 
(Cho et al. 2008) is shown.
Other branch 2 histidine phosphatases include prostatic acid phosphatases (PAP) 
and  the  Francisella  tularensis HAP.  Human  prostatic  acid  phosphatase  has  attracted 
significant medical interest since serum PAP levels were previously used to diagnose and 
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stage prostate cancer (though recently has been replaced by prostate specific antigen test). 
It has surprisingly also been found in breast cancer (Ortlund et al. 2003). It has activities 
towards alkyl, aryl, and orthophosphate monoesters as well  as phosphotyrosyl proteins 
(Apostoł et al. 1985). So far, no studies has been carried out on its activity towards inositol 
polyphosphates.  Francisella  tularensis is  a  highly  infectious  intracellular  bacterial 
pathogen that causes the potentially fatal disease tularemia (Oyston et al. 2004). Deletion 
of acpA, acpB, acpC, and hap (the gene encoding HAP) in Francisella novicida decreases 
the virulence and intra-macrophage survival rate, suggesting that HAP is responsible for 
the  virulence  and  survival  of  the  Francisella  spp  (Mohapatra et  al. 2008).  Better 
understanding of the histidine phosphatase superfamily would provide insight to cancer 
diagnostic and bioterrorism prevention.
1.2.2 Protein tyrosine phosphatase (PTP)-like phytases
Protein  tyrosine  phosphatase  (PTP)-like  phytases  are  usually  found  in  the  gut 
bacteria of ruminant animals (Nakashima et al. 2007), and more recently in Bdellovibrio 
bacteriovorus, a parasitic bacterium that preys on other bacteria (Gruninger et al. 2014). 
As  the  name  suggests,  PTP-like  phytases  share  homology  with  protein  tyrosine 
phosphatases, which are usually enzymes associated with virulence of pathogens, such as 
Yersinia (Bliska et al. 1991) and Salmonella (Fu et al. 1998). The first structure of a PTP-
like  phytase from  Selenomonas ruminantium was  solved in  2004,  and is  annotated as 
PhyAsr (PhyA from Selenomonas ruminantium) (Chu et al. 2004). The structure deposited 
in the PDB is of the enzyme complexed with inositol  hexasulfate  (InsS6),  a  mimic of 
phytate, suggesting two binding pockets with a processive phytate degradation mechanism 
and a preference towards the hydrolysis of the 5-phosphate (Chu et al. 2004). However, a 
later paper suggested otherwise, with a distributive mechanism involving a single active 
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site and a preference towards the hydrolysis of the 3-phosphate (Puhl et al. 2007).
As shown in  figure 1.2.2.1, the overall structure of PhyAsr consists of a major 
“sandwich” domain surrounded by mainly alpha helices (Chu et al. 2004). Located in the 
core of the structure is the catalytic site with the motif HCX5R, which is responsible for 
phosphate binding, and is referred to as the P-loop. The P-loop can be observed in an open 
(ligand  free)  or  closed  (ligand  bound)  conformations  (Chu et  al. 2004),  which  also 
corresponds to inactive and active conformations (Puhl et al. 2007).  
Figure 1.2.2.1. Overall structure of PhyAsr in cartoon representation. The enzyme consists of 
a major domain with a five-stranded beta-sheet sandwiched by helices, and a minor domain near  
the C-terminal end which consists mainly of alpha helices. The catalytic motif, the P-loop is shown 
as red sticks. PDB code: 1U24 (Chu et al. 2004).
1.2.3 β-propeller phytases
β-propeller phytases (BPPs) have a β-propeller fold, a fold shared by proteins with 
a diverse set of functions (Chen et al. 2011). The BBPs are shown to be more thermostable 
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than the HAP phytases, a characteristic which would potentially render them more useful 
in  animal  feed  applications  (Ha et  al. 2000).  They  are  also  referred  to  as  “tartrate-
resistant” acid phosphatases, as opposed to HAPs which are inhibited by tartrate (Shin et  
al. 2001). The crystal structure of a BPP from Bacillus amyloliquefaciens has been solved 
(referred  to  in  the  literature  as  TS-Phy,  thermostable  Phytase) (Ha et  al. 2000).  The 
phosphate-bound TS-Phy (figure 1.2.3.1) consists of 6 'propeller blades', made of 5 four-
stranded and 1 five-stranded anti-parallel beta-sheets (Shin et al. 2001).
Figure 1.2.3.1. Cartoon representation of B. amyloliquefaciens BBP. Beta sheets are coloured 
in magenta, helices in cyan, and loops in salmon. Phosphates and calcium ions are bound, and they  
are shown as orange sticks and green spheres, respectively. PDB code: 1H6L (Shin et al. 2001).
A total of seven calcium ions are found in the active site of TS-Phy. Three of these 
bind to the enzyme with high affinity and are required for thermostability. Two of the high 
affinity calcium ions are found in the peripheral region holding together three separate 
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regions of polypeptide, and the last is found in the centre forming a bridge between blades 
both directly through bonding and indirectly through coordinating the water molecules 
(Ha et al. 2000). Another three calcium ions bind to the enzyme with low affinity at the 
active site, coordinating the amino acid side chains, and are required for activity (Ha et al. 
2000). The binding of the last calcium ion is induced by the binding of phosphates in the 
active site (Shin et al. 2001). A more recent study reporting the crystal structure of a BBP 
from  Bacillus  subtilis had  identified  an  eighth  calcium  ion  which  was  previously 
unobserved, and the calcium ion was reported to be essential to the activity by involving a 
hydrogen bond that interacts with a sulfate group in InsS6 (an analogue of InsP6) (Zeng et  
al. 2011).
Two  phosphate  binding  sites  are  present  in  the  active  site  of  TS-Phy,  and  a 
mechanism was proposed where one of them is designated the “cleavage site” and the 
other one the “affinity site”. The enzyme affinity for substrate is much higher when both 
sites are filled, thus TS-Phy preferentially hydrolyzes every second phosphate from InsP6, 
producing Ins(1,3,5)P3 and  Ins(2,4,6)P3 (lower  InsPs  are  produced  over  a  longer  time 
frame) (Shin et al. 2001). 
1.2.4 Purple acid phosphates (PAP) phytases
Purple acid phosphatases are so called because of the colour of its oxidized form 
which results from tyrosine to iron(III) charge transfer (Olczak et al. 2003). PAP phytases 
have been identified in various plants  (Dionisio et al. 2011). A catalytic mechanism has 
been proposed in which an iron(III) ion and a zinc(II) ion are involved in stabilizing a 
penta co-ordinated phosphorous in the transition state (Klabunde et al. 1996). However, no 
structures of PAPs annotated as phytases are present in the PDB.
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1.2.5 Inositol polyphosphate 5-phosphatase
Inositol polyphosphate 5-phosphatases (INPP5s) are a family of Mg2+-dependent 
phosphoesterases  that  are  implicated  in  phosphoinositide  signalling  pathways.  They 
remove the 5-phosphates from the inositol ring of various water-soluble and lipid-bound 
second messengers, such as Ins(1,4,5)P3. Ins(1,3,4,5)P4, PtdIns(4,5)P2, PtdIns(3,4,5)P3 and 
PtdIns(3,5)P2 (Whisstock et  al. 2002).  All  known INPP5s  share  a  conserved  catalytic 
domain,  and  the  crystal  structure  of  INPP5  catalytic  domain  (INPP5C)  from 
Schizosaccharomyces pombe (fission yeast) has been solved, both in its apo form and in 
complex with Ins(1,4)P2 (Tsujishita et al. 2001). The overall structure of INPP5C is shown 
in figure 1.2.5.1, with two beta-sheets flanked by alpha helices, and the N and C termini 
helices extending away from the rest of the domain.
Figure 1.2.5.1. Overall structure of InsP2 complexed INPP5C in cartoon representation. Two 
β-sheets are in the centre of the structure, consisting of mainly anti-parallel strands, with helices  
flanked around them. The N and C termini are found on α helices extending away from the core. 
InsP2 is shown in ball and stick representation. PDB code: 1I9Z (Tsujishita et al. 2001).
INPP5C  shows  homology  with  apurinic/apyrimidinic  (AP)  endonucleases, 
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enzymes  responsible  for  DNA repair  by  creating  a  nick  at  mismatched  nucleotides 
(Tsujishita et al. 2001). There are two characteristic conserved motifs within the catalytic 
domains found in INPP5s, GDXNXR and PXWXDR (Whisstock et al. 2002). A catalytic 
mechanism for INPP5 based on that of AP endonuclease has been proposed, in which the 
phospho group of a substrate is held in the catalytic pocket by a histidine, an asparagine 
and a magnesium ion held further by acidic residues, and nucleophilic attack is initiated by 
an aspartate residue through a water molecule to the phosphorous on the phospho group. 
This forms a pentacovalent transition state stabilized by the magnesium ion, followed by 
cleavage  achieved  via  inversion  of  configuration,  generating  the  inositol  containing 
leaving group (Whisstock et al. 2002).
There are two SH2 domain-containing inositol 5-phosphatase (SHIP) homologues, 
SHIP1  and  SHIP2.  SHIP1  comprises  the  INPP5  catalytic  domain,  an  N-terminal  src 
homology-2  (SH2)  and  a  proline-rich  C-terminal  domain.  SHIP2,  on  the  other  hand, 
consists of an extra ubiquitin interacting motif and a sterile alpha motif (SAM) at the C-
terminal  to  the  proline-rich  region  (Erneux et  al. 2011).  Their  main  substrate  is 
PtsIns(3,4,5)P3, which they down-regulate to produce PtsIns(3,4)P2 (Blero et al. 2007). It 
had been shown that SHIP1 is only expressed in the haematopoietic system, and is crucial 
to negatively control growth factor-mediated protein kinase B (PKB) and myeloid cell 
survival  (Liu et al. 1999).  SHIP2 is expressed in a wide range of tissues, and acts as a 
negative regulator for insulin signalling sensitivity (Clément et al. 2001), with its absence 
confers resistance to dietary obesity as well as perturbed facial structure to mice (Sleeman 
et al. 2005). SHIP2 is also reported to attenuate fibroblast growth factor (FGF) signalling 
in mammals (Jurynec et al. 2010), and it has been suggested that SHIP2 plays a bigger 
role than in the inositide signalling pathway with its non-catalytic properties (Erneux et al. 
2011).
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1.3 Inositol phosphate kinases
As  mentioned  previously,  inositol  phosphate  kinases  (sometimes  inositol 
polyphosphate kinases or just inositol kinases) generate higher InsPs from InsP3, which is 
formed  from the  breakdown of  PtdInsP(4,5)2 by  phospholipase  C  (Tsui et  al. 2010). 
Kinases,  alternatively  known  as  phosphotransferases,  are  enzymes  that  phosphorylate 
substrates. As the name phospho-transferase suggests, the phosphate has to be transferred 
from high energy doner molecules such as ATP (Manning et al. 2002).
1.3.1 Inositol 1,4,5-trisphosphate 3-kinase (IP3K)
Mammalian  inositol  1,4,5-trisphosphate  3-kinase  (IP3K)  phosphorylates 
Ins(1,4,5)P3  at the 3 position to produce Ins(1,3,4,5)P4. There are three isoforms, IP3KA, 
which is expressed exclusively in the brain and testis, IP3KB, which is expressed in the 
brain, heart, lung, testis and thymus, and IP3KC, which has a more general tissue protein 
distribution (Chamberlain et al. 2005). The structures of the catalytic cores of IP3KA from 
human  (González et  al. 2004)  and  rat (Miller et  al. 2004), IP3KB  from  mouse 
(Chamberlain et  al. 2005),  and IP3KC from human (Structural Genomics Consortium) 
have been solved by X-ray crystallography. They do not share sequence homology with 
kinases  of  known structure  but  they  do  share  similarity  in  tertiary  structure  with  the 
protein kinase superfamily (Miller et al. 2004). The IP3K catalytic core consists of three 
subdomains, as shown in figure 1.3.1.1. The N-terminal  α/β subdomain is referred to as 
the N-lobe, the C-terminal α/β subdomain is referred to as the C-lobe, and a long insertion 
in the C-lobe forms a α-helix only subdomain IP-binding lobe (González et  al. 2004). 
Regions of polypetide from the N-lobe and C-lobe (which contains the highly conserved 
GSSLL and IDFG motifs)  form a hydrophobic pocket  for  the binding of  adenine and 
ribose from ATP, and regions of polypetide from IP-lobe forms the binding pocket for InsP 
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substrate (González et al. 2004).
Figure  1.3.1.1. Overall  structure  of  human  IP3KA  catalytic  domain  in  cartoon 
representation. The structure comprises of the subdomains N-lobe (cyan), C-lobe (green) and IP-
lobe (magenta). AMPNP (blue sticks), InsP3 (red sticks) and Mn ion (metallic grey sphere) are 
bound. PDB code: 1W2C (González et al. 2004).
1.3.2 Inositol phosphate multikinase (IPMK)
Inositol  phosphate  multikinase  (IPMK),  alternatively  named  Ipk2,  can 
phosphorylate a number of inositol polyphosphate substrates. 6-, 3- and 5-kinase activity 
had been reported for this class of enzyme, and crystal structure had been solved for IPMK 
from yeast (Holmes et al. 2006) and Arabidopsis thaliana (Endo-Streeter et al. 2012). The 
overall  fold of IPMK is similar to that of human IP3K, but there is a huge region of 
insertion in IP3K relative to IPMK, which rationalises IP3K's greater substrate selectivity 
(Endo-Streeter et al. 2012). It also shares the conserved SSLL and IDF motifs, where the 
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leucine from the SSLL motif and the isoleucine from the IDF motif contributes to the ATP 
binding activity of the enzyme (Holmes et al. 2006).
1.3.3 Inositol 1,3,4,5,6-pentakisphosphate 2-kinase (IP5K)
Inositol 1,3,4,5,6-pentakisphosphate 2-kinase (IP5K), alternatively known as Ipk1, 
is  the  only  InsP kinase  that  phosphorylates  the  axial  hydroxyl  group,  rather  than  the 
equatorial  hydroxyl  group(s),  of  the  myo-inositol  ring.  The  crystal  structure  of 
Arabidopsis thaliana IP5K has been solved at high resolution, and although it still shares 
structural homology with other IP kinases, it is the most divergent in the group (González 
et al. 2010). Like IP3K and IPMK, IP5K consists of the subdomains N-lobe and C-lobe, 
but instead of a small IP-lobe embedded at the beginning of the C-lobe, a much larger 
inositol binding domain is present in IP5K, which is embedded throughout the C-lobe, as 
shown in  figure 1.3.3.1 (González et al. 2010). IP5K does not have the SSLL and IDF 
ATP binding motifs, instead possessing a DCSIMI and IDL(D/S)L(K/R)P motifs at the 
corresponding regions (González et al. 2010).
Figure 1.3.3.1. Simplified schematic domain representation of InsP kinases. IPMKs contain a 
smaller IP-lobe compared to IP3Ks, and IP5Ks contain a completely different CIP-lobe. Adapted 
from González et al. 2010. Not drawn to scale.
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1.3.4 Inositol 1,3,4-trisphosphate 5/6-kinase (ITPK1 Or IP56K)
Inositol 1,3,4-trisphosphate 5/6-kinase (ITPK1 or IP56K) is a unique InsP kinase 
because,  other  than  acting  as  a  5/6  kinase  on  Ins(1,3,4)P3,  it  can  also  reversibly 
phosphorylate and dephosphorylate Ins(3,4,5,6)P4 and Ins(1,3,4,5,6)P5, respectively (Ho et  
al. 1997).  There are structures available for  Entamoeba histolytica ITPK1  (Miller et al. 
2005) and human ITPK1 (Chamberlain et al. 2007). The structures of ITPK1s are different 
to those of the other IP kinases (Miller et al. 2005). The ITPK1 structures consist of three 
domains,  an  N-terminal  domain,  a  central  domain  and a  C-terminal  domain,  together 
surrounding an ATP binding cleft.  ITPK1 shares structural homology to the ATP-grasp 
domain family rather than to the other protein kinases (Miller et al. 2005). For ITPK1s in 
higher  organisms  such  as  humans,  Ins(1,3,4)P3  act  as  a  stimulator,  rather  than  a 
competitive  inhibitor  of  the  dephosphorylation  of  Ins(1,3,4,5,6)P5.  It  was  found  that 
Ins(1,3,4,5,6)P5 transfers its phosphate to ADP, which in turn transfers the phosphate to 
Ins(1,3,4)P3. Mutagenesis confirmed that His-162 in the hITPK1 structure is responsible 
for this intersubstrate phosphate transfer (Chamberlain et al. 2007).
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1.4 Aims of this work
The aim of this work is to study the structure-function relationships of multiple 
inositol  phosphate  phosphatases  (Minpp),  a  member  of  the  histidine  acid  phosphatase 
(HAP) family, produced by commensal gut bacteria. Previously reported Minpp proteins 
are of eukaryotic origin, and are expressed in highly differentiated cells. Minpps found in 
commensal gut bacteria are generally referred to as 'phytases' (Haefner et al. 2005; Steer 
et al. 2004; Tamayo-Ramos et al. 2012), but they are more closely related to eukaryotic 
Minpp than to other bacterial phytases (see later chapters).
In this study, the structures of bacterial Minpps were characterised through X-ray 
crystallography.  Enzymological  characterization  of  the  Minpps  was  peformed  with 
reaction products separated by high performance liquid chromatography (HPLC). Using 
structural insights gained from X-ray crystallography, site-directed mutagenesis  (SDM) 
were employed to better understand the catalytic properties of Minpp and related enzymes. 
Since  phytases  have  industrial  uses,  attempted  had  been  made  to  increase  the 
thermostability of Minpp via introduction of disulfide bridges. In addition, attempts were 
made towards the crystallization and structure determination of InsP kinases in the hope of 
shedding more light on the structure function relationships of these intriguing enzymes.
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Chapter 2. The X-ray Crystal Structure of a Minpp from a 
Major Human Commensal Bacterium, B. 
thetaiotaomicron
The human gut microbiota has many essential roles in the metabolism of the host 
and interactions  between microbes and the host  are  linked to  development  of  obesity, 
cardiovascular  disease  and  metabolic  syndromes  (Tremaroli et  al. 2012).  Bacteroides  
thetaiotaomicron is a gram-negative anaerobic bacteria and a member of the human gut 
microbiota. It produces  multiple inositol polyphosphate phosphatase (Minpp)  (Xu et al. 
2003),  an  enzyme  found  in  animal,  plants  and  bacteria  with  the  ability  to  hydrolyse 
inositol polyphosphate metabolites (Chi et al. 1999). 
Substantial amount of InsP6 are ingested regularly by humans, as it is the primary 
storage  form of  phosphorus,  inositol  and  minerals  in  plants  (Raboy  2003).  However, 
humans and other monogastric animals lack enzymes to break down InsP6, and instead 
rely on microbes that produce phosphatases in the gut (Haros et al. 2007). Though InsP6 is 
traditionally  viewed as  an  anti-nutrient  due  to  its  ability  to  chelate  essential  minerals 
(Schlemmer et al. 2009), it is also shown to be involved in cellular processes such as DNA 
repairing  (Hanakahi et al. 2000), RNA editing  (Macbeth et al. 2005) and mRNA export 
(York et al. 1999). Therefore, it had been suggested that the regulation of InsP6 level by 
microbes in the gut such as Bacteroides thetaiotaomicron via BtMinpp may have effects to 
the health of the host (Stentz et al. 2014).
This chapter reports the production of recombinant BtMinpp, and presents a high 
resolution crystal structure of the protein and its substrate analogue-bound form.
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2.1 Experimental
2.1.1 Bacterial strains, plasmids, media and over-expression
E. coli strain BL21-(DE3)-RIL (Stratagene) was used as the expression host. This 
strain contains extra copies of genes to encode tRNA that recognize uncommon codons in 
E.  coli  (in  a  plasmid  that  confers  chloramphenicol  resistance).  Bacteroides 
thetaiotaomicron Minpp gene, cloned into pET-15b vector into NdeI-BamHI subcloning 
sites,  was  provided  by  Dr.  Regis  Stentz  (Institute  of  Food  Research,  Norwich).  A 
schematic vector map is shown as figure 2.1.1.1. The DNA sequence translating into the 
first 20 amino acids at the N-terminal region of BtMinpp gene, predicted as signal peptide 
by  SignalP 3.0  Server  (Emanuelsson et  al. 2007),  was  excluded  from the  expression 
construct.  The bacterium was grown on LB medium with ampicillin  (100 μg/ml)  and 
chloramphenicol (30 μg/ml). The cells containing the plasmid were selected by growing 
overnight  at  37 °C on LB agar  plate  containing the appropriate  antibiotics.  Overnight 
culture grown from a single colony was used to inoculate 250 ml of media at 30 °C with 
shaking until an OD600 of 0.6. Over-expression was induced by adding isopropyl β-D-1-
thiogalactopyranoside (IPTG) to a final concentration of 0.5 mM. The induced culture was 
left to grow overnight to an OD600 of 2.5. The cells were harvested by centrifugation at 
6000 rpm at 4 °C for 15 minutes. The supernatant was removed and the cells were frozen 
at -80 °C to aid lysis.
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Figure 2.1.1.1. Schematic of the pET-15b vector used to produce recombinant BtMinpp. The 
recombinant  BtMinpp gene fragment was cloned using the NdeI/BamHI restriction sites. The T7 
promoter and lac operator are present  for over-expression of the protein,  and the AmpR gene 
confers ampicillin resistance for selection purposes.
2.1.2 Purification of BtMinpp
Lysozyme (final concentration 1 mg/ml) and Benzonase (1 unit/ml of culture) was 
added to the lysis buffer (50 mM Tris-HCl or NaH2PO4 pH 8, 300 mM NaCl, 10 mM 
imidazole), and used to re-suspend the cells. The cell suspension was then incubated on 
ice for 30 minutes, with gently swirling. The cell debris was then centrifuged at 14,000 x g 
for 30 minutes at 4°C. The supernatant was loaded onto a gravity-flow chromatographic 
column containing 0.5 ml of Ni-NTA resin (GE healthcare). The resin was washed with 
wash buffer (50 mM Tris-HCl or NaH2PO4 pH 8, 300 mM NaCl, 20 mM imidazole) and 
the protein eluted with elution buffer (50 mM Tris-HCl or NaH2PO4 pH 8, 300 mM NaCl, 
250 mM imidazole). The sample was then exchanged with the GF buffer (25 mM Tris-HCl 
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pH 7.2, 150 mM NaCl, 2 mM DTT) using a PD-10 desalting column (GE Healthcare).
Prior to crystallization, recombinant BtMinpp was purified by gel filtration using a 
HiLoad™ 16/60 Superdex 75 gel  filtration  column (GE Healthcare)  equilibrated  with 
buffer (10 mM Tris-HCl pH 7.4, 150 mM NaCl, 2mM DTT), using an ÄKTAprime liquid 
chromatography system (GE Healthcare). The purity of the protein was assessed by SDS-
PAGE. The final concentration of the sample was estimated by measuring its A280nm using a 
Nanodrop ND-1000 Spectrophotometer (Thermo Scientific). Recombinant BtMinpp has a 
theoretical extinction coefficient (ε)  of 76445 M-1 cm-1 as  calculated using the method 
described by (Gill et al. 1989).
2.1.3 Preparation of a Selenomethionyl Derivative
To solve  the  phase  problem using  the  single-wavelength  anomalous  dispersion 
(SAD) method, a selenomethionyl derivative of Minpp was provided by Dr. Regis Stentz 
(Institute of Food Research, Norwich). The methodology used was based on that published 
by  (Ramakrishnan et al. 1993).  The plasmid expression construct was transformed into 
methionine requiring auxotrophic E. coli strain B834 (DE3). Pelleted cells from overnight 
culture were washed with SelenoMet medium (Molecular Dimensions), which is based on 
a synthetic M9 minimal media supplemented with glucose, vitamins and amino acids with 
the exception of L-methionine. The cells were re-suspended with 1 ml of the SelenoMet 
medium, and used to inoculated one litre of minimal media containing L-SeMet at 30 °C. 
The cells were grown to an OD600 of 0.6, and over-expression was induced by adding 
IPTG to a final concentration of 0.5 mM. Growth was continued for further 16 hours at 30 
°C before the cells were harvested. Purification of the selenomethyl derivative proceeded 
as described above for the wild type enzyme.
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2.1.4 Crystallization, Cryoprotection and X-ray Data Collection
Initial crystallization screening experiments using the sitting drop vapour diffusion 
technique were carried out  at  both 4 °C and 16 °C with Structure Screens™ 1 and 2 
(Jancarik et  al. 1991),  the  JCSG-plus Screen  (Page et  al. 2003), the  Stura  FootPrint 
Screens  (Stura et  al. 1992) from Molecular Dimensions and the PEG/Ion Screen from 
Hampton Research. The experiments were set using an OryxNano protein crystallization 
robot (Douglas Instruments Ltd) employing 0.5-1.0 μl droplets containing equal volumes 
of concentrated protein and screen solution, with 50 μl of screen solution in each well.  
Crystals grew in a variety of conditions. Optimizations were carried out for conditions 
containing ammonium acetate buffer with PEG 3350 as precipitant (see  section 2.2.2), 
using  sitting  drop  vapour  diffusion  techniques.  Single  crystals  from  both  the  initial 
crystallization  experiments  and optimizations  were  harvested  using  either  a  CryoLoop 
(Hampton Research) or a LithoLoop (Molecular Dimensions) at 4 °C. The crystals were 
soaked in solutions containing mother liquor and 25 % (v/v) ethylene glycol prior to being 
stored in liquid nitrogen.
X-ray diffraction experiments were carried out on the beamlines I02 and I24 at the 
Diamond Light Source (Didcot,  Oxfordshire) using a ADSC Q315 CCD detector with 
Rigaku ACTOR sample changer. The X-ray beam was operated at an energy of 12.658 
keV (0.979 Å) for wild-type protein and 12.653  keV (0.9799 Å) for SeMet derivative, 
being the methionine K-edge.
2.1.5 Data processing and refinement
The indexing and data processing were performed using iMosflm (Battye et al. 
2011), and the data sets were scaled using SCALA (Evans 2006). SAD phasing proceeded 
using the SeMet dataset, with heavy metal sites found using SHELX (Sheldrick 2008). 
33
Buccaneer  (Cowtan  2006)  was  used  to  trace  the  amino  acid  chains.  Using  the  low 
resolution SeMet BtMinpp model as a search copy, molecular replacement was carried out 
with MOLREP (Vagin et al. 2010) on the other datasets. Alternate rounds of automatic and 
manual refinement were performed with Refmac (Vagin et al. 2004) and Coot (Emsley et  
al. 2010).
PISA (Krissinel et al. 2007) was employed to calculate the total solvent-accessible 
and buried surface area of the protein in the asymmetric unit.
2.1.6 Comparing the Structure of BtMinpp With Structures of 
Other Branch 2 HAPs
MUSTANG (Konagurthu et al. 2006) was used to align a representative subset of 
branch 2 histidine acid phosphatase (HAP) structures (Rigden 2008) with the solved and 
refined structure of  BtMinpp. Using the structure based sequence alignment generated, 
Jalview (Waterhouse et al. 2009) produced a phylogram base on average distance and the 
BLOSUM 62 matrix. The structures and PDB codes of the representative subset of branch 
2 HAPs used in the alignment are as follows: human prostatic acid phosphatase (1CVI) 
(LaCount et  al. 1998),  Escherichia  coli phytase  AppA (1DKL)  (Lim et  al. 2000), 
Escherichia  coli glucose-1-phosphatase  (1NT4)  (Lee et  al. 2003),  Aspergillus  niger 
phytase  PhyB (1QFX)  (Kostrewa et  al. 1999),  rat  prostatic  acid  phosphatase  (1RPA) 
(Lindqvist et  al. 1993),  Aspergillus fumigatus phytase PhyA (1SK8) (Liu et  al. 2004), 
Debaryomyces  castellii phytase  (2GFI)  (Ragon et  al. 2009),  Francisella  tularensis 
histidine acid phosphatase (3IT1) (Singh et  al. 2009),  Aspergillus niger phytase PhyA 
(3K4Q) (Oakley 2010) and Hafnia Alvei phytase (4ARO) (Ariza et al. 2013).
2.1.7 Enzymatic Properties
Phytase activity was detected using the PiColorLock Gold Phosphate Detection 
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System (Innova Biosciences) by measuring the increase in free inorganic phosphate. The 
presence  of  phospho-molybdate  complex  induces  a  change  in  absorbance  of  the  dye 
malachite green, which allows the dephosphorylation rate to determined.
To produce the pH profile, the PiColorLock Gold Phosphate Detection assay was 
performed in a variety of buffers at a range of pH values: pH 2.0 – pH 3.5 50 mM glycine-
HCl; pH 4.0 – pH 5.5 50 mM sodium acetate; pH 6.0 – pH 8.0 50 mM HEPES-NaOH. 
Varying concentrations of  BtMinpp were incubated with 50μM InsP6(Sigma) at 30°C to 
obtain  free  phosphate  within  the  detectable  range,  and  the  result  was  normalised  to 
account for the enzyme concentration used at each pH. 
To determine the kinetic parameters (Km, kcat) of the enzyme at pH 2.5 and pH 7.5, 
40.8  pM  and  1.02  nM  of  BtMinpp,  respectively,  were  incubated  with  varying 
concentrations of InsP6(Sigma) at 30°C. Experiments were done in triplicate, and samples 
were taken at 5 minutes interval to obtain initial rates. Non-linear regression analysis was 
used to estimate was used to estimate the kinetic parameters.
To investigate the effect of inhibition by citrate, 102 pM of BtMinpp was incubated 
for 10 minutes in 100 mM glycine HCl pH 3.0 with 50μM InsP6(Sigma) and 0.2 – 10 mM 
sodium citrate at 30°C. The experiment was carried out in triplicate.
2.1.8 Preparation of substrate analogue-bound crystal structure 
In order to determine the substrate analogue-bound structure, a crystal of BtMinpp 
grown in 0.2M ammonium acetate pH 5.0, and 20% PEG 3350 was soaked in a solution 
containing mother liquor, 1 mM myo-inositol hexasulfate hexapotassium salt, and 25 % 
ethylene glycol prior being stored in liquid nitrogen. The data collection, processing and 
refinement were the same as described for the native dataset.
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2.1.9 Preparation of inhibitor-bound crystal structure
A BtMinpp crystal was grown in imidazole DL-malate buffer pH 6.0, and  15% 
(w/v)  PEG 4000 for the malate-bound structure,  and a  BtMinpp crystal  was grown in 
imidazole L-(+)-tartrate buffer pH 6.0, and  15% (w/v)  PEG 4000 for the tartrate-bound 
structure.  The  crystals  were  soaked  in  a  solution  containing  mother  liquor  and  25% 
ethylene glycol prior to being stored in liquid nitrogen. The data collection, processing and 
refinement were the same as described for the native dataset.
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2.2 Results and Discussion
2.2.1 Over-expression and Purification of Recombinant BtMinpp
BtMinpp  was  over-expressed  and  purified  as  discussed  in  section  2.1.2.  After 
nickel affinity chromatography, yields of 11 mg per litre and 3 mg per litre were achieved 
for the native protein and selenomethionyl derivative, respectively. Use of a previously 
calibrated HiLoad 16/60 Superdex 75 gel filtration column indicated that purified product 
is a ~45 kDa protein, corresponding to the molecular weight of a monomer (the predicted 
molecular weight of the recombinant  BtMinpp is 49 kDa). The majority of the purified 
protein appeared as a single band in SDS-PAGE experiment, as shown in figure 2.2.1.1.
Figure 2.2.1.1.  10% acrylamide reducing SDS-PAGE for the purification of  recombinant 
BtMinpp. Lane MW is the molecular weight marker; lane 1 is the supernatant after lysis; lane 2 is  
the  elute  from loading  sample onto Ni-NTA column;  lane 3  is  the  first  wash  of  the  Ni-NTA 
column; lane 4 is the second wash of the Ni-NTA column; lane 5 is the purified product from Ni-
NTA column; lane 6 is the sample desalted using PD-10 column; lane 7 is the sample injected onto 
gel filtration column; lane 8 is the concentrated protein employed in crystallization experiments.
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2.2.2 X-ray Crystal Structure of BtMinpp
Crystals grew in a variety of conditions, in a variety of sizes, in space group P21. 
Figure 2.2.2.1 shows an image of a BtMinpp crystal, obtained by vapour diffusion using a 
1:1 mixture of 1.0 – 1.5 mg mL-1 BtMinpp and a mother liquor of 200 mM ammonium 
acetate buffer pH 5.0, 18% (w/v) PEG 3350, which gives the dataset for the P i-complexed 
BtMinpp structure.
Figure 2.2.2.1. Image showing the crystal of BtMinpp used for X-ray data collection.
The  structure  of  the  selenomethionyl  BtMinpp  derivative  was  solved  by  SAD 
phasing, which was then used for molecular replacement on the other datasets. The final 
model of the Pi complex solved at 1.93 Å was refined to R-work and R-free values of 16.6 
% and 21.3 %, respectively,  with 2 residues (0.25 %) in  the disallowed region of the 
Ramachadran plot. 
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Table 2.2.2.1. Data collection and refinement statistics for SAD data and Pi complex.
SAD data Pi complex
Data collection
Wavelength (Å) 0.9799 0.9778
Space group P 21 P 21 
Cell parameters
a , b , c (Å)
β (°)
53.1, 121.0, 76.0
107.8
52.7, 120.6, 76.1
107.9
Resolution limit (Å) 50.00 – 2.50 (2.64 – 2.50) 62.07 – 1.93 (1.98 – 1.93) 
Rmerge 0.098 (0.265) 0.048 (0.473)
(I)/sd(I) 16.4 (7.3) 12.6 (2.1)
Completeness (%) 100.0 (100.0) 97.1 (97.0)
Multiplicity 7.4 (7.5) 2.3 (2.4)
Anomalous completeness (%) 99.9 (100.0) -
Anomalous multiplicity 3.8 (3.8) -
Overall temperature factor (Å2) 26.0
Refinement Statistics
Protein monomers per asymmetric unit 2
Total atoms 7194
Water molecules 451
Rwork 16.6%
Rfree 21.3%
Ramachandran Analysis (%)
Most favoured
Outliers
97.58 
0.25 
RMS deviations
Bonds (Å)
Angles (°)
Planes (Å)
0.007
0.976
0.005
Mean Atomic B-value (Å2) 24.2
*Statistics for data in the high resolution bin are in brackets.
Rmerge = Σ | Ii - <I> | / Σ Ii where <I> is the average of symmetry equivalent reflections and the 
summation extends over all observations for all unique reflections.
Rwork = Σ | |Fo| - |Fc| | / Σ | Fo| where Fo and Fc are the measured and calculated structure factors, 
respectively.
For Rfree the summations extends over a randomly selected subset (5%) of reflections excluded 
from all stages of refinement.
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Two  monomers  are  present  in  the  asymmetric  unit.  The  overall  structure  of 
BtMinpp consists of two domains, an α/β domain and an α-helices domain, as shown in 
figure 2.2.2.2. At the catalytic core of each protein monomer bounded a single phosphate, 
presumably  scavenged  during  bacterial  growth  or  early  stages  of  purification,  thus 
showing an enzyme-product complex.  BtMinpp appears as a monomer in the reducing 
conditions of gel filtration and SDS-PAGE (see section 2.2.1), but a pair of cysteines are 
found in close proximity at the dimer interface (Cys344 and Cys396 from chain A with 
Cys396 and Cys344 from chain B, respectively). This suggests that cystines may form 
under  oxidising  conditions,  resulting  in  dimerization  of  the  recombinant  protein.  The 
assembly has a total solvent-accessible surface area of 33841.5  Å2 and a buried surface 
area of 2107.7 Å2.
Figure 2.2.2.2. Cartoon representation of phosphate-complexed BtMinpp. Figure shows an α/β 
domain on top (blue) and an α-helices domain (red) at the bottom. The bound phosphate group is  
shown as yellow spheres.
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The disallowed residues from the Ramachadran plot  comprised of Ala322,  one 
from each monomer. Ala322 preceded the HAE proton donor motif and the oxygen atom 
in its carbonyl group was in close proximity with the amide group of catalytic His59, thus 
indicating the formation of of hydrogen bond between the two residues. Therefore, Ala322 
was slightly restrained (thus falling out of the allowed region of the Ramachadran plot) to 
preserve the integrity of the active site.
 When  compared  against  sequences  of  protein  with  known  structure,  BtMinpp 
shares sequence homology with the fungal phytases in branch 2 of the HAP superfamily. 
Using BLAST (Altschul et al. 1997), the highest scoring hits are from A. ficuum (niger)  
phytase and A. fumigatus phytase, with an identity of 24% and 23% respectively (around 
the  50th to  the  300th residues).  Despite  the  low  amino  acid  sequence  homology  and 
functional  diversity  of  proteins  in  branch  2  HAP,  they  all  share  the  general  domain 
arrangement of an α/β “core” domain and a more variable α-only “cap” domain,  with 
conserved active site residues found within the cleft between the two domains  (Rigden 
2008). For example, a comparison of A. niger PhyA (Oakley 2010) and BtMinpp yielded 
an rmsd of only 2.5 Å.  Figure 2.2.2.3 shows a structure based dendrogram of branch 2 
HAPs. Out of the available structures, BtMinpp is more structurally similar to the fungal 
3-phytases  than  to  E.  coli 6-phytase.  Close  inspection  of  the  superimposed  structures 
reveals that the major structural differences to the 6-phytases occurs in the  α-domain.. 
Even  within  the  clade  of  fungal  phytases,  BtMinpp  forms  its  own  branch,  further 
supporting the idea that it represents a a novel HAP sub-clade.
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Figure  2.2.2.3.  A structure-based dendrogram of  selected  branch 2 histidine acid 
phosphatases. From  top  to  bottom:  Escherichia  coli phytase  AppA (EcAppA);  Hafnia  Alvei 
phytase  (HaPhyA);  Escherichia  coli glucose-1-phosphatase  (EcG1Pase);  Francisella  tularensis 
histidine acid phosphatase (FtHAP); human prostatic acid phosphatase (HsPAP); rat prostatic acid 
phosphatase (RnPAP);  Aspergillus fumigatus phytase PhyA (AfPhyA);  Aspergillus niger phytase 
PhyA (AnPhyA);  Aspergillus  niger phytase  PhyB  (AnPhyB);  Debaryomyces  castellii phytase 
(DcPhyt); Bacteroides thetaiotaomicron Minpp (BtMinpp).
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2.2.3 Structure of Substrate Analogue-bound BtMinpp
Solving  the  structure  of  the  enzyme-substrate  complex  would  allow  the 
interactions between  BtMinpp and InsP6 to be identified, thus providing insights to the 
catalytic mechanism. However, attempts at both co-crystallization and soaking of BtMinpp 
crystals with InsP6 yielded no success. Inositol hexasulfate (InsS6) is a non-hydrolysable 
phytate  mimetic  and  has  been  used  in  structural  studies  of  phytases  (Oakley  2010). 
Comparison of the structures of phosphate- and InsS6-bound forms of Minpp revealed an 
rmsd of only 0.20 Å for Cα atoms, thus suggesting that no significant conformational 
changes has been caused by the binding of the substrate analogue. InsS6 is bound at the 
catalytic core of both molecular copies of  BtMinpp in the crystallographic asymmetric 
unit, giving the substrate analogue-bound structure. The final model of the InsS6 complex 
was refined to R work and R free values of 16.8% and 23.1%, respectively, and has no 
residues in the disallowed region of the Ramachadran plot.
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Table 2.2.3.1. Data collection and refinement statistics for InsS6 complex. 
InsS6 complex
Data collection
Wavelength (Å) 0.9778
Space group P 21 
Cell parameters
a , b , c (Å)
β (°)
52.2, 117.3, 75.5
107.46
Resolution limit (Å) 39.10 – 2.29 (2.35 – 2.29)
Rmerge 0.083 (0.740)
(I)/sd(I) 8.6 (2.2)
Completeness (%) 99.0 (99.1)
Multiplicity 3.3 (3.3)
Overall temperature factor (Å2) 43.5
Refinement Statistics
Protein monomers per asymmetric unit 2
Total atoms 6757
Water molecules 137
Rwork 16.8%
Rfree 23.1%
Ramachandran Analysis (%)
Most favoured
Outliers
97.19%
0.00%
RMS deviations
Bonds (Å)
Angles (°)
Planes (Å)
0.008
1.136
0.005
Mean Atomic B-value (Å2) 44.1
*Statistics for data in the high resolution bin are in brackets.
Rmerge = Σ | Ii - <I> | / Σ Ii where <I> is the average of symmetry equivalent reflections and the 
summation extends over all observations for all unique reflections.
Rwork = Σ | |Fo| - |Fc| | / Σ | Fo| where Fo and Fc are the measured and calculated structure factors, 
respectively.
For Rfree the summations extends over a randomly selected subset (5%) of reflections excluded 
from all stages of refinement.
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The active site is lined with basic residue to balance the charge of the negatively 
charged sulfates of InsS6 (equivalently, phosphates on InsP6), some of those residues are 
shown on the omit map in figure 2.2.3.1 (A). The mechanistically important residues are 
shown in figure 2.2.3.1 (B), with Nε2 of His59 being 3.1 Å away from the sulfur atom of 
the 3-sulfate, and the oxygen of Glu325 being 3.3 Å away from the oxygen linking the 
sulfomonoester  bond. Thus confirming that  Glu325 serves the role  of the presumptive 
proton donor in the catalytic mechanism.
Figure  2.2.3.1.  A close  up  of  the  active  site  of  InsS6-complexed  BtMinpp. (A)  Simulated 
annealing omit map revealing the location of InsS6 bound to the active site of BtMinpp. A region of 
the simulated annealing omit electron density map (grey lines)  (Brünger et al. 1997) calculated 
with data to a resolution of 2.42 Å and contoured at 1.8 σ. Selected active site residues are shown 
in stick representation and labelled. The location of the inhibitor in the final refined structure of the 
complex is shown superimposed on the omit map electron density. (B) Catalytic histidine (H59), 
presumptive proton donor (E325N) and InsS6 molecule were shown in stick representation. Nε2 of 
His59 is 3.1 Å away from the sulfur atom of the 3-sulfate, and the carboxyl group of Glu325 is 3.3  
Å away from the sulfomonoester bond.
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Since the 3-sulfate in InsS6 is the closest to the catalytic histidine in the crystal 
structure, it can be rationalized that  BtMinpp has the ability to remove the 3-phosphate 
from its natural substrate, InsP6. Although BtMinpp does indeed remove 3-phosphate from 
InsP6, it  also removes other phosphates from the substrate (see  chapter 3 for a more 
detailed analysis of InsP6 hydrolysis products by BtMinpp), which suggests that InsP6 can 
bind to the enzyme in different orientations. As mentioned in section 2.2.2, A. niger PhyA 
phytase is a member of a different subfamily of clade 2 histidine acid phosphatases, and 
despite  having low sequence  identity,  the overall  topologies  between  BtMinpp and  A. 
niger PhyA are superficially similar, as shown in  figure 2.2.3.2 (A).  A. niger PhyA had 
been reported to hydrolyse InsP6 by specific removal of 3-phosphate (Oakley 2010). When 
the backbone of the catalytic motif (RHGXRXP; residues 58-64 in BtMinpp) and the short 
tripeptide of the presumed proton donor motif (HAE; 323-325 in BtMinpp) were aligned 
between the two enzymes,  the rmsd was found to be 0.30  Å for these 30 atoms. The 
conformations  of  the  bound  InsS6 were  also  very  similar  between  the  two  crystal 
structures,  with an rmsd of 0.50 Å for the six inositol  ring carbon atoms. Despite the 
structural similarities, this superpositioning of active site residues also revealed significant 
differences, as shown in figure 2.2.3.2 (B) and (C). R183 in BtMinpp replaces D188 in A. 
niger PhyA and forms ion pairs with the 2-sulfate of InsS6. The substitution of the proton 
donor D339 in  A. niger PhyA by A324 in  BtMinpp caused an increase in volume and 
decrease  in  polarity  for  the  S2  and  S4  binding  pockets  of  BtMinpp.  The  A31/Y28 
substitution  shows  a  similar  effect,  significantly  increasing  the  volume of  S4  and  S5 
pockets of BtMinpp.
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Figure  2.2.3.2.  Superpositioning  of  InsS6 bound-BtMinpp  and  A.  niger PhyA. (A)  The 
superpositioning of  the  overall  structures  of  the  two enzymes in  cylinder  and ribbon diagram 
showed very similar topologies. BtMinpp is shown with α-helices in red and β-strands in yellow, 
and  A. niger PhyA shown with α-helices in cyan and β-strands in blue. The InsS6 molecule is 
shown in stick representation. (B) and (C) display the superpositioned catalytic pocket of BtMinpp 
(green  surface)  and  A.  niger PhyA (cyan  surface).  The  InsS6 molecule  and  other  interesting 
residues are shown as sticks, with sulfur coloured in yellow, oxygen in red, nitrogen in blue and 
carbon cyan. Residues are labelled with their one letter code and number, and selected sulfate 
binding pockets are labelled in brackets.
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2.2.4 Enzymatic Properties of BtMinpp
BtMinpp, despite being a histidine acid phosphatase, showed three pH optima at 
pH 3.0, 4.5 and 5.5, as shown in figure 2.2.4.1. Activity in a wide range of pH presumably 
allowed its host to adapt to different environments in the GI tract. It was interesting to note 
that the activity dropped between the pH optima. Since the active site was lined with basic 
residues which interacted with the polyprotic InsP6, changes in the pH would affect the 
protonation states of both the residues and the phosphate groups on InsP6, altering the rate 
of catalysis.
Figure 2.2.4.1. pH profile of BtMinpp. The relative InsP6 phosphatase activity of BtMinpp was 
plotted against the pH.
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Enzyme assays were performed at both pH 2.5 and 7.5 to determine the kinetic 
parameters of BtMinpp. Figure 2.2.4.2 shows the phosphate release activity by BtMinpp 
against concentration of InsP6 and the obtained parameters are shown in  table 2.2.4.1. 
Agreeing with the pH profile above,  BtMinpp shows a much higher Vmax of 318 μmole 
min-1 mg-1 at pH 2.5 compared to that of 17.6 μmole min-1 mg-1 at pH 7.5. A much lower 
Km of 4.64 μM at pH 2.5 compared to that of 32.6 μM at pH 7.5 indicates a much higher 
affinity of InsP6 to  BtMinpp at low pH, probably due to basic residues of the active site 
being charged at low pH.
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Figure  2.2.4.2. Rate  of  phosphate  release  by  BtMinpp  was  plotted  against  InsP6 
concentration. Experiments were performed at pH 2.5 (A) and 7.5 (B) at 30 °C. Each data point 
was  accompanied  with  an  error  bar  showing  one  standard  error.  Data  points  were  fitted  to 
Michaelis-Menton kinetics. Values of estimated Vmax were indicated on the plot.
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Table  2.2.4.1. The  kinetic  parameters  of  BtMinpp  at  30  °C.  Note  that  values  of  Vmax were 
normalised to that of μmol min-1 mg-1.
pH 2.5 pH 7.5
Vmax (μmol min-1 mg-1) 318 ± 1.71 17.6 ± 1.75
Km (μM) 4.64 ± 0.131 32.6 ± 6.19
kcat (s-1) 259 ± 1.4 14.4 ± 1.43
2.2.5 Inhibition of BtMinpp by Organic Acids
Tartaric acid is a known inhibitor of histidine acid phosphatases  (LaCount et al. 
1998). Similar organic acids such as citric, malic and oxalic acid are also shown to be 
inhibitors of phytases (Tang et al. 2006). In this work, structures of malate- and tartrate-
bound BtMinpp were solved and refined. Each copy of the protein monomer contained a 
single molecule the inhibitor bound to the catalytic pocket, as shown by the omit maps in 
figure 2.2.5.1. Like the InsS6-bound structure, no significant conformational changes had 
resulted from the binding of the inhibitors.  The final structure of the  BtMinpp malate 
complex has  R work and R free of  16.9 % and 18.3 %, respectively,  while  the  final 
structure of  BtMinpp tartrate complex has R work and R free of 15.6 % and 16.9 %, 
respectively. Each of the inhibitor bound structures has 2 residues in the disallowed region 
of the Ramachadran plot.
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Table  2.2.5.1. Data  collection  and  refinement  statistics  for  malate  and  tartrate  complex  of 
BtMinpp.
Malate complex Tartrate complex
Data collection
Wavelength (Å) 0.9795 0.9795
Space group P 21 P 21
Cell parameters
a , b , c (Å)
β (°)
53.2, 121.0, 75.9
107.7
53.2, 120.2, 76.0
108.1
Resolution limit (Å) 46.77 – 1.46 (1.50 – 1.46) 61.92 – 1.75 (1.80 – 1.75)
Rmerge 0.040 (0.442) 0.098 (0.557)
(I)/sd(I) 12.9 (2.2) 6.9(2.0)
Completeness (%) 98.3 (96.7) 99.7 (100.0)
Multiplicity 3.2 (2.7) 3.7 (3.7)
Overall temperature factor (Å2) 18.5 16.9
Refinement Statistics
Protein monomers per asymmetric unit 2 2
Total atoms 7671 7610
Water molecules 860 923
Rwork 16.9 % 15.6 %
Rfree 18.3 % 18.4 %
Ramachandran Analysis (%)
Most favoured
Outliers
97.6
0.2
97.5
0.3
RMS deviations
Bonds (Å)
Angles (°)
Planes (Å)
0.006
1.080
0.006
0.007
1.053
0.006
Mean Atomic B-value (Å2) 24.3 21.6
*Statistics for data in the high resolution bin are in brackets.
Rmerge = Σ | Ii - <I> | / Σ Ii where <I> is the average of symmetry equivalent reflections and the 
summation extends over all observations for all unique reflections.
Rwork = Σ | |Fo| - |Fc| | / Σ | Fo| where Fo and Fc are the measured and calculated structure factors, 
respectively.
For Rfree the summations extends over a randomly selected subset (5%) of reflections excluded 
from all stages of refinement.
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Figure 2.2.5.1. Simulated annealing omit maps revealing the location of D-malate (A) and L-
(+)-tartrate (B) bound to the active site of BtMinpp. A region of the simulated annealing omit 
single difference electron density map (grey lines) (Brünger et al. 1997) calculated with data to a 
resolution of 1.46 Å and contoured at 2.75 σ (malate, A), 1.75 Å and contoured at 3.5 σ (tartrate,  
B). Selected active site residues are shown in stick representation and labelled. The location of the 
inhibitor in the final refined structure of the complex is shown superimposed on the omit map 
electron density.
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The inhibitors are bound to the catalytic pocket of the protein, suggesting that these 
organic acids serve as competitive inhibitors to the hydrolysis of InsP6 by BtMinpp. Since 
both malic acid and tartaric acid are dicarboxylic acids and share the same functional 
groups,  one would expect  the functional  groups to be in the same positions when the 
inhibitors are bound to the protein.  However,  this  is  not  the case,  as shown in  figure 
2.2.5.2. While both oxygen atoms on C1 (the carbon facing downwards on the page) are 
involved in hydrogen bonding to Arg149 and His323 in the case of malate, only one of the 
oxygen atoms in tartrate participate in hydrogen bonding with Arg149 only. In addition, 
catalytic residue His59 interacts with both a carboxylate group and a hydroxyl group in 
malate, but only to a hydroxyl group in tartrate. It therefore appears that, it is the general 
shape  and  charge  of  the  organic  acids  that  contribute  to  the  inhibition,  rather  than 
specifically the carboxylate functional groups. It is also of interest to note that a racemic 
mixture of malic acid was used in the crystallization, and D-malate rather than L-malate, 
the naturally occurring form, was bound at the active site, as evidenced by the omit map. 
This suggest that malate may not be an effective inhibitor of BtMinpp in vivo.
54
Figure  2.2.5.2. Diagrams  illustrating  the  interactions  between  BtMinpp  and  complexed 
malate (A) and tartrate (B). The complexed molecules are represented in purple. C, N and O 
atoms are represented in black, blue and green, respectively. Hydrogen bonds are represented by 
green dashed lines, with their lengths labelled in Å. Hydrophobic interactions are represented by  
red strokes radiating towards the complexed molecules. Diagrams were generated using Ligplot+  
(Laskowski et al. 2011).
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With the proposition that organic acids are inhibitors to  BtMinpp, assays on the 
rate  of phosphate release were carried out  to further  investigate the inhibition.  Figure 
2.2.5.3 plots the rate of InsP6 hydrolysis by BtMinpp against citrate concentration. Due to 
the fact  that  organic acids  are  competitive inhibitors  and BtMinpp has  a  low Km,  the 
relative activity only dropped to around 30 % in the presence of a high concentration (10 
mM) of citrate. With the available data, 50 % inhibition was observed at roughly 2 mM 
citrate.
Figure 2.2.5.3. Effect of citrate on the rate hydrolysis of InsP6 by BtMinpp at 30 °C. Relative 
activity is plotted against citrate concentration. Each data point is accompanied with an error bar  
showing one standard error.
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2.3 Conclusion
This chapter describes the crystal structure of Minpp from B. thetaiotaomicron, a 
novel structure from an enzyme of the family of branch 2 histidine acid phosphatases. 
Although  BtMinpp  has  the  ability  to  hydrolyse  InsP6 and  acts  as  a  phytase,  it  is 
evolutionarily distinct from bacterial phytases. Different to other branch 2 histidine with a 
HD motif where the aspartate serves as a proton donor for the mechanism, BtMinpp has a 
HAE motif with the glutamate as the proton donor. Since this is the first structure of a 
Minpp,  it  should  be  useful  for  the  purpose  of  molecular  modelling  of  its  eukaryotic 
cousins. This structural information would perhaps provide insight to those who study the 
physiological impact of eukaryotic Minpps.
The binding of InsS6, a substrate analogue, reveals the D-3 phosphate as a potential 
cleavage  target.  However,  BtMinpp  removes  the  phosphates  on  InsP6 distributively, 
releasing products after each hydrolysis. As we shall see in the next chapter,  BtMinpp is 
promiscuous in terms of its hydrolysis of inositol polyphosphates. Due to this substrate 
promiscuity of the enzyme, it is perhaps unsurprising that the inhibitors do not bind in the 
same conformation, and instead overall charge and general shape appear to be crucial to 
recognition and binding.
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Chapter 3. The Catalytic Landscape of Minpp from B. 
thetaiotaomicron
Monogastric  animals  lack  the  enzymes  necessary  to  digest  InsP6 and  as  a 
consequence,  animal feeds with high InsP6 content  lack mobilizable phosphorous.  The 
undigested  InsP6 from  these  feeds  can  lead  to  environment  problems  such  as 
eutrophication in regions of intensive pig and poultry farming (Lei et al. 2013).  In the 
previous  chapter,  it  was  shown  that,  despite  low  sequence  similarity,  BtMinpp  is 
structurally similar to the phytase PhyA from A.niger. PhyA was one of the first phytases 
used commercially as an animal feed additive to reduce the negative impact of undigested 
InsP6 (Lei et al. 2013). A. niger PhyA and its homologues in other fungal species produce 
a single major InsP5 product from the hydrolysis of InsP6 (Konietzny et al. 2002). In this 
chapter the  positional promiscuity of BtMinpp against InsP6 is investigated.
Minpp  homologues  in  eukaryotes  are  known  to  be  of  physiological  and 
developmental importance. Minpp homologues in humans and rodents are the only known 
InsP6 phosphatases in their respective organisms (Windhorst et al. 2013), and have been 
reported to be involved in endochondral ossification (Caffrey et al. 1999). Although InsP6 
has been reported to inhibit tumor cells proliferation at high concentrations (≥100 μM) 
(Vucenik et al. 2006), it had been more recently reported that, at low concentrations (≤50 
μM), InsP6 can be employed by tumour cells to improve their proliferation (Windhorst et  
al. 2013).
In  this  chapter,  site-directed  mutagenesis  (SDM) has  been employed to mutate 
active  site  residues  in  the  BtMinpp  active  site  to  their  A.  niger PhyA and  HsMinpp 
counterparts, hereafter referred to as 'fungalizing' and 'humanizing' mutations. Using high 
performance  liquid  chromatography  (HPLC),  the  products  of  hydrolysis  of  InsP6 by 
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BtMinpp and its mutants were separated. By analysing the effects of the mutations, the 
differences in the HPLC product profiles between BtMinpp and A. niger PhyA have been 
rationalized, and a structural model developed to help rationalize the catalytic specificity 
of HsMinpp.
3.1 Experimental
3.1.1 Identification of Active Site Residues in Minpp Homologues
Residues within 4 Å of oxygen atoms of the sulfate groups of InsS6 from the X-ray 
crystal structures of InsS6-complexed BtMinpp (chapter 2) and A. niger PhyA (PDB code: 
3K4Q) (Oakley 2010) were identified. The backbone of the catalytic motif (RHGXRXP; 
residues 58-64 in  BtMinpp) and the short tripeptide of the presumed proton donor motif 
(HAE; 323-325 in  BtMinpp) were aligned between the two enzymes. Those active site 
residues from BtMinpp were matched with their equivalents in AnPhyA.
T-coffee (Notredame et al. 2000) was used to align sequences of BtMinpp (Uniprot 
entry:  Q89YI8) (Xu et  al. 2003),  HsMinpp (UniProt  entry:  Q9UNW1) (Caffrey et  al. 
1999),  rat  Minpp (UniProt  entry:  O35217) (Craxton et  al. 1997),  and chicken Minpp 
(UniProt  entry:  Q92170) (Reynolds et  al. 1996).  A homology model  of HsMinpp was 
generated  using  the  SWISS-MODEL  web  server  (Biasini et  al. 2014)  with  the 
aforementioned alignment and InsS6-complexed  BtMinpp as a template. With the model 
aligned against the template, residues within 6 Å of InsS6  were identified and matched 
with their equivalents.
3.1.2 Site-directed Mutagenesis of BtMinpp
For  the  'fungalizing'  mutants  and  the  H59A  inactive  mutant,  mutagenesis 
polymerase chain reactions (PCRs) were carried out in 50 μl reactions with Phusion Site-
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Directed Mutagensis Kit (Thermo Scientific) using  5'-phosphorylated primers. The list of 
primers,  contents of the reaction and the PCR steps are recorded in  Appendix 2.  The 
products were verified by DNA gel electrophoresis.
Successfully cloned plasmids were transformed into E. coli cells, strain D5Hα, via 
electroporation. They were then plated onto LB agar with ampicillin (100 μg/ml). Plates 
were incubated overnight and single colonies were picked and inoculated into LB with 
ampicillin (100 μg/ml). The resulting plasmids were sent for sequencing. Plasmids with 
the  correct  sequences  were  transformed  into  E.  coli strains  for  expressing,  via 
electroporation.  BL21-(DE3)-RIL  cells  were  used  for  expression  of  the  A324D  and 
A324D/E325N mutants, and Rosetta 2 (DE3) pLysS cells were used for the remainder of 
the mutants. 
For  the  'humanizing'  mutants,  mutagenesis  PCRs  were  carried  out  in  20  μl 
reactions  with  the  QuikChange  Lightning  Site-Directed  Mutagensis  Kit  (Agilent 
Technologies). For the 'humanizing' quadruple mutant, mutagenesis PCRs were carried out 
in 20 μl reactions with the QuikChange Lightning Multi  Site-Directed Mutagensis Kit 
(Agilent Technologies). The list of primers, contents of the reaction and the PCR steps are 
recorded in Appendix 2. The products were verified by DNA gel electrophoresis.
PCR products from all  five 'humanizing'  mutants were transformed into XL-10 
Gold  Ultracompetent  E.  coli cells  via  heat  shocking.  Plasmids  from the  successfully 
transformed cells were extracted and sequenced. Verified plasmids were then transformed 
into Rosetta 2 (DE3) pLysS E. coli cells for protein expression.
3.1.3 Overexpression and Purification of Mutants
The mutant proteins were overexpressed in the cells  produced according to the 
previous section. The cells were harvested and lysed, with the proteins purified from the 
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cell free extract. The overexpression and the purification of the proteins were carried out 
in the same manner as described for the wild-type protein in sections 2.1.1 and 2.1.2.
3.1.4 Relative Phytase Activities of Mutants
The  relative  phytase  activities  of  the  mutants  were  measured  using  the 
PiColorLock  Gold  Phosphate  Detection  System  (Innova  Biosciences)  as  described  in 
section  2.1.7.  For  the  'fungalizing'  mutants,  varying  concentrations  of  enzymes  were 
incubated with 50 μM InsP6(Sigma) in 50 mM sodium acetate pH 5.5 at 37 °C to obtain 
free phosphate within the calibration range, and the result was normalised to account for 
the enzyme concentration used. For the humanizing mutants, 1 mM InsP6 (Sigma) in 50 
mM  glycine  HCl  pH  3.5  was  used  and  the  reactions  were  diluted  20-fold  before 
measurement of phosphate concentration.
3.1.5 HPLC Assays
BtMinpp and its mutants were incubated with both InsP6 (Merck) and with InsP6 
labelled with 32P at the 2-position (provided by Dr. Charles Brearley, UEA). Enzymes were 
inactivated by boiling.  Products  of InsP6 hydrolysis  by  BtMinpp and its  mutants were 
separated  using  high  performance  liquid  chromatography  (HPLC),  and  detected  by 
radioactivity and by UV absorbance. To produce the final figures, enzymes were titrated to 
give detectable amounts of InsP5.
Inositol phosphate products of assays using 32P-labelled substrate were resolved by 
HPLC on a 23.5 cm x 4.6 mm i.d.WVS Partisphere SAX column (Whatman, UK, Ltd) 
fitted with a SAX guard cartridge (Whatman). The column was eluted at 1 mL/min with a 
gradient formed by mixing solvents from buffer reservoirs containing: water (A) and 1.25 
M (NH4)2HPO4, adjusted to pH 3.8 with H3PO4 (B). Solvents were mixed according to the 
following gradient: time (min), % B; 0, 0; 5, 0; 65, 100; 75, 100. Additional separations 
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were  performed  on  a  25  cm  x  4.6  mm  Alltech  Adsorbosphere  SAX  column  (Grace 
Davison Discovery Sciences, Deerfield, IL, USA) fitted with a Alltech guard cartridge. 
The column was eluted at  1 mL/min with a gradient formed by mixing solvents from 
buffer reservoirs containing: water (A) and 1.25M (NH4)2HPO4, adjusted to pH 3.8 with 
H3PO4 (B). Solvents were mixed according to the following gradient: time (min), %B; 0,  
0; 5, 0; 65, 25; 67, 0. Radioactivity was estimated by Cerenkov counting with a Canberra 
Packard (Pangbourne, Berks, UK) A500 series Radiomatic Flo Detector fitted with a 0.5 
mL flow cell. The integration interval for counting was 12 s.
Inositol  phosphates were separated by high performance liquid chromatography 
(HPLC) on a 3 mm x 250 mm CarboPac PA200 column (Dionex) and 3 mm x 50 mm 
guard  column  of  the  same  material.  The  column  was  eluted  with  a  gradient  of 
methanesulfonic acid delivered from solvent reservoirs A and B containing 60 mM and 
600 mM methane sulfonic acid, respectively. The gradient was delivered at a flow rate of 
0.4 mL/min according to the following programme: time (min), %B; 0, 10; 22, 60; 25, 
100, 38, 100. Solvents were delivered using a Jasco PU-2089i Plus inert quaternary pump 
and  samples  were  injected  at  49  min  intervals  using  a  Jasco  AS-2055i  Plus  inert 
autosampler. The solvent stream eluting from the column was mixed, using a mixing T, 
with a solution of 2 % perchloric acid containing 0.1 % w/v ferric nitrate delivered at a 
flow rate of 0.2 mL/min using a Jasco PU-1585 pump, before detection of peaks at 290 
nm in a Jasco UV-2077 Plus UV detector.
3.1.6 Crystallization and X-ray Crystal Structure Determination
To solve the X-ray crystal structures of the mutants, crystals were prepared in the 
same protocol as described for the wild-type protein. See also the wild-type protocol for 
data collection and data processing. The solved mutant structures were aligned with the P i-
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complexed wild-type structure using DaliLite pairwise structure alignment (Hasegawa et  
al. 2009) to provide the root mean square deviation (rmsd) of Cα atoms.
Prior to storage in liquid nitrogen, crystals of the E325N mutant were soaked in 
solutions containing the mother liquor along with 25 % (v/v) ethylene glycol, as well as 5 
mM  InsP6 and  5  mM  Ins(1,2,4,5,6)P5  (Sigma), for  the  E325N-InsP6  and  E325N-
Ins(1,2,4,5,6)P5 complexes respectively.
3.1.7 Molecular Docking
Molecular docking experiments using torsionally-flexible phytate as ligand and the 
crystal structures of BtMinpp and A. niger PhyA (Oakley 2010) as receptors were carried 
out using AutoDock Vina (Trott et al. 2010). A D-2 axial model for phytate (D-2 axial and 
five equatorial phosphates) was used as representative of the predominant conformation at 
acidic pH where the enzyme is most active (Isbrandt et al. 1980). Atomic coordinates for 
the ligand were obtained from the Hic-Up database (Kleywegt et al. 2003). The structures 
of ligand and receptor were formatted with AutoDockTools 1.5.4 (Morris et al. 2009). The 
chemical  bonds  involving  the  phosphate  groups  of  phytate  were  defined  as  rotatable 
giving a total of 12 degrees of torsional freedom. Fixed (i.e. inflexible) enzyme models 
were  employed.  A  search  space  of  16  ×  16  ×  16  Å3 was  used,  centred  on  and 
encompassing each enzyme active site. 
3.2 Results and Discussions
3.2.1 Comparison of Active Site Residues in BtMinpp and 
AnPhyA
For  each  structure  of  InsS6-complexed  BtMinpp  and  AnPhyA,  residues  in  the 
vicinity of the sulfate groups on InsS6 forming the sulfate binding pockets, were identified 
and listed in  table 3.2.1.1.  Figure 3.2.1.1 shows a visual representation of a number of 
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those  residues.  To  investigate  the  effects  of  the  individual  active  site  residues,  the 
following residues  were chosen to  generate  BtMinpp mutants:  A31Y, R183D, A324D, 
E325N and A324D/E325N double mutant. A31Y mutates alanine into a bulky tyrosine, 
potentially changing the size of the catalytic pocket. R183D mutates a basic arginine into 
an acid aspartate, affecting the charge of the S2 binding pocket. The last three mutants 
replaces the HAE proton donor motif from  BtMinpp with the HD motif from standard 
branch 2 histidine acid phosphatases. E325N should give little or no catalytic activity as 
this mutant has the putative catalytic proton donor removed.
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Table  3.2.1.1. Table  listing  the  residues  forming  each  of  the  sulfate  binding  pockets  in  the 
structures of  BtMinpp and  AnPhyA. Each residue is  matched with its  counterpart  in the other 
structure.
Sulfate binding pocket BtMinpp AnPhyA
S1 R149 R142
S2 R149 R142
R183 D188
H323 H338
S3 R149 R142
R62 R62
H59 H59
R58 R58
A324 D339
H323 H338
S4 R58 R58
E325 D339
K280 K278
A31 Y28
R62 R62
T30 Q27
S5 A31 Y28
R62 R62
K68 K68
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Figure 3.2.1.1. A stereoview of the superposition of the sidechains of InsS6-binding residues 
(shown as  sticks)  of  BtMinpp (carbon atoms coloured cyan)  and  Aspergillus  niger PhyA 
(carbon atoms coloured green). The  residues  selected  for  display  form the  primary  sites  of 
interaction with InsS6 in both complexes. The van der Waals surface of InsS6 is shown in grey. 
Residue labels follow the numbering for the BtMinpp structure. The leading character identifies  
the residue in BtMinpp whilst the trailing identifies the corresponding variant residue found in  
PhyA. An asterisk (*) indicates the position of the A324D substitution. Selected binding pockets 
(S1,  S2,  S5 and S6) are indicated,  numbered according to corresponding sulfate group on the 
bound ligand. Pocket S4 is obscured in this orientation by the 6-sulfate group of the ligand. The  
interaction distance between a carboxyl group oxygen of residue E325 and the bridging ether  
oxygen of the S3 sulfate group of InsS6 is 3.3 Å and is indicated by a dashed line.
3.2.2 Crystal Structures of 'Fungalizing' BtMinpp Mutants
The  BtMinpp  'fungalizing'  mutants  were  all  successfully  over-expressed  and 
purified,  and  their  crystal  structures  have  been  solved  and  refined.  The  crystals  are 
isomorphous to that of the wild-type. Table 3.2.2.1 shows the data collection and structure 
refinement statistics.
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Table 3.2.2.1.a Data collection and refinement statistics for crystal structures of the mutants A31Y, 
H59A and R183D.
A31Y H59A R183D
Data collection
Wavelength (Å) 0.9794 0.9173 0.9690
Space group P 21 P 21 P 21 
Cell parameters
a , b , c (Å)
β (°)
52.6, 115.2, 76.0
107.9
52.9, 120.5, 75.9
108.1
52.4, 119.1, 76.0
108.0 
Resolution limit (Å) 61.28 – 1.98(2.09 – 1.98)
30.95 – 1.87
(1.92 – 1.87) 
30.76 – 2.36
(2.42 – 2.36)
Rmerge 0.084 (0.346) 0.062 (0.630) 0.087 (0.400)
(I)/sd(I) 9.2 (3.4) 10.8 (2.4) 7.6 (3.0)
Completeness (%) 98.6 (97.7) 100.0 (100.0) 98.9 (98.6)
Multiplicity 3.2 (3.3) 3.5 (3.4) 3.0 (3.0)
Overall temperature factor (Å2) 17.3 27.9 36.6
Refinement Statistics
Protein monomers per asymmetric unit 2 2 2
Total atoms 7111 6918 6639
Water molecules 376 321 155
Rwork 15.0 17.0 18.1
Rfree 18.8 20.7 23.8
Ramachandran Analysis (%)
Most favoured
Outliers
97.70
0.61
97.87
0.00
96.69
0.25
RMS deviations
Bonds (Å)
Angles (°)
Planes (Å)
0.007
1.042
0.005
0.007
1.008
0.005
0.007
1.057
0.005
Mean Atomic B-value (Å2) 19.3 27.6 35.0
*Statistics for data in the high resolution bin are in brackets.
Rmerge = Σ | Ii - <I> | / Σ Ii where <I> is the average of symmetry equivalent reflections and the 
summation extends over all observations for all unique reflections.
Rwork = Σ | |Fo| - |Fc| | / Σ | Fo| where Fo and Fc are the measured and calculated structure factors, 
respectively.
For Rfree the summations extends over a randomly selected subset (5%) of reflections excluded 
from all stages of refinement.
67
Table  3.2.2.1.b Data  collection  and  refinement  statistics  for  crystal  structures  of  the  mutants 
A324D, E325N and A324D/E325N.
A324D E325N A324D/E325N
Data collection
Wavelength (Å) 0.9690 0.9690 0.9690
Space group P 21 P 21 P 21 
Cell parameters
a , b , c (Å)
β (°)
53.0, 119.7, 75.9
108.2
52.8, 119.6, 76.1
108.1
52.5, 117.9, 76.1
108.1
Resolution limit (Å) 39.89 – 1.73(1.77 – 1.73)
36.30 – 2.06
(2.11 – 2.06)
26.61 – 1.95
(2.00 – 1.95)
Rmerge 0.052 (0.697) 0.078 (0.747) 0.076 (0.942)
(I)/sd(I) 10.3 (2.0) 7.9 (2.2) 10.1 (2.1)
Completeness (%) 99.4 (99.9) 99.4 (99.1) 98.1 (99.8)
Multiplicity 3.4 (3.5) 3.4 (3.4) 3.3 (3.4)
Overall temperature factor (Å2) 25.9 32.0 29.1
Refinement Statistics
Protein monomers per asymmetric unit 2 2 2
Total atoms 7131 6714 6697
Water molecules 520 238 217
Rwork 16.9 18.0 19.35
Rfree 19.4 22.2 24.02
Ramachandran Analysis (%)
Most favoured
Outliers
97.27
0.37
97.19
0.38
96.94
0.38
RMS deviations
Bonds (Å)
Angles (°)
Planes (Å)
0.006
1.036
0.005
0.007
1.056
0.005
0.007
1.023
0.005
Mean Atomic B-value (Å2) 31.38 39.29 39.64
*Statistics for data in the high resolution bin are in brackets.
Rmerge = Σ | Ii - <I> | / Σ Ii where <I> is the average of symmetry equivalent reflections and the 
summation extends over all observations for all unique reflections.
Rwork = Σ | |Fo| - |Fc| | / Σ | Fo| where Fo and Fc are the measured and calculated structure factors, 
respectively.
For Rfree the summations extends over a randomly selected subset (5%) of reflections excluded 
from all stages of refinement.
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All  mutations  were  verified  by  inspecting  the  electron  density  maps  of  the 
structures. In addition,  while structures for the majority of mutants have shown bound 
phosphate  like  the  wild-type  structure,  a  phosphohistidine  reaction  intermediate  was 
captured in the crystal structure of A324D/E325N instead, as shown in figure 3.2.2.1.
Figure  3.2.2.1. Catalytic  core  of  the  A324D/E325N  mutant  showing  a  phosphohistidine 
hydrolysis intermediate. 2Fo  – Fc  map contoured at 1.1 sigma shows clearly the density for a 
phosphohistidine.
Aligning the  Cα atoms of  mutant  monomers  to  wild-type  structure  gave  small 
values  of  rmsd  as  shown  in  table  3.2.2.2.  The  small  rmsd  values  showed  that  the 
mutations are effectively only changing the structure at the site of mutation and have not 
disrupted the overall fold of the protein.
Table 3.2.2.2. Table showing rmsd values between the mutants and wild-type BtMinpp.
Mutant Rmsd (Å) Number of aligned residues
A31Y 0.6 396
H59A 0.2 393
R183D 0.2 395
A324D 0.2 395
E325N 0.2 395
A324D/E325N 0.3 395
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For the most part, the interactions between the bound-phosphates and the active 
site residues are similar between wild-type protein and the mutants, and the differences 
between the  distances  are  less  than  0.2 Å as  shown in  figure  3.2.2.2.  However,  it  is 
interesting to note that the hydrogen bonds that are formed or destroyed by the mutations. 
For example, while the catalytic His59 in the wild-type protein (A) does not interact with 
the  bound phosphate  despite  the  proximity  to  it  (2.8 Å between NE2 and the  closest 
oxygen atom on phosphate), due to it not being in the correct orientation to form hydrogen 
bonds,  Ala59 in the H59A mutant  (B) interacts  with one of the oxygen atoms via the 
backbone nitrogen atom. It  appears that the H59A mutation has not only removed the 
catalytic histidine, but may also prevent the leaving of product. It also rationalized why a 
'product' is present in the active site despite a lack of catalytic activity. Due to the fact that 
the phosphate is  bound to the S3 pocket  of  the enzymes,  changes  made in  the A31Y 
mutation (C) and the R183D mutation (D) are not immediately obvious. Interactions were 
lost between phosphate and one of the NH atom of Arg62 in the A31Y active site, and an 
NE atom of Arg149 in the R183D active site. Both of those arginines made more than one 
interaction  with  the  phosphate,  so  the  loss  of  those  described  may  not  cause  any 
significant effects. One thing of note is that ND1 atom of His 323 in the R183D active site 
is closer to the phosphate (2.52 Å to the oxygen atom) compared to the wild-type (2.87 Å 
to  the  oxygen atom),  which  may indicate  that  the  R183D mutation  has  increased  the 
enzyme affinity for the product. For the A324D mutant (E), Asp324 has replaced the role 
of Ala324 in the wild-type, with similar distances between the backbone nitrogen atom 
and the phosphate. For the E325N mutant  (F), Asn325 has introduced a new interaction 
with the phosphate and a water molecule,  which may also have increased the enzyme 
affinity for the product. To summarize, additional interactions with bound phosphate are 
observed in the structures of most of the mutants and may be indicative of a more tightly-
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bound product complex. This increase in affinity may reduce the ability of the enzyme to 
release the product and bind new substrate). The fact that a phosphohistidine intermediate 
was observed in the A324D/E325N double mutant suggests that this specific mutation has 
greatly reduced the enzyme ability to proceed from its intermediate state.
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Figure  3.2.2.2.a  Diagrams illustrating the  interactions  between the bound-phosphate  and 
wild-type BtMinpp  (A); H59A mutant (B); A31Y mutant (C); R183D mutant (D).  C, N, O 
and P atoms are represented in black, blue, green respectively. Hydrogen bonds are represented by 
green dashed lines, with their lengths labelled in Å. Hydrophobic interactions are represented by  
red strokes radiating towards the complexed molecules. Diagrams were generated using Ligplot+  
(Laskowski et al. 2011).
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Figure  3.2.2.2.b  Diagrams illustrating the  interactions between the  bound-phosphate  and 
A324D mutant (E); E325N mutant (F). Continued from the last figure.
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When the structures of the  BtMinpp A324D/E325N double mutant and  A. niger 
PhyA were superimposed, the active site residues in the catalytic motif and the proton 
donor motif were seen to share similar conformations, as shown in figure 3.2.2.3. Asn325 
is the only residue with significantly different conformation between the two proteins. 
However, this residue is not involved in the proposed catalytic mechanism, thus its effect 
on catalysis should be minimal.
Figure 3.2.2.3. Superimposed residues in the active site of  BtMinpp A324D/E325N double 
mutant and A. niger PhyA. The apo A. niger PhyA was used (PDB code: 3K4P) (Oakley 2010). 
The residues are shown in stick representation. N, O and P atoms are coloured in blue, red and 
orange respectively. C atoms are coloured in green and cyan for A324D/E325N mutant and  A. 
niger PhyA respectively.
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3.2.3 Enzymatic Studies of BtMinpp and Its 'Fungalized' Mutants
The relative activities against InsP6 of the 'fungalized' mutants were compared with 
that  of  wild-type  recombinant  BtMinpp  using  phosphate  release  assays.  As  shown  in 
figure 3.2.3.1, the A31Y mutant had activity similar to the wild-type (107 %). The H59A 
showed practically no activity (0.062 %). R183D showed little activity (2.9 %), while all  
the  HAE  motif  mutants  showed  lower  activity  of  0.64  %,  0.59  %,  and  0.54  %, 
respectively,  for  A324D,  E325N and  the  A324D/E325N double  mutant.  These  results 
demonstrate that adding a bulky residue and changing the size of the S5 binding pocket 
has little effect to the activity (unpaired t-test: p = 0.5380). Removing His59 rendered the 
enzyme  inactive,  thus  proving  it  as  the  catalytic  residue  vital  for  the  mechanism. 
Unsurprisingly, replacing Glu325 proton donor with asparagine also greatly reduced the 
enzyme activity, thus suggesting that the proton donor is important to the rate of catalysis.  
One would expect that putting a proton donor back with the A324D/E325N double mutant 
would restore the activity but that was not the case. The residues surrounding the active 
site were probably optimized with the HAE motif during evolution, thus simply replacing 
the HAE motif with HDN disrupted the balance and caused a significant drop in activity. 
As described in the previous section, a phosphohistidine intermediate is only seen with the 
structure of the A324D/E325N mutant, which may suggest the reduced ability in moving 
on from the intermediate state to generate a leaving group. The data also demonstrated that 
replacing active site residues with acidic ones also greatly decreased the enzyme activity, 
thus suggesting that a basic pocket is essential for binding of substrate.
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Figure 3.2.3.1. Bar chart showing the relative activities of the 'fungalized' BtMinpp mutants 
at pH 5.5. From left  to right:  wild-type enzyme, A31Y mutant,  H59A mutant,  R183D mutant, 
A324D mutant, E325N mutant and A324D/E325N double mutant. Each data point is accompanied 
with an error bar showing one standard error.
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BtMinpp,  fungal  phytase  PhyA from  Aspergillus  ficuum,  and  HsMinpp  from 
human were incubated with radiolabelled InsP6, and their products separated by HPLC, as 
shown in  figure  3.2.3.2.  Two InsP5 peaks  can  be  seen  from the  product  profiles;  the 
InsP5(4/6-OH)  peak  which  contains  a  pair  of  enantiomers,  and  the  InsP5(1/3-OH) 
enantiomers  which  also  co-elute  with  InsP5(5-OH).  Since  the  2-phosphate  was  radio-
labelled, the InsP5(2-OH) cannot be detected. Only one InsP5 peak was generated by the 
fungal phytase and although three different InsP5 species can elute at that position, it is 
generally accepted that fungal phytases produce InsP5(3-OH) as their predominant InsP5 
product  (Konietzny et  al. 2002).  In  contrast,  two  InsP5 peaks  were  present  in  both 
BtMinpp and HsMinpp, thus showing that the Minpps are more positionally promiscuous 
towards the phosphate groups on InsP6. The 'fungalized' mutants of BtMinpp is expected 
to change the enzyme's positional specificity towards InsP6.
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Figure 3.2.3.2. The products of BtMinpp activity against InsP6 are distinct from the products 
of  attack  of  fungal  phytase. Phytase  and  Minpps  were  incubated  with  myo-inositol(1,
[32P]2,3,4,5,6)P6 and the products resolved on a Partisphere SAX HPLC column eluted with a  
gradient  of  (NH4)2HPO4.  HsMinpp (a),  Aspergillus  ficuum phytase  (Sigma)  (b),  recombinant 
BtMinpp (c). The traces show the elution of internal standards of AMP, ADP and ATP monitored at 
a wavelength of 259nm (grey line),  and radioactivity monitored on-line by Cerenkov counting 
(black line). The regions of the chromatogram in which InsP2, InsP3 and InsP4 isomers elute are 
indicated in (A). The Ins(1,[32P]2,3,4,5,6)P6 preparation used in (A) contained residual [32P]ATP. 
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Each of the 'fungalized' mutants were also incubated with radiolabelled InsP6, and 
their products separated by HPLC. As seen in figure 3.2.3.3, the A31Y mutant produced 
the same product  peaks  in similar  ratios to  the wild-type enzyme,  suggesting that  the 
mutation had not altered the positional specificity of the enzyme. Even though the A324D 
mutant gave both InsP5 peaks like the wild-type, its ratio differs, with InsP5(1/3/5-OH) 
being the dominant peak. R183D, E325N and A324D/E325N mutants all gave a single 
InsP5 peak  like  A.  ficuum PhyA.  Though  the  peak  may  contain  more  than  one  InsP5 
product, the aforementioned mutants have succeeded in limiting the positional promiscuity 
of BtMinpp and making it behave more like a fungal phytase.
It should be noted there that the absence of peaks may not necessarily indicate a 
lack of the specific InsP5 product. It is possible that the specific InsP5 product was present, 
but got further dephosphorylated almost immediately after it was produced. Using mono-
sulfate  analogues  of  InsP6 would  not  work,  since  what  the  question  is  not  whether  a 
phosphate at a specific position can be removed, but the positional preference given that 
all phosphates are present. A work around would be to use different InsP5 as substrates, 
and compare its  breakdown products to those seen from InsP6 hydrolysis by the same 
enzyme. If InsP4 products are different to those on InsP6 hydrolysis, the InsP5 isomer can 
be  excluded.  See  later  in  this  section  where  the  same  technique  was  employed  to 
distinguish between stereoisomers from a single InsP5 peak.
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Figure 3.2.3.3.  The products of BtMinpp against InsP6 compared to that of the 'fungalized' 
mutants. BtMinpp and its mutants were incubated with  myo-inositol(1,[32P]2,3,4,5,6)P6 and the 
products resolved on a Partisphere SAX HPLC column eluted with a gradient of (NH 4)2HPO4. The 
identity of the enzyme is labelled on the top left  of each graph.  The traces show radioactivity 
monitored on-line by Cerenkov counting. The regions of the chromatogram in which InsP 2, InsP3 
and InsP4 isomers elute are indicated in the top graphs.
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Using a CarboPac PA200 column, the InsP5 products are better separated, with the 
InsP5(5-OH) resolve  well  away  from InsP5(1/3-OH) enantiomers.  As  shown in  figure 
3.2.3.4, the product profile of BtMinpp against InsP6 generated three of the four possible 
InsP5 peaks (1/3-, 4/6- and 5-OH) demonstrating the enzyme positional promiscuity.
Figure 3.2.3.4. The product profile of BtMinpp compared to the products of acid hydrolysis 
of InsP6. BtMinpp was incubated with InsP6 and the products were resolved on a CarboPac PA200 
column. Below it is a profile of InsP6 acid hydrolysis products as a standard. The traces show 
absorbance monitored at 290 nm.
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Using the same column, products produced by the  BtMinpp mutants were also 
resolved, as shown in figure 3.2.3.5. A324D gives the same InsP5 peaks as the wild-type 
enzyme, and like the separation on Partisphere SAX column, different ratios of InsP5 were 
generated compared to the wild-type. However, this separation showed InsP5(4/6-OH) as 
the major InsP5 product while the separation on Partisphere SAX column showed the other 
peak as the major one. It might be due to that the profile was taken at a different point 
during the reaction. The degradation of InsP6 is not only about the interaction between the 
enzyme and InsP6, but also the interactions between the enzyme and the lower inositol 
polyphosphates, which may react at a higher rate or act inhibitory to degradation. Since 
there was a higher InsP6 to product ratio in the separation on the current figure, it can be 
assumed that the hydrolysis was of an earlier stage. As a result, it can be proposed that 
although  more  InsP5(4/6-OH)  was  produced  initially,  it  got  further  hydrolysed  more 
quickly than the other InsP5 isomers, allowing those products to “catch up”. As for the 
other three mutants, it can be seen that the InsP5(1/3-OH) peak, rather than InsP5(5-OH), is 
the major InsP5 product, thus further demonstrating their positional specificity.
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Figure 3.2.3.5. The product profile of  BtMinpp “fungalizing” mutants.  Mutants of  BtMinpp 
was incubated with InsP6 and the products were resolved on a CarboPac PA200 column.  The 
identity of  the  enzyme is  labelled on the top left  of  each graph.  The traces  show absorbance 
monitored at 290 nm.
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The A324D/E325N double  mutant  was incubated with InsP6 and  two peaks of 
InsP4s were shown, as seen in figure 3.2.3.6. To identify which enantiomer of InsP5 was 
generated, the double mutant was incubated separately with firstly InsP5(1-OH) and then 
InsP5(3-OH).  As  shown in  figure  3.2.3.6,  the  A324D/E325N mutant  did  not  generate 
sufficient InsP4 to be detected when incubating with InsP5(1-OH), however two peaks, 
identical to the InsP4s generated when incubated with InsP6, were present in the product 
profile  with  InsP5(3-OH).  Therefore,  it  can  be  concluded  that  the  InsP5 produced  by 
A324D/E325N double mutant is in fact InsP5(3-OH) and not its enantiomer InsP5(1-OH). 
Though this method is useful for telling the enantiomers apart when only one InsP5 peak is 
present, and the InsP4 products are distinct, it gets much more complicated when more 
than one InsP5 peak is present.
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Figure 3.2.3.6. The product profile of A324D/E325N double mutant against InsP6, InsP5(1-
OH) and InsP5(3-OH).  From top to bottom: A324D/E325N double mutant was incubated with 
InsP6,  InsP5(1-OH)  and  InsP5(3-OH)  and  the  products  were  resolved  on  a  CarboPac  PA200 
column. The traces show absorbance monitored at 290 nm.
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3.2.4 Molecular Docking Simulation of InsP6 into the active sites 
of BtMinpp and fungal PhyA
Using AutoDock Vina (Trott et al. 2010), InsP6 was docked into the active sites of 
BtMinpp and PhyA from A. niger (Oakley 2010) (a close homologue to A. ficuum PhyA in 
the previous section). Productive binding modes were identified by their relative binding 
energies and binding proximity of the phosphate to the catalytic histidine (His59 in both 
enzymes).  Table  3.2.4.1 and  figure  3.2.4.1 shows  the  binding  modes  with  binding 
energies  within  1  kcal  mol-1 of  the  global  energy  minimum  and  with  phosphate 
phosphorous to His59 imidazole Nε2 atom distance of 4 Å or less. The S3 subsite is where 
the 3-sulfate is bound in the InsS6 complexes and the proposed cleavage site, while the S2 
subsite is where the 2-sulfate is bound in the InsS6 complexes. Three binding modes were 
found in  A. niger PhyA, all with InsP6 binding in the same orientation. Seven binding 
modes were found in  BtMinpp, with four of them non-redundant. The  in silico docking 
results  agree with the  in  vitro experiments,  showing that  3-,  5-,  and 6-phosphates  are 
potential targets of cleavage, thus generating InsP5(3-OH), InsP5(5-OH) and InsP5(6-OH) 
for BtMinpp. For  AnPhyA, 3-phosphate is the main target, and InsP5(3-OH) is the only 
InsP5 generated. In conclusion, BtMinpp has a greater positional promiscuity binding of 
InsP6 compared  to  the  fungal  phytase  PhyA.  Although  the  binding  modes  may  not 
necessarily translate to hydrolysis, this data agrees with the InsP6 hydrolysis profile from 
the previous section.
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Table 3.2.4.1 Predicted low energy binding modes resulting from  in silico docking of InsP6 to 
enzyme structures. Columns show the identities of the phosphate groups of InsP6 bound at either 
the S3 or S2 specificity subsites of  BtMinpp and PhyA (A. niger PhyA, PDB entry 3K4Q). The 
binding modes are indicated as either obverse (O) or reverse (R). The obverse mode is the same 
found  in  the  crystal  structure  of  the  InsS6 complexes,  while  the  reverse  mode  represents  the 
aforementioned InsS6 flipped along the  plane  of  the  inositol  ring  (while  keeping  the  original 
stereochemistry). 
Enzyme S3 Subsite (cleavage) S2 Subsite (binding) Binding Mode
BtMinpp D-5
D-6
D-3
D-6
D-6
D-1
D-2
D-5
R
R
O
O
A. niger PhyA D-3 D-2 O
Figure 3.2.4.1 Predicted binding modes of InsP6 and (A) PhyA and (B)  BtMinpp within 1 kcal 
mol-1 of  the  minimum binding  energy.  Selected  active  site  residues  are  shown as  sticks  and  
labelled. The enzyme molecular surfaces are shown in grey. (A) shows 3 binding modes, all with  
D-3 phosphate docked within the S3 subsite, and D-2 phosphate docked within the S2 subsite.  
Contrasting (B) with 7 modes, showing 4 different binding orientation, “cleaving” the D-3, D-5, or 
D-6 phosphate.
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3.2.5 Crystal Structures of Substrate-Bound BtMinpp E325N 
Mutant
Both H59A and E325N are mutants of BtMinpp with important catalytic residues 
removed  and  showed  little  to  no  activities  against  InsP6 as  substrate  (see  previous 
sections). Attempts were made to soak the crystals in solutions of mother liquor with the 
substrates InsP6 and InsP5(3-OH). While no electron density other than that of a single 
phosphate was seen at the catalytic pocket of the H59A mutant, electron density for the 
ligands can be seen in E325N soaked with both InsP6 and  InsP5(3-OH). Rmsds of 0.2Å 
and 0.3Å were observed for InsP6 and InsP5(3-OH) complexes of E325N against the wild-
type  phosphate  complex,  showing  no  significant  conformational  changes.  The  final 
structure  of  the  E325N-InsP6 complex  has  R  work  and  R  free  of  16.2% and  19.5% 
respectively, while the final structure of E325N-InsP5(3-OH) complex has R work and R 
free of 18.9% and 25.8% respectively.
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Table 3.2.5.1. Data collection and refinement statistics for InsP6 and  InsP5(3-OH) complexes of 
BtMinpp E325N mutant.
E325N-InsP6 complex E325N-InsP5(3-OH) complex
Data collection
Wavelength (Å) 0.9795 0.9795
Space group P 21 P 21
Cell parameters
a , b , c (Å)
β (°)
52.9, 120.6, 75.9
107.7
53.7, 119.8, 75.4
108.1
Resolution limit (Å) 50.25 – 1.81 (1.86 – 1.81) 39.94 – 2.45 (2.51 – 2.45)
Rmerge 0.043 (0.553) 0.091 (0.637)
(I)/sd(I) 15 (2.0) 9.1 (1.7)
Completeness (%) 98.8 (98.5) 97.6 (98.0)
Multiplicity 3.1 (3.1) 2.9 (3.0)
Overall temperature factor 
(Å2) 22.8 28.1
Refinement Statistics
Protein monomers per 
asymmetric unit 2 2
Total atoms 7111 6686
Water molecules 486 102
Rwork 16.2 % 18.9 %
Rfree 19.5 % 25.8 %
Ramachandran Analysis (%)
Most favoured
Outliers
98.1
0.4
93.5
0.5
RMS deviations
Bonds (Å)
Angles (°)
Planes (Å)
0.007
1.059
0.005
0.009
1.332
0.006
Mean Atomic B-value (Å2) 28.8 55.0
*Statistics for data in the high resolution bin are in brackets.
Rmerge = Σ | Ii - <I> | / Σ Ii where <I> is the average of symmetry equivalent reflections and the 
summation extends over all observations for all unique reflections.
Rwork = Σ | |Fo| - |Fc| | / Σ | Fo| where Fo and Fc are the measured and calculated structure factors, 
respectively.
For Rfree the summations extends over a randomly selected subset (5%) of reflections excluded 
from all stages of refinement.
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Figure 3.2.5.1 shows the simulated annealing omit maps of both InsP6 and InsP5(3-
OH). The electron density for the substrate was not as clear as those for the enzyme-
inhibitor  complexes  in  the  previous  chapter,  probably  due to  the  fact  that  the  E325N 
mutant still retains minor activity, and presumably resulted in a small amount of lower 
inositol  polyphosphate  products  binding  to  the  enzyme  molecules.  The  E325N-InsP6 
complex showed InsP6 binding with its 3-phosphate at the cleavage site, just as in the 
wild-type  BtMinpp-InsS6 complex, and agreeing with the product profile of E325N. For 
the E325N-InsP5(3-OH) complex, two orientations of InsP5(3-OH) were modelled into the 
catalytic pocket, both with P6 at the cleavage subsite (S3 according to the nomenclature of 
the above section). The obverse one with D-5 phosphate at the binding subsite (S2) has an 
occupancy of 35% after refinement, and the reverse one with D-1 phosphate at the binding 
subsite (S2) has an occupancy of 65% after refinement. The virtual docking experiment 
predicted that InsP6  binds to BtMinpp with 6-phosphate at the S3 subsite in both obverse 
and reverse mode, and the two modelled InsP5(3-OH) in the crystal structure show the 
same modes.
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Figure  3.2.5.1.  Simulated  annealing  omit  maps  revealing  the  location  of  InsP6 (A)  and 
InsP5(3-OH) (B) bound to the active site of BtMinpp E325N mutant. A region of the simulated 
annealing  omit  single  difference  electron  density  map  (green  lines)  (Brünger et  al. 1997) 
calculated with: data to a resolution of 1.81 Å and contoured at 2.1 σ for InsP 6 complex; data to a 
resolution of 2.45 Å and contoured at 2.1 σ for InsP5(3-OH) complex. Selected active site residues 
are shown in stick representation and labelled. C, N, O and P atoms are coloured in yellow, blue,  
red and purple  respectively.  The location of  the  substrate  in  the  final  refined structure  of  the  
complex is shown superimposed on the omit map electron density.
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The InsP6 complex of the E325N mutant was superimposed with the InsP6-bound 
E. coli phytase AppA (PDB code: 1DKQ)  (Lim et  al. 2000).  E.coli AppA is the only 
crystal structure of HAP phytase complexed with InsP6 which is available in the PDB. In 
the EcAppA crystal structure, the catalytic histidine was mutated to an alanine in order to 
produce a substrate-enzyme complex, and although the enzyme was reported to be a 6-
phytase, InsP6 was bound with 3-phosphate in the active site (Lim et al. 2000). BtMinpp 
has a larger binding pocket compared to EcAppA, especially at the S-5 and S-6 subsites. 
In  EcAppA,  Lys24  forms  polar  interactions  with  both  the  D-5  and  D-6  phosphates 
(distances between NZ atom to the closest oxygen atoms are 3.8 and 3.0 Å respectively),  
while Met216 has a steric effect on the D-5 phosphate. In contrast, the residues in the 
BtMinpp binding pocket form less interactions with the D-5 phosphate, and none with the 
D-6  phosphate.  It  appears  that  the  larger  binding  pocket  of  BtMinpp  rationalizes  the 
positional  promiscuity  of  the  enzyme (assuming that  the  E325N mutation  has  no  far-
reaching effects  on the size of binding pocket),  while  the narrower binding pocket  of 
EcAppA neatly explains that enzyme's reported preference towards the 6-phosphate of 
InsP6 substrate.
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Figure 3.2.5.2. Substrate binding pockets of BtMinpp (A) and EcAppa (B). The surfaces of the 
protein are shown, with selected residues at the outer surface displayed in stick representation. N,  
O and P atoms are coloured in blue, red and orange respectively. C atoms are coloured in: green  
for BtMinpp; cyan for EcAppa. Surfaces are coloured similarly to the C atoms.
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3.2.6 Comparison of Active Site Residues in BtMinpp and 
HsMinpp
The amino acid sequence of  BtMinpp was aligned with those of its  eukaryotic 
homologues  and the  conserved residues  identified  (figure  3.2.6.1).  These  enzymes all 
carry  the  histidine  acid  phosphatase  motif  RHGXRXP,  and  the  Minpp-specific  HAE 
(rather than HD) proton donor motif.
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Figure 3.2.6.1. T-coffee alignment of B. thetaiotaomicron, human, rat and chicken Minpp. The 
secondary structure from the crystal structure is aligned to the sequences. Absolutely conserved 
residues are highlighted in red, while conserved residues are coloured in red. Triangles indicate the 
residues within 6Å of the active site of BtMinpp. The alignment is visualized using ESPript (Gouet 
et al. 2003).
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A HsMinpp homology model was generated using this alignment. The generated 
model was then aligned to the BtMinpp-InsS6 complex to identify residues with 6Å of the 
InsS6 ligand. Table 3.2.6.1 shows the list of these residues, which are also labelled in the 
alignment with black triangles in figure 3.2.6.1. It can be seen that most of those residues 
are identical, and a few of the other ones are conservatively substituted such as arginine to  
lysine  and  isoleucine  to  leucine.  To  “humanize”  BtMinpp,  the  following  residues  are 
selected:  A31K  changes  a  non-polar  alanine  into  a  basic  lysine;  V147K  changes  a 
hydrophobic valine into a hydrophilic lysine; K195V does the opposite to V147K; S279K 
changes an uncharged serine into a negatively charged lysine. Olignonucleotde primers 
were designed for these mutants for single and multi site-directed mutagenesis.
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Table  3.2.6.1. A list  of  residues  surrounding  the  catalytic  pocket  of  BtMinpp  and  HsMinpp. 
BtMinpp-InsS6 complex was aligned with HsMinpp model, and residues within 6Å of InsS6 were 
picked. They are numbered according to BtMinpp in the coordinate file. * indicates that the residue 
differs  between  both  enzymes,  while  **  indicates  the  chosen  residues  for  mutagenesis 
experiments. Each pair of residues is assigned to a binding pocket whenever possible.
Res. # BtMinpp HsMinpp Binding subsites (S-)
30 T T 4
31** A K 4
58 R R 3/4
59 H H 3
62 R R 3/4/5
65 T T 1/5
66* S V -
147** V K 2
149 R R 1/2/3
150* S C -
183 R R 2
185 F F -
186 D D -
195** K V 6
275* R K 5
276 Q Q 4
279** S K 4/5
280* K R 4
322* A G -
323 H H 2/3
324 A A 3
325 E E 4
328* I L -
359* S V -
361* M Y -
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3.2.7 Enzymatic Studies of BtMinpp 'Humanized' Mutants
Except  for  the V147K mutant,  PCR mutagenesis  of  A31K, K195V and S279K 
mutants, along with the quadruple mutant containing all four mutations were successfully 
performed  and  the  products  were  verified  through  DNA sequencing.  The  resulting 
plasmids were transformed into Rosetta 2 (DE3) pLysS E. coli cells, and the mutants were 
successfully over-expressed and purified to homogeneity.
The relative  activities  of  the 'humanized'  mutants  against  InsP6 were compared 
with wild-type BtMinpp using phosphate release assays. Unlike the 'fungalized' mutants, 
most of the 'humanized' mutants showed enhanced activities, as shown in  table 3.2.7.1. 
The A31K mutant had slightly higher activity than the wild-type (130 %), the K195V 
mutant had twice the activity (214 %), and the S279K mutant had 12 times the activity 
(1198 %). However, when the mutations are combined along with V147K, the activity 
dropped to 16.3 % to that of wild-type.
Table 3.2.7.1. Relative activities of BtMinpp “humanzing” mutants with standard errors.
Enzyme Activity (%) Standard error
Wild-type 100 1
A31K 130 2
K195V 214 7
S279K 1198 109
Quadruple 16.3 1.2
Each  of  the  humanizing  mutants  was  incubated  with  InsP6,  and  their  products 
separated with HPLC, as shown in figure 3.2.7.1. Note that, unfortunately, this substrate 
had a minor  InsP5 contamination, which is revealed by the substrate only plot. All mutants 
appeared to be positionally promiscuous like the wild-type enzyme. Both the K195V and 
S279K mutants had produced a bigger ratio of InsP5(5-OH) compared to the other InsP5s, 
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just like the wild-type enzyme. However, the quadruple mutant produced a higher peak of 
InsP5(4/6-OH) compared to InsP5(5-OH).
Figure 3.2.7.1. The products of BtMinpp against InsP6 compared to that of the 'humanized' 
mutants.  Mutants of  BtMinpp was incubated with InsP6 and the products were resolved on a 
CarboPac PA200 column. The identity of the enzyme is labelled on the top left of each graph. The 
traces show absorbance monitored at 290 nm.
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In the results above, the quadruple mutant demonstrated different effects to that of 
individual single mutants. All the single mutants showed enhanced activities towards InsP6 
as a substrate, while a reduced activity was been observed with the quadruple mutant. 
Figure 3.2.7.2 shows the positions of the mutations relative to the InsS6 in the InsS6-
complexed wild-type crystal structure. The single site mutations A31K and S279K both 
made the active site more basic and positively charged, and presumably promotes binding 
of  acidic  and  negatively  charged  InsP6,  thus  increasing  the  activity  of  the  enzyme. 
However,  the  quadruple  mutant  involving  three  mutations  acted  contrarily  to  the  two 
aforementioned mutants. Unfortunately, the V147K mutant was not successfully produced 
and so the effect of this single residue remains undetermined. The wild-type active site is 
already highly basic and adding three additional basic residues may distort the shape of the 
catalytic  pocket,  hence  lowering  catalytic  activity.  However,  the  K195V  mutation 
enhanced the activity even though it removed a basic residue from the catalytic pocket.  
Inspection of  figure 3.2.7.2, reveals that the basic lys195 of the wild-type enzyme may 
‘pull’ the  acidic  substrate  away  from the  catalytic  nucleophile  His59,  thus  impairing 
enzyme activity. Replacing it with a non-polar residue like valine counteracted this effect, 
hence increasing the activity of BtMinpp.
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Figure 3.2.7.2. BtMinpp “humanizing” mutations and their positions relative to InsS6. InsS6-
complexed BtMinpp (green) was aligned with modelled HsMinpp (cyan). The InsS6 molecule and 
the mutated residues, along with the catalytic His59 are shown in stick representation.
3.4 Conclusion
In this chapter,  two series of site-directed mutagenesis  experiments of  BtMinpp 
have been reported. These series of mutations were designed with the aim of making the 
active site more like that of (i) fungal phytase and (ii) human Minpp. In the case of the 
'fungalized' mutants, the positional specificity of BtMinpp was found to have been limited, 
mimicking that of fungal phytase. In the case of the 'humanized' mutants, the ratio of the 
InsP5 products was successfully altered for the quadruple mutant (the most human-like of 
the mutants investigated) to be more like HsMinpp.
Structural  information  had  provided  valuable  insights  to  the  enzymatic  results, 
explaining  the  significantly  reduced  active  of  the  A324D/E325N  double  mutant. 
Furthermore, the use of the proton donorless E325N mutant has allowed substrate-enzyme 
complexes to be solved, allowing a closer inspection of the binding of substrate, which 
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was not possible with the wild-type protein. A greater understanding of the 'humanized' 
mutants would be provided if their structures were to be solved but this work was not 
possible within the timeframe of this project.
A trend seems to have appeared in the mutagenesis experiments.  BtMinpp has a 
basic catalytic pocket to accommodate the acidic InsP6.  Its activity was lowered when 
acidic  residues  are  introduced,  and  enhanced  when  single  basic  residues  were  added. 
However, it could be possible that the mutations shifted the pH optimum rather than just 
changing the rate. It would be useful, though time-consuming, to confirm the pH profiles 
of each mutant. It has also been demonstrated in this chapter with the 'humanized' mutant 
that, when attempting to change product profiles of the enzyme, a combination of residues 
may produce different results to that of single mutations, which is useful to keep in mind 
when designing new mutants.
Phytases are important to the agricultural industry. Some of the current commercial 
phytases face bottlenecks against InsP4 products (Mike Bedford, private communication), 
and HsMinpp are known to degrade inositol (1,3,4,5)-tetrakisphosphate  (Nogimori et al. 
1991). Thus, a BtMinpp mutated to be more human-like (the quadruple mutant produced 
in this chapter) could be potentially added to said phytases are remove the bottleneck. 
Detailed examination of the interactions between InsP4 and the enzyme would be useful 
but difficult and costly with the techniques used within this chapter, since there are 15 
different InsP4 and 20 different InsP3 compared to only six of InsP5.
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Chapter 4. Structure-function Studies of Minpp Enzymes 
from Gram-positive Commensal Bacteria in the 
Bifidobacterium Genus
Phytase activity  has  been reported in  two histidine acid phosphatases from the 
gram-positive  commensal  gut  bacteria  species  Bifidobacterium longum and 
Bifidobacterium pseudocatenulatum (Tamayo-Ramos et al. 2012). Both are HAP phytases 
containing  the  HAE  proton  donor  motif  unique  to  Minpp  enzymes.  The  human  gut 
microbiota has many essential  roles in the metabolism of the host,  and some bacterial 
strains in the  Bifidobacterium genus are considered probiotics,  beneficial to the host's 
health when administered (Tremaroli et al. 2012).
It is known that disordered regions in proteins leads to a reduced propensity for 
crystallization (Price et al. 2009). In order to increase the likelihood of obtaining crystals 
of diffraction quality, truncated constructs were designed for the Bifidobacterium Minpps. 
This chapter reports the production of recombinant Minpp from  Bifidobacterium longum 
(BlMinpp)  and  from  Bifidobacterium  pseudocatenulatum (BpMinpp),  their  enzymatic 
properties, and a high resolution crystal structure of BlMinpp.
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4.1 Experimental
4.1.1 Disorder Prediction
The  amino  acid  sequences  of  Minpps  from  both  B.  longum  (Uniprot  entry: 
B7GTV0)  (Sela et al. 2008) and  B. pseudocatenulatum  (Uniprot entry: C0BTR1) were 
submitted to the Protein DisOrder prediction System (PrDOS) server (Ishida et al. 2007). 
To predict where the signal sequences end, they were also submitted to the SignalP 4.1 
Server (Petersen et al. 2011) with default settings for proteins from gram-positive bacteria. 
Sequences of the Bifidobacterium Minpps were also aligned with that of BtMinpp using T-
coffee (Notredame et al. 2000).
4.1.2 Cloning of The Truncated Constructs
Minpp genes from both  B. longum and  B. pseudocatenulatum were supplied by 
Vicente  Monedero  (IATA-CSIC,  Spain)  in  pQE80 plasmids.  Primers  for  the  truncated 
contstructs were used with Phusion High-Fidelity DNA Polymerase (Thermo Scientific) 
and cloned into pOPINf plasmid using the In-Fusion Cloning kit (Clontech). The list of 
primers  are  recorded  in  Appendix  2.  The  products  were  verified  by  DNA  gel 
electrophoresis. The resulting pOPINf plasmids with the desired inserts were transformed 
into Stellar  Competent  E. coli cells  via  heat  shocking.  Plasmids from the successfully 
transformed cells were extracted and confirmed by sequencing. Verified plasmids were 
then transformed into Rosetta 2 (DE3) pLysS E. coli cells for protein expression.
4.1.3 Over-expression and Purification of Bifidobacterium Minpps
The truncated  BlMinpp and  BpMinpp proteins  were  overexpressed  in  the  cells 
produced by the methods described in the above section. The cells were harvested and 
lysed by french pressing, with the proteins purified from the cell free extract. The over-
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expression and the purification of the proteins were carried out in the same manner as 
described for BtMinpp in section 2.1.1 and 2.1.2.
Prior to crystallization,  partially purified Minpp from  B. longum was incubated 
overnight  at  4°C with 3C protease (Thermo Scientific)  to cleave the His-tag from the 
recombinant protein at the same time as being dialysed into 50 mM Tris-HCl pH 8, 300 
mM NaCl, 10 mM imidazole. The sample was then passed through an Ni-NTA resin to 
remove uncleaved protein. The flow-through was then further purified by gel filtration 
using a HiLoad 16/60 Superdex 75 gel filtration column (GE Healthcare) equilibrated with 
buffer (20 mM HEPES-NaOH pH 7.4, 150 mM NaCl, 5mM DTT), using an ÄKTAprime 
liquid chromatography system (GE Healthcare). The purity of the protein was assessed by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
4.1.4 pH profile of BlMinpp
To  produce  the  pH  profile,  a  phosphate  release  assay  (see  chapter  2)  was 
performed in a variety of buffers at a range of pH: pH 2.0 – pH 3.5 50 mM glycine-HCl; 
pH 4.0 – pH 5.5 50 mM sodium acetate; pH 6.0 – pH 8.5 50 mM HEPES-NaOH. Varying 
concentrations of  BtMinpp were incubated with 1 mM  InsP6 (Sigma) at 37  °C, and the 
reactions  were  diluted  20-fold  before  measurements.  The samples  were  normalised  to 
account for the enzyme concentration used for each pH.
4.1.5 HPLC profiles
Recombinant  BlMinpp and  BpMinpp were incubated with InsP6.  Enzymes were 
inactivated  by  boiling.  Products  of  InsP6 hydrolysis  were  separated  using  high 
performance liquid chromatography (HPLC), and detected by UV absorbance. To produce 
the final figures, enzymes were titrated to give detectable amounts of InsP5.
Inositol  phosphates were separated by high performance liquid chromatography 
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(HPLC) on a 3 mm x 250 mm CarboPac PA200 column (Dionex) and 3 mm x 50 mm 
guard  column  of  the  same  material.  The  column  was  eluted  with  a  gradient  of 
methanesulfonic acid delivered from solvent reservoirs A and B containing 60 mM and 
600 mM methane sulfonic acid, respectively. The gradient was delivered at a flow rate of 
0.4 mL/min according to the following programme: time (min), %B; 0, 10; 22, 60; 25, 
100, 38, 100. Solvents were delivered using a Jasco PU-2089i Plus inert quaternary pump 
and  samples  were  injected  at  49  min  intervals  using  a  Jasco  AS-2055i  Plus  inert 
autosampler. The solvent stream eluting from the column was mixed, using a mixing T, 
with a solution of 2% perchloric acid containing 0.1% w/v ferric nitrate delivered at a flow 
rate of 0.2 mL/min using a Jasco PU-1585 pump, before detection of peaks at 290 nm in a 
Jasco UV-2077 Plus UV detector.
4.1.6 Crystallization and X-ray Crystal Structure of BlMinpp
The purified BlMinpp was concentrated using a Vivaspin centrifugal concentrator 
(10,000  MWCO)  to  a  concentration  of  approximately  9  mg/ml.  Initial  crystallization 
screening  experiments  using  the  sitting  drop  vapour  diffusion  technique,  with  equal 
amounts  of  protein  and  well  solution,  were  carried  out  at  both  4°C  and  16°C,  with 
Structure Screens 1 and 2 (Jancarik et al. 1991), the JCSG-plus Screen (Page et al. 2003) 
and PACT premier (Newman et al. 2005). The conditions in which the crystals grew were 
then optimized. A single crystal grown in 0.01 M zinc chloride, 0.1 M MES pH 6.25, 18% 
(w/v) PEG 6000 at 16°C was harvested using a litho loop (Molecular Dimensions) into a 
solution containing mother liquor and PEG 400 prior to being stored in liquid nitrogen. X-
ray diffraction data  were collected on the  beamline  I02 at  the  Diamond Light  Source 
(Didcot, Oxfordshire).
Data  reduction  was  performed  with  xia2  (Winter et  al. 2013).  Molecular 
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replacement was performed with Phaser (McCoy et al. 2007) employing a model based on 
BtMinpp.  Alternate  rounds  of  automatic  and  manual  refinement  starting  from  the 
molecular replacement solution were performed with Phenix refine (Adams et al. 2010) 
and Coot (Emsley et al. 2010).
4.1.7 Differential Scanning Fluorimetry
Differential  scanning fluorimetry  (DSF) was performed using  a  Biorad  CFX96 
Real-Time PCR Detection System. The assays were carried out in volumes of 20 μl in a 96 
well PCR plate, with a temperature gradient in the range of 25°C and 95 °C, in 0.5 °C 
steps  with  20  seconds  equilibration  in  each  step.  Assays  consists  of  0.1  mg/ml 
recombinant BlMinpp and 50 mM glycine HCl pH 3.0, 50 mM sodium acetate pH 5.0 or 
50 mM HEPES-NaOH pH 7.0. SYPRO Orange (Life Technologies) was added to a final 
concentration of 5x for each reaction. Each condition was carried out in triplicate, and data 
was analysed by software from the manufacturer.
4.1.8 Structural Alignments
To obtain the root mean square deviation (rmsd) of Cα atoms between  BlMinpp 
and  BtMinpp  monomer  structures,  alignment  was  carried  out  using  DaliLite  pairwise 
structure  alignment (Hasegawa et  al. 2009).  To  align  BlMinpp  to  InsS6-complexed 
BtMinpp, the 'align' function was used in PyMOL (Schrödinger, LLC), and residues were 
selected based on their proximity to the oxygen atoms of the sulfate groups on InsS6.
To generate a model for BpMinpp, SWISS-MODEL (Biasini et al. 2014) was used 
to perform homology modelling with the crystal structure of BlMinpp as template.
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4.2 Results and Discussions
4.2.1 Designing Protein Constructs For Structural Studies
Both  B.  longum  and  B.  pseudocatenulatum  Minpp displayed N-terminal  signal 
peptides for secretion and a C-terminal sortase dependent cell wall-anchoring L(P/A)XTG 
domain  (Tamayo-Ramos et  al. 2012).  As  shown  in  figure  4.2.1.1,  the  histidine  acid 
phosphatase domain is flanked by a signal peptide and a linker to the anchoring domain. 
Since  the  signal  peptide  gets  cleaved  in  vivo,  and  the  flexible  linker  lacks  secondary 
structure, a construct with just the ordered catalytic domain should increase the propensity 
for the protein to crystallize.
Figure 4.2.1.1. Schematic of the domain structure of a Bifidobacterium Minpp. The histidine 
acid phosphatase domain is preceded by a signal peptide and followed by a flexible linker before  
the sortase dependent cell wall-anchoring LAXTG domain.
PrDOS predicted a small segment of the N-terminal and the majority of around 80 
residues at the C-terminal of the Minpp enzymes to be disordered (see figure 4.2.1.2). The 
small segment at the N-terminus represents a part of the signalling peptide, and the the last 
~80 residues represent the flexible linker and the sortase dependent cell wall-anchoring 
LAXTG anchoring domain.
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Figure 4.2.1.2. Output from PrDOS showing the predicted disordered regions of Minpp from 
B.  longum (top)  and  B.  pseudocatenulatum (bottom). The  y-axis  represents  the  disorder 
probability and the red line is the threshold with the false positive rate set at 5%.
The SignalP 4.1 Server predicted the first 32 amino acids of BlMinpp to institute 
signal peptide, cleaved at (PAQA↓MEAD) (see figure 4.2.1.3). For BpMinpp, the server 
did not give a conclusive result, but a weak signal can be seen at the 53 rd residue, cleaving 
at (AALA↓GEGT). This happened to align with that of the predicted cleavage sequence of 
BlMinpp.
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Figure 4.2.1.3. Output from SignalP 4.1 server showing the predicted signal peptide from B. 
longum (top) and B. pseudocatenulatum (bottom). The C-score (red) is at its peak right after the 
cleavage site. The S-score (green) is high for the signal peptide, while low for the mature protein. 
The Y-score (blue) is a combination of the two aforementioned scores.
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The sequences of  Bifidobacterium Minpps were aligned to that of  BtMinpp, and 
secondary  structure  of  BtMinpp was displayed on top  of  the  alignment.  As  shown in 
figure 4.2.1.4, the first α-helix in BtMinpp starts right after the predicted signal peptides 
of Bifidobacterium Minpp (BtMinpp already had its signal peptide replaced with His-tag), 
and the Bifidobacterium Minpp sequences goes on for another ~80 residues after the last 
α-helix in BtMinpp.
Figure  4.2.1.4.  Edited  T-coffee  alignment  of  BtMinpp,  BlMinpp  and  BpMinpp. Only  the 
sequences near the beginning and the end of the BtMinpp structure were shown here. Generated 
using ESPript (Robert et al. 2014).
The  final  designs  for  the  constructs  start  at  MEAD  (residue  number  33)  for 
BlMinpp and GEGT (residue number 53) for  BpMinpp, and terminate at DARI (res no. 
542) for BlMinpp and DARL (residue number 553) for BpMinpp. By cloning into pOPINf 
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vectors, cleavable His-tags were introduced at the N-termini of both recombinant proteins. 
Figure 4.2.1.5 shows the schematic of the resulting plasmids.
Figure  4.2.1.5.  Simplified  schemetic  of  BlMinpp  and  BpMinpp  in  pOPINf  plasmid. The 
Minpp gene was inserted between KpnI site at the 5' end and HindIII site at the 3' end. A His-tag 
was introduced at the beginning of the target gene. The T7 promoter and the  lac operon allows 
over-expression  of  the  target  protein  by  isopropyl  β-D-1-thiogalactopyranoside  (IPTG),  and 
ampicillin resistance for selection.
4.2.2 Cloning and Production of Bifidobacterium Minpp
The  PCR  experiments  was  carried  out  successfully.  Figure  4.2.2.1 shows  the 
product  separated  on  an  agarose  gel  along  with  the  linearised  pOPINf  vector.  The 
amplified genes were just above 1500 bp, which is the correct size. Vectors containing the 
Bifidobacterium Minpp genes were successfully transformed into Rosetta 2 (DE3) pLysS 
E. coli cells for protein expression.
112
Figure  4.2.2.1.  1%  agarose  gel  showing  the  PCR products  of  truncated  Bifidobacterium 
Minpp  along  with  the  linearised  pOPINf  vector. Lane  MW is  the  DNA ladder;  lane  1  is 
linearised pOPINf vector; lane 2 is the amplified BlMinpp gene; lane 3 is the amplified BpMinpp 
gene.
 For enzymatic studies, the proteins simply went through a two step purification 
procedure.  For  structural  studies,  BlMinpp  was  subjected  to  an  extra  step  of  His-tag 
cleavage by 3C protease. As shown in figure 4.2.2.2, the band for BlMinpp shifted after 
incubation with 3C protease, suggesting that the His-tag had been cleaved. After passing 
the sample through the Ni-NTA column again, an almost homogeneous product over fifty 
kDa  resulted,  which  was  further  purified  through  gel  filtration  before  crystallization 
experiments.
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Figure 4.2.2.2. 8% acrylamide SDS-PAGE gel showing 3C protease digest of BlMinpp. Lane 
MW is the DNA ladder; lane 1 is BlMinpp before incubation with 3C protease; lane 2 is BlMinpp 
after incubation with 3C protease; lane 3 is the digested sample after passing through Ni-NTA.
4.2.3 Enzymatic Studies of Recombinant Bifidobacterium Minpp
The  pH profile  of  BlMinpp  hasbeen  previously  reported  to  show a  single  pH 
optimum of  pH 5.5 at 50 °C with no activity at acidic pH (Tamayo-Ramos et al. 2012). 
Since  the  experiment  was  carried  out  in  citrate  buffer  at  acidic  pH,  and citrate  is  an 
inhibitor of HAPs (see chapter 2), the reliability of the results was questioned.
Figure  4.2.3.1 shows  a  more  reliable,  citrate-free  pH  profile  at  37°C.  Like 
BtMinpp, BlMinpp showed more than one pH optimum, at pH 5 and pH 7. As explained in 
the case of BtMinpp, pH affects the interactions between InsP6 and the active site, altering 
the relative activity. Interestingly, BlMinpp showed no activity at acidic pH even though it 
is a histidine acid phosphatase. 
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Figure 4.2.3.1. pH profile of BlMinpp. Percentage activity of BlMinpp plotted against pH.
BlMinpp  and  BpMinpp  were  incubated  with  InsP6,  and  the  resulting  products 
separated by HPLC, as shown in figure 4.2.3.2. Unfortunately, an impurity in the form of 
InsP5(1/3-OH)  was  present  in  the  substrate  used,  thus  it  is  uncertain  whether  the 
InsP5(1/3-OH)  peaks  in  the  profile  result  from  the  substrate  itself  or  the  enzyme 
hydrolysis. However, it is still clear to see that two of the other InsP5 peaks, InsP5(4/6-OH) 
and InsP5(5-OH) resulted from the enzyme hydrolysis. Therefore, this result suggests that, 
like BtMinpp, the Bifidobacterium Minpp enzymes are promiscuous with respect to InsP6 
hydrolysis.
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Figure 4.2.3.2. HPLC product profiles of  Bifidobacterium Minpp enzymes. Bifidobacterium 
Minpp enzymes were incubated with InsP6 and the products were resolved on a CarboPac PA200 
column.  The identity of the enzyme is labelled on the top left of each graph.  The traces show 
absorbance monitored at 290 nm.
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4.2.4 X-ray crystal structure of BlMinpp
Crystallization trials  of  BlMinpp were set  up with both His-tagged protein and 
protein without his-tag. Crystals of BlMinpp grew only from the protein without the His-
tag. Crystals grew in space group P1, as verified by Xtriage from the Phenix software suite 
(Adams et al. 2010).
To solve the structure of  BlMinpp, molecular replacement was carried out with a 
homology  model  based  on  the  crystal  structure  of  BtMinpp.  The  final  model  of  the 
BlMinpp crystal structure was solved at 1.65  Å, and was refined to R work and R free 
values of 15.3% and 17.7% respectively, with 3 residues (0.28%) in the disallowed region 
of the Ramachadran plot.
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Table 4.2.2.1. Data collection and refinement statistics for BlMinpp crystal structure.
BlMinpp
Data collection
Wavelength (Å) 0.9795
Space group P 1
Cell parameters
a , b , c (Å)
α, β, γ (°)
54.7, 72.9, 88.2
71.6, 72.1, 77.2 
Resolution limit (Å) 46.53 – 1.65 (1.69 – 1.65) 
Rmerge 0.059 (0.45)
(I)/sd(I) 8.4 (1.9)
Completeness (%) 96.3 (94.9)
Multiplicity 2.2 (2.1)
Overall temperature factor (Å2) 15.9
Refinement Statistics
Protein monomers per asymmetric unit 2
Total atoms 9328
Water molecules 1287
Rwork 15.3%
Rfree 17.7%
Ramachandran Analysis (%)
Most favoured
Outliers
98.11
0.28
RMS deviations
Bonds (Å)
Angles (°)
Planes (Å)
0.006
1.008
0.005
Mean Atomic B-value (Å2) 21.4
*Statistics for data in the high resolution bin are in brackets.
Rmerge = Σ | Ii - <I> | / Σ Ii where <I> is the average of symmetry equivalent reflections and the 
summation extends over all observations for all unique reflections.
Rwork = Σ | |Fo| - |Fc| | / Σ | Fo| where Fo and Fc are the measured and calculated structure factors, 
respectively.
For Rfree the summations extends over a randomly selected subset (5%) of reflections excluded 
from all stages of refinement.
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Two monomers  were  present  in  the  asymmetric  unit.  Like  BtMinpp and  other 
histidine acid phosphatases, the BlMinpp monomer consists of 2 domains, an α/β domain 
and an α-helical domain, as shown in figure 4.2.4.1 (A). Two Zn2+ ions were present at the 
interface between the two monomers, with one of the Zn2+ ion coordinated by His 242 
(monomer A), Glu 251 (monomer A), Asp 488 (monomer B) and a water molecule, as 
shown in figure 4.2.4.1 (B). The other Zn2+ ion interacts with the same residues but in the 
other monomer. Two more Zn2+ ions were found within the model, coordinating with Glu 
94,  His  326  and  a  water  molecule  in  each  monomer,  with  each  of  these  further 
coordinating with either aspartate or glutamate in monomers in symmetry mates. The zinc 
ions are probably an artefact of crystallization as it  likely aids the stabilization of the 
crystal  lattice.  Figure  4.2.4.1  shows  two  partially  reduced  disulfide  bridges  in  the 
monomer, between cys278 and cys291 (C), and between cys483 and cys501 (D). In the 
refined coordinates, the oxidized (cystine forming) conformer of cys278 had an occupancy 
of 0.40,  while  the reduced (free cysteine)  conformer had an occupancy of  0.60.   The 
oxidized  (cystine forming)  conformer  of  cys501 had an occupancy of  0.52,  while  the 
reduced  (free  cysteine)  conformer  had  an  occupancy  of  0.48.  Considering  that 
dithiothreitol (DTT) was used in preparation of the protein, and possible photoreduction 
effect  has  occurred  during  X-ray  data  collection,  a  reducing  environment  had  been 
produced for the crystal,  thus the disulfide bridges may be preferred in relatively less 
reducing environments.
119
Figure 4.2.4.1. Crystal structure of BlMinpp. The overall structure of BlMinpp monomer (A), 
with the α/β domain shown in magenta and the α-helices domain shown in cyan. One of the zinc  
ions at the monomer interface (B) is shown with carbon atoms in cyan, oxygen atoms in red and 
nitrogen  atoms  in  blue  respectively.  The  letter  in  brackets  on  the  figure  indicates  the  chain 
identifier. The disulfide bridges between cysteines 278 and 291 (C) and cysteines 483 and 501 (D).
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Despite  sequence  identity  of  only  22% between the  recombinant  BlMinpp and 
BtMinpp (discounting the His-tags), the overall folds of the protein are very similar, and 
an alignment between the Minpp monomers produced an rmsd of 2.2 Å between the Cα 
atoms. BlMinpp was significantly larger than BtMinpp with 515 amino acids (in the final 
truncated form, with His-tag cleaved), while BtMinpp has only 425 amino acids (counting 
the  His-tag  but  not  the  N-terminal  methionine).  Regions  of  polypeptide  insertion  are 
present in BlMinpp relative to BtMinpp. Overall, BlMinpp has more random coil content, 
and less secondary structure features, as shown in figure 4.2.4.2. Figure 4.2.4.2 (A) shows 
a region of insertion present in  BlMinpp following helix (141-158) relative to  BtMinpp, 
and said insertion leads to a stretch of random coil in BlMinpp in place of an ordered β-
strand in BtMinpp. Figure 4.2.4.2 (B) shows the insertion after helix (185-188), extending 
the random coil following the helix, while the latter part is incorporated into the following 
helix (206-220).  Figure 4.2.4.2 (C) shows that a small  helix (251-259 in  BlMinpp) is 
followed by a large helix (301-321 in BlMinpp) in both BlMinpp and BtMinpp, but a long 
stretch  of  random  coil-rich  region  (260-300)  has  been  inserted  into  the  structure  of 
BlMinpp, which in turn is stabilized by a pair of disulfide bridges.  Figure 4.2.4.2 (D) 
shows a region of random coil (453-466) between two β-strands which has been extended 
due to an insertion in BlMinpp relative to BtMinpp.
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Figure 4.2.4.2.  BlMinpp had regions of long insertion when compared with  BtMinpp. The 
protein structures are shown in cartoon representation,  with  BlMinpp in cyan and  BtMinpp in 
green.  Residues  numbers  were  shown  for  important  secondary  structures.  Cysteine  residues 
responsible for the disufide bridge in  BlMinpp were shown, with sulfur atoms in yellow, carbon 
atoms in cyan, oxygen atoms in red, and nitrogen atoms in blue.
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As with  BtMinpp, the active site  of  BlMinpp is  lined with basic  residues.  The 
crystal  structure  of  BlMinpp was  aligned with that  of  InsS6 complexed  BtMinpp,  and 
residues within approximately 4 Å of InsS6 were identified. Out of 15 residues identified, 
eight of them (53 %) were identical. Selected residues are displayed in  figure 4.2.4.3, 
showing some interesting differences between the active sites. Like eukaryotic Minpps, a 
lysine (Lys13) in  BlMinpp is found in place of an alanine (Ala31) in  BtMinpp. On the 
other  hand,  the  highly  conversed  RFFD  motif  in  Bacteroides and  eukaryotic  Minpp 
enzymes (see chapter 3) is replaced with YFHK in BlMinpp. A bulky hydrophobic Tyr189 
in BlMinpp replaces a basic Arg183 in BtMinpp, which may cause the binding of the D-2 
phosphate to be less preferable, thus preventing the D-3 phosphate to be the preferred one 
in the first step of InsP6 hydrolysis. On the other hand, basic residues His191 and Lys192 
in  BlMinpp replace hydrophobic Phe185 and the acidic Asp186 in  BtMinpp, which may 
increase  the  overall  affinity  for  InsP6 substrate.  When  comparing  the  Bifidobacterium 
Minpp enzymes, 18 out of 19 residues (95%) within 6 Å of the active site are identical 
between the crystal structure of BlMinpp and a model of BpMinpp. The only difference is 
that an isoleucine in BpMinpp is found in place of Met404 in BlMinpp. Since it is 4.3 Å 
away from the aligned substrate analogue, and that both residues are hydrophobic, it may 
be assumed that the replacement causes no significant effects (see also the HPLC product 
profiles).
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Figure 4.2.4.3. A comparison of active site residues in  BlMinpp and BtMinpp. BlMinpp and 
InsS6-complexed  BtMinpp were aligned, and side chains of interesting residues were displayed 
around   InsS6,  with  the  catalytic  histidine  (45  in  BlMinpp)  as  a  reference  to  the  active  site 
orientation. The BlMinpp residues were coloured in cyan, while BtMinpp residues were coloured 
in green.
4.2.5 Thermal stability of BlMinpp
Given  that  the  two  Bifidobacterium Minpps  are  very  similar,  the  one  that 
crystallized was chosen for further characterization. The thermal stability of BlMinpp was 
investigated via differential scanning fluorimetry at one of its pH optima (pH 5.0) and at 
pH 3.0 where the enzyme was inactive.  Figure 4.2.5.1  shows results of the experiment 
and table  4.2.5.1  shows  the  melting  temperatures  obtained.  BlMinpp  demonstrated  a 
melting temperature of 43.5 °C at pH 5.0, which is above the human body temperature. At 
pH 3.0, a pH where the enzyme had little activity, no discernible melting temperature was 
observed in the melt curve, suggesting the protein has unfolded at low temperatures. The 
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unfolding of the  BlMinpp at low temperature at low pH may explain why the enzyme 
shows little activity despite being a histidine acid phosphatase. The melting temperature of 
37.5 °C at pH 7.0 suggests why two pH optima are present at 37 °C, but only one pH 
optimum was reported (50 °C) (Tamayo-Ramos et al. 2012).
Figure 4.2.5.1. DSF results for  BlMinpp at different pHs.  Representative traces were chosen 
from the  triplicates. The  rate  of  change  in  relative  fluorescence unit  against  temperature  was 
plotted against temperature, with the peaks indicating the melting temperature of the enzyme.
Table 4.2.5.1. Melting temperatures of BlMinpp at different pH.
pH Melting temp. (°C)
3.0 ND
5.0 43.5
7.0 37.5
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4.3 Conclusion
In this chapter, the apo-structure of a Minpp from a gram-positive commensal gut 
bacterium is reported. Solving the X-ray crystal structure of an InsS6-complexed BlMinpp 
would provide further insight to its catalytic properties. Unfortunately, the crystals of the 
enzyme only grew in the presence of zinc and absence of InsP6. Attempts to soak InsP6 
into pre-grown crystals of the apo-enzyme were unsuccessful as added InsP6 chelates to 
zinc causing the crystals  to  dissolve.  Attempts were made to wash the crystals  before 
soaking it with InsS6 containing mother liquor with no success.
Minpp enzymes from  Bifidobacterium behaved like typical Minpps in terms of 
their positional specificity against InsP6, being catalytically promiscuous and producing 
multiple InsP5 products. At 37 ºC,  BlMinpp showed multiple pH optima, similar to that 
seen for BtMinpp. However,  BlMinpp appeared to be inactive at low pH despite being a 
member  of  the  histidine  acid  phosphatase  superfamily.  The  results  of  DSF  analysis 
suggests that this may be due to it being unfolded at acidic pHs. The crystal structure 
revealed  that,  compared  to  BtMinpp,  BlMinpp  has  more  random coil  than  secondary 
structure features, which may explain its tendency to unfold. Since the average human 
body temperature is 37 ºC, BlMinpp would only be active in slightly acid to neutral pH in 
the  human  body.  In  fact,  it  may  be  unnecessary  for  BlMinpp  to  be  active  in  acidic 
environments because species from the Bifidobacterium genus reside in the colon where 
the pH is slightly acidic to neutral. 
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Chapter 5. Improving Thermostability of BtMinpp by 
Engineered Disulfide Bridges
Enzymes  with  phosphatase  activity  towards  InsP6 have  potential  application  in 
industry as animal feed supplements (Lei et al. 2013). Since phytases used in feeds need to 
be able  to withstand high temperatures (60 to 90  °C) temporarily during the pelleting 
(Wyss et al. 1998), the search for thermostable phytases is a hot spot for research (Fei et  
al. 2013; Fonseca-Maldonado et al. 2014; Kim et al. 2008; Sanchez-Romero et al. 2013; 
Wyss et  al. 1998).  The methods employed to enhance thermostability  in  phytases  has 
included direct evolution (Kim et al. 2008), introduction of disulfide bridges (Sanchez-
Romero et  al. 2013)  or  salt  bridges  (Fei et  al. 2013),  and  glycosylation  (Fonseca-
Maldonado et al. 2014). However, engineered disulfide bridges can be both stabilizing and 
destabilizing, and stabilizing disulfide bridges have a large loop size and a location that 
involves a flexible part of the molecule  (Matsumura et  al. 1989). Molecular dynamics 
simulations had been reported to provide insight into flexible regions of a protein as it 
unfolds, and helps rationalizing the design of non-natural disulfide bridges that enhance 
the thermostability  of a  protein (Le et  al. 2012).  In  this  chapter,  attempts  to  engineer 
disulfide bridges into BtMinpp are described and the resulting mutants characterized.
5.1 Experimental
5.1.1 Molecular Dynamics Simulations of BtMinpp
Gromacs 4.6.5, along with the GROMOS96 54a7 force field was used to perform 
MD simulations (Pronk et al. 2013). MD simulations in aqueous solutions were performed 
at three different temperatures (300 K, 400 K and 500 K) for 2 nanoseconds. A monomer 
of phosphate-bound BtMinpp with residues added in place of the unresolved polypeptide 
in a flexible loop of the crystal structure was used in the experiment. The simulations were 
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performed in a cubic box with sides at least 5 Å from the molecule. The box was solvated 
with water molecules, with 34 chloride counter ions to ensure charge neutrality. Prior to 
the unrestrained MD simulations, energy minimization and position-restrained MD were 
performed to equilibrate the water molecules in the box. Root mean square fluctuations 
(r.m.s.f.) of the Cα atoms was calculated with the original model as a reference.
5.1.2 Designing Disulfide Mutants
The coordinates of phosphate-bound BtMinpp structure were input to the Disulfide 
by Design 2 server (Craig et al. 2013). Figure 5.1.2.1 shows the schematic of a disulfide 
bridge. Parameters for predicted disulfides were restricted to -87 ± 20 ° or +97 ± 20 ° for 
χ3 angles, and 114.6 ± 10 ° for the Cα-Cβ-Sγ angle. The generated disulfide pairs were 
picked based on their combined B-factors and bond energies.
Figure  5.1.2.1.  Schematic  of  a  disulfide  bridge. The  Cα,  Cβ,  Sγ atoms and the  χ3 angle  are 
annotated.
5.1.3 Multi Site-directed Mutagenesis
Mutagenesis PCRs were carried out in 20 μl reactions with QuikChange Lightning 
Multi  Site-Directed  Mutagensis  Kit  (Agilent  Technologies)  according  to  the 
manufacturer's instructions. The list of primers used are shown in Appendix 2. The PCR 
products  were  verified  by  gel  electrophoresis  and  transformed  into  XL-10  Gold 
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Ultracompetent  E.  coli cells  via  heat  shocking.  Plasmids  from  the  successfully 
transformed cells were extracted and sequenced. Verified plasmids were then transformed 
into Rosetta 2 (DE3) pLysS E. coli cells for protein expression. 
5.1.4 Over-expression and Purification
Transformed Rosetta 2 (DE3) pLysS E. coli cells were grown in Lysogeny Broth 
(LB) medium with ampicillin, until an OD600 of 0.6 was reached. Over-expression of the 
protein was then induced by adding isopropyl β-D-1-thiogalactopyranoside (IPTG) to a 
final concentration of 0.5 mM, and incubated overnight at  30 °C. The cells were then 
harvested by centrifugation and lysed by sonication.
The resulting cell free extracts were purified via immobilized metal ion affinity 
chromatography (IMAC) using His GraviTrap columns (GE Healthcare). The purity of the 
samples were assessed by SDS-PAGE, desalted using a PD-10 column into 20 mM Tris 
HCl pH 7.4, 150 mM NaCl, and quantified by measuring absorbance at 280 nm using 
extinction coefficient calculated with sequence data (Gill et al. 1989). The protein samples 
were then stored at -80 °C after the addition of glycerol to 30% (v/v).
5.1.6 Differential Scanning Fluorimetry
Differential  scanning fluorimetry  (DSF) was performed using  a  Biorad  CFX96 
Real-Time PCR Detection System. The reactions were carried out in volumes of 20 μl in a 
96 well PCR plate. A temperature gradient was set up between 25°C and 95 °C, in 0.5 °C 
steps  with  20  seconds  equilibration  in  each step.  Prior  to  the  experiment,  the  protein 
samples were dialysed into a buffer of 20 mM HEPES pH 7.4, 150 mM NaCl. Protein 
concentration of 0.1 mg/ml was used for wild-type BtMinpp and the cysteine free mutant, 
and 0.2  mg/ml  was  used  for  the  A292C-A416C mutant. For  the  reducing conditions, 
dithiothreitol (DTT) was added to a final concentration of 50 mM. SYPRO Orange (Life 
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Technologies) was added to a final concentration of 5x for each reaction. Each condition 
was carried out in triplicate and data was analysed using software from the manufacturer.
5.1.7 Activities and Protease Sensitivities
The  relative  phytase  activities  of  the  mutants  were  measured  using  the 
PiColorLock  Gold  Phosphate  Detection  System  (Innova  Biosciences)  as  described  in 
Chapter 2. 50 ng/ml protein were incubated with 1 mM InsP6 (Sigma) in 50 mM glycine 
HCl pH 3.5 at 37°C for 20 minutes, and was diluted 20-fold before mixing with the colour 
reagent.
In  order  to  determine  the  protease  sensitivities,  porcine  trypsin  (1922  BAEE 
units/mg) and pepsin (3839 units/mg) (both from Sigma) were dissolved in 1 and 10 mM 
HCl, respectively, to make 1 mg/ml stock solutions. Reactions were set up in volumes of  
100 μl, with 10 μg (0.1 mg/ml) of protein each. Reactions with trypsin were carried out in  
100 mM HEPES NaOH pH 7.5, with protein/protease ratios (w/w) of 50, 100, 200 and 
1000.  Reactions  with  pepsin  were  carried  out  in  100  mM glycine  HCl  pH 2.5,  with 
protein/protease ratios (w/w) of 100, 200, 400 and 1000. Protein-protease mixtures, along 
with a protease-free standard were incubated at 37 °C for 2 hours, and stopped by either 
boiling (for SDS-PAGE analysis) or by incubation on ice (for testing of residue activity). 
To measure the residual activity, the protein-protease mixtures were diluted 500-fold into a 
solution of 1 mM InsP6 (Sigma) in 100 mM sodium acetate pH 3.5 at 37°C for 20 minutes 
and were diluted 20-fold before mixing with the colour reagent.
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5.2 Results and Discussions
5.2.1 Design of Disulfide Bridge Mutants
Molecular dynamics can be used to study the folding and unfolding of proteins 
(Fersht et al. 2002). Simulations of BtMinpp were run at tempertures of 300, 400 and 500 
K for 2 nanoseconds, and their r.m.s.f. were calculated, as shown in figure 5.1.1.1 (A). As 
expected, the residue r.m.s.f. generally increased with temperature, and regions with high 
r.m.s.f. are mostly consistent at different temperatures. However, the r.m.s.f. values for the 
region  between  residues  145  and  200  are  low  at  300K,  but  increased  at  higher 
temperatures, suggesting that the region may be among the first to unfold in the protein. 
Figure 5.1.1.1 (B) shows where this unfolding region is located in the tertiary structure. 
This corresponds to a surface-exposed strand of amino acids mainly in the α/β domain and 
continuing into the interface between α/β domain and α-helical domain. It seems logical 
that the protein begins unfolding at the surface-exposed strand (as opposed to unfold from 
inside out). Stabilizing this strand may delay the unfolding of the protein, thus increasing 
the enzyme thermostability.
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Figure 5.2.1.1. R.m.s.f. of BtMinpp residues as a function of temperature calculated from MD 
simulations. (A) Figure presented the r.m.s.f. values plotted residue number, with results for 300 
K coloured in blue, 400 K coloured in orange, and 500 K coloured in yellow. Positions of the 
desgined disulfide bridges are indicated on the graph. (B) Figure presented the model of BtMinpp 
in orthogonal views, with the unfolding region coloured in red, and the rest of the protein coloured 
in green.
The Disulfide by Design 2 (DbD2) server selects potential disulfide candidate pairs 
based on (i) the potential to form cystines with appropriate angles (see experimental), and 
(ii) on the basis that ideal candidate pairs have low disulfide bond energies (Craig et al. 
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2013). Aside from the angles, large loop length and high B-factors (residues from regions 
of high mobility) are instrumental in creating stabilizing disulfide bonds (Matsumura et al. 
1989).  For  BtMinpp, ideal candidate residue pairs would fit all these criteria, as well as 
including a  residue  between number 145-200 in the structure.  Unfortunately,  applying 
these  criteria  did  not  lead  to  the  identification  of  suitable  residue  pairs  using  DbD2. 
Instead, two pairs of residues to form disulfide bridges were selected that satisfied most of 
the criteria (see figure 5.2.1.2). The Y27C-W269C pair links the N terminus to the core of 
the protein, stabilizing the α-helical domain. The A292C-A416C pair links the C terminus 
to the core of the protein, stabilizing the α/β domain.
Figure  5.2.1.2.  Model  of  BtMinpp  with  the  two  designed  disulfide  bridges. The  overall 
structure was displayed in green cartoon representation, and the designed disulfide bridges were 
displayed as sticks, with sulfur atoms coloured yellow.
5.2.2 Cloning and Preparation of BtMinpp Disulfide Mutants
To  generate  disulfide  bridge  mutants,  the  plasmid  for  a  cysteine  free  mutant 
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(C160S-C344S-C396S) was first generated to avoid any adventitious interactions between 
existing cysteines with those newly introduced. Figure 5.2.2.1 shows the products of the 
PCR, which amplified the mutant plasmid successfully, and that the reaction gave more 
products  with  the  addition  of  Quiksolution (Agilent  Technologies),  which  is  packaged 
DMSO. The PCR product was transformed into XL10-Gold ultracompetent E. coli cells. 
Colonies were picked and plasmid preps were performed for verification by sequencing. 
Employing the correct plasmid sample of the cysteine free mutant, further mutagenesis 
PCR were performed with the Y27C-W269C and the A292C-A416C primer pairs, as well 
as the quadruple cysteine mutant using both pairs of primers. The plasmids containing 
Y27C-W269C,  A292C-A416C  and  the  quadruple  cysteine  mutations  were  amplified 
successfully and verified via sequencing. Plasmid samples with the correct sequences were 
transformed into Rosetta 2 (DE3) pLysS E. coli cells for protein expression.
Figure 5.2.2.1. 1% agarose gel showing the PCR products from the mutagenesis.  From left to 
right: DNA ladder, template DNA, PCR products from reaction performed with Quiksolution, PCR 
products from reaction performed without Quiksolution.
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Both the cysteine-free mutant  and the  A292C-A416C mutant  were successfully 
over-expressed and purified. The Y27C-W269C and the quadruple cysteine mutants were 
over-expressed successfully but the proteins isolated to the insoluble fraction after cell 
lysis, possibly suggesting improper folding.  As the Y27C-W269C mutant replaces two 
bulky aromatic residues with cysteines, it may destabilize the fold of the protein. It may 
also be due to the formation of undesirable inter-molecular disulfide bridges between the 
newly introduced cysteines  (since  the cytosolic  environment  is  reducing these  bridges 
probably formed after cell lysis).
5.2.3. Verification of Disulfides
To demonstrate the removal of cysteines in the cysteine free mutant, SDS-PAGE 
was  performed in  the  presence  and absence  of  the  reductant  dithiothreitol  (DTT).  As 
shown  in  figure  5.2.3.1,  recombinant  wild-type  BtMinpp  protein  monomer  has  an 
apparent molecular weight of 40 kDa in the presence of DTT, while an extra band at 
around 80 kDa was present in the absence of DTT. On the other hand, the cysteine free 
mutant only showed the 40 kDa monomer band in both the presence and absence of DTT. 
This suggests that the recombinant wild-type protein dimerized by forming intermolecular 
disulfide bridges. The lack of a dimer suggests that most, if not all of the cysteines were 
replaced in the cysteine free mutant, and coupled with the fact that the sequencing results 
for the plasmid was positive, the presumption is that there are no cysteine residues in the 
protein.
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Figure  5.2.3.1.  10  %  acrylamide  SDS-PAGE  gel  comparing  BtMinpp  and  cysteine  free 
mutant with and without reductant. Lane 1 is  the recombinant  wild-type protein with DTT 
added; lane 2 is the recombinant wild-type protein without DTT; lane 3 is the cysteine free mutant  
with DTT added; lane 4 is the cysteine free mutant without DTT; lane MW is the molecular weight 
marker.
In the absence of DTT, the A292C-A416C mutant ran slightly lower in molecular 
weight on a SDS-PAGE gel, as shown in figure 5.2.3.2. This demonstrated the formation 
of a disulfide bridge in non-reducing condition, shortening the amino acid chain (since the 
protein was linearised in the SDS-PAGE experiment), thus causing the protein to appear 
smaller.
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Figure  5.2.3.2.  10  %  acrylamide  SDS-PAGE  gel  comparing  BtMinpp  cysteine  free  and 
A292C-A416C mutant with and without reductant. Lane MW is the molecular weight marker; 
lane 1 is the cysteine free mutant with DTT added; lane 2 is the cysteine free mutant without DTT; 
lane 3 is the A292C-A416C mutant with DTT added; lane 4 is the A292C-A416C mutant without 
DTT.
5.2.4. Investigation of Melting Temperatures by DSF
To investigate whether the introduced disulfide bridge has an effect on the thermal 
stability of BtMinpp, differential scanning fluorimetry (DSF) was employed to determine 
the melting temperature of the enzymes. Table 5.2.4.1 shows the melting temperatures of 
BtMinpp and its mutants obtained by DSF in figure 5.2.4.1. In the absence of DTT, where 
the disulfide bridges were allowed to form, the cysteine free mutant showed a 1.0 °C 
decrease in melting temperature compared to the wild-type protein, suggesting that the 
removal of cysteines lowers thermostability. This is not surprising as the wild-type protein 
contains cysteine residues that allow the formation of dimers, thus probably has stabilizing 
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effect  on  the  protein.  For  the  A292C-A416C mutant,  two  melting  temperatures  were 
found, with the first one 1.0 °C lower than that of the cysteine free mutant, and the other  
one  7.5  °C higher.  Since  the  A292C-A416C mutant  was intended to  stabilize  the  α/β 
domain, it may be that the lower melting temperature represents the unfolding of the α-
helical domain, while the α/β domain unfolds at a higher temperature. However, there is 
no data  which  establishes  this  unambiguously.  In  the  presence  of  DTT,  the  wild-type 
protein  showed  a  1.5  °C  decrease  in  melting  temperature  compared  to  the  condition 
without DTT. As explained earlier, the cysteines in the wild-type protein forms stabilizing 
intermolecular  disulfide  bridges,  and  reducing  them caused  a  drop  in  thermostability. 
Unexpectedly, the cysteine free mutant also showed a reduction in thermostability in the 
presence of  DTT, which may indicate  that  DTT has  further  destabilizing effect  to  the 
protein  above  and  beyond  that  arising  from  the  reduction  of  disulfide  bridges. 
Interestingly,  the  A292C-A416C  mutant  had  the  highest  melting  temperature  in  the 
presence of DTT, suggesting increased thermostability.
Table 5.2.4.1. Melting temperatures of BtMinpp and mutants with and without DTT.
Melting temp. (°C) +DTT -DTT
WT 44.5 46.0
Cysteine free 44.0 45.0
A292C-A416C 45.0 44.0, 52.5
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Figure 5.2.4.1. DSF analysis of  BtMinpp and engineered mutants.  The DSF experiment was 
carried out in both the presence (A) and absence (B) of DTT.  Representative traces were chosen 
from the  triplicates. The  change  in  relative  fluorescence  unit  against  temperature  was  plotted 
against  temperature,  with the  peaks representing the  melting  temperature  of  the  enzyme.  The  
results  for wild-type (WT) were coloured in blue,  cysteine free mutant (CF) were coloured in 
orange, and A292C-A416C mutant (S2) were coloured in yellow.
5.2.5. Relative Phytase Activities
The relative activities of cysteine free and A292C-A416C mutants against InsP6 as 
substrate were compared with wild-type recombinant  BtMinpp using phosphate release 
assays at pH 3.5 and 37 °C. As shown in figure 5.2.5.1, the cysteine free mutant and the 
A292C-A416C mutant showed 59 ± 7 % and 77 ± 4 % activity compared to that of the 
wild-type, respectively. Since the mutations do not affect the active site, the origin of this 
effect is unclear.
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Figure 5.2.5.1. Relative activities of BtMinpp and the disulfide mutants. From bottom to top: 
wild-type  protein,  cysteine  free  mutant  (CF)  and  A292C-A416C  mutant  (S2).  Each  bar  is 
accompanied with an error bar representing one standard error.
5.2.6. Protease Sensitivity
BtMinpp  and  mutants  were  tested  for  their  protease  sensitivities.  Wild-type 
BtMinpp, cysteine free,  and  A292C-A416C mutants were incubated with protease and 
analysed  with  SDS-PAGE.  For  the  wild-type  enzyme  (see  figure  5.2.6.1  (A)),  the 
degradation profile by trypsin showed multiple bands, suggesting that parts the protein 
sample had been proteolysed  into fragments of different molecular weights. Except for 
the lane with the highest typsin concentration, the high molecular weight bands are the 
dominant ones, suggesting that majority of the protein either (i) remain undigested or (ii) 
that only small fragments from one or both the termini of the protein were cleaved, thus 
probably  not  affecting  the  catalytic  core  of  the  protein.  At  the  highest  trypsin 
concentration, most of the bands disappeared, suggesting that the protein has been broken 
down into low molecular weight fragments that cannot be observed on the gel. Wild-type 
enzyme  degradation  by  pepsin  showed  two  high  molecular  weight  bands,  and  their 
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intensities remain constant regardless of the pepsin concentration, suggesting that (i) little 
proteolysis had taken place and (ii) pepsin cleaves small fragments from one or both the 
termini of the protein with high specificity. The results were similar for the cysteine free 
mutant (see figure 5.2.6.1 (B)), except that only one band is visible for the degradation by 
pepsin. However, in a similar fashion to the wild-type, the intensity of staining remains 
constant regardless of pepsin concentration.  For the A292C-A416C mutant (see  figure 
5.2.6.1  (C)),  similar  bands  to  the  wild-type  appeared  for  trypsin  degradation,  but  the 
intensity of the bands fade more rapidly as trypsin concentration increased. For pepsin 
degradation, only faint bands can be seen, suggesting the protein had been broken down 
into small fragments.
Since the cysteine free mutant gave similar results to wild-type BtMinpp in SDS-
PAGE in terms of protease degradation, only wild-type BtMinpp and A292C-A416C were 
selected to further test for their residual activities against trypsin (see figure 5.2.6.1 (D)) 
and pepsin (see figure 5.2.6.1 (E)). The residual activities for wild-type enzyme dropped 
gradually in increasing concentrations of trypsin between trypsin/protein (w/w) ratios of 0 
to 0.01, but it dropped to 8.2 ± 0.4 % at a ratio of 0.02. This corresponds to the drop in 
band intensities on the SDS-PAGE gel, further suggesting that the protein had been mostly 
degraded. Compared to the wild-type, the residual activities for A292C-A416C dropped 
more rapidly in increasing concentrations of trypsin,  which corresponds to the drop in 
band intensities on the SDS-PAGE gel. Wild-type enzymes remains relatively unaffected 
by pepsin, with activity remaining at 58.5 ± 1.8 % even at a pepsin/protein (w/w) ratio of 
0.01. However, there are little residual activities for A292C-A416C after incubation with 
pepsin. The residual activities appear to correlate with band intensities on the SDS-PAGE 
gel. To conclude, the A292C-A416C disulfide bridge mutant showed decreased protease 
resistance compared to the wild-type BtMinpp.
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Figure  5.2.6.1  Protease  sensitivity  of  the  wild-type  and  mutant  Minpp  enzymes.  15% 
acrylamide SDS-PAGE gels for protease incubation with wild-type  BtMinpp (A), cysteine free 
mutant  (B) and  A292C-A416C mutant  (C).  Lane MW is the molecular marker;  lane 1 shows 
Minpp  enzyme  without  addition  of  protease;  lane  2  –  5  shows  degradation  by  trypsin,  with 
Minpp/trypsin ratios (w/w) of 1000, 200, 100 and 50 respectively; lane 6 – 9 shows degradation by 
pepsin, with Minpp/pepsin (w/w) ratios of 1000, 400, 200 and 100 respectively. Residue activities 
with trypsin (D) and pepsin (E) were plotted against protease/protein ratios.
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5.3 Conclusion
This chapter describes the design of disulfide bridge mutants of BtMinpp, and the 
successful  production  of  the  A292C-A416C disulfide  bridge  mutant  along  with  the 
cysteine free mutant. The A292C-A416C mutant showed a second melting temperature of 
52.5 °C, which suggests that the introduced disulfide bridge may have stabilized the α/β 
domain and prevented it unfolding below 52.5 °C. However, it is unlikely for the enzyme 
to function with only one domain since the active site is sandwiched between the two 
domains,  thus  the  first  melting  temperature  of  44.0  °C should  provide  a  more  useful 
indicator as to when the enzyme loses activity, which is less than that of the wild-type 
(46.0  °C  in  non-reducing  condition).  Moreover,  the  mutant  is  more  susceptible  to 
proteolysis  by  trypsin  and  pepsin,  which  is  far  from ideal.  On  the  other  hand,  these 
experiments have shown that wild-type  BtMinpp is resistant to degradation by digestive 
enzymes, which is unsurprising since the enzyme is produced naturally by bacteria in the 
human gut. 
As explained in the results section, there were no disulfide candidates that satisfied 
all criteria for a stabilizing mutant. Although the chosen candidates had ideal angles, low 
predicted bond energies and a long loop length, but the residues lacked high B-factors, and 
none of the designed disulfide bridges have residues in the region predicted to be first to 
unfold.  Therefore,  it  is  possible  that  the  introduced  disulfide  bonds  has  caused 
destabilizing effects rather than stabilizing ones, which may help explain why the A292C-
A416C mutant has a lower melting temperature and reduced protease resistance compared 
to  the  wild-type.  The  same  rationale  can  explain  why  the  Y27C-W269C  mutant  is 
insoluble.
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Chapter 6. Cloning, Expression, Purification and 
Crystallization of Potato Kinases
Potato (Solanum tuberosum) is one of world's largest food crops. Homologues of 
inositol  kinases IPMK and IPKα are found in the genome of potato.  The IPMK from 
Saccharomyces  cerevisiae (yeast),  ScIpk2  (aka  Arg82,  ArgRIII)  is  known  to  regulate 
arginine  biosynthesis  by  stabilizing  transcriptional  complexes,  as  well  as  producing 
Ins(1,4,5,6)P4 and  Ins(1,3,4,5,6)P5 (Odom et  al. 2000).  To  show that  potato  IPMK is 
functionally equivalent to ScIpk2, it was cloned into the mutant yeast strain ScIpk2Δ and 
was able to  restore arginine biosynthesis (Caddick et al. 2007).  An ITPK1 homologue 
from  potato,  alternatively  named  StIPKα,  exhibited  phosphatase  and  intersubstrate 
phosphotransferase  ability  similar  to  human  ITPK1  (Caddick et  al. 2008).  StIPKα  is 
versatile,  showing  (i)  kinase  activity  towards  Ins(3,4)P2,  Ins(1,3,4)P3,  Ins(1,4,6)P3, 
Ins(3,4,5)P3,  Ins(3,4,6)P3 and  Ins(3,4,5,6)P4;  (ii) phosphomutase  activity  between 
Ins(1,3,4,5)P4 and Ins(1,3,4,6)P4; (iii) phosphotransferase activity, transferring a phosphate 
from Ins(1,3,4,5,6)P5 to either Ins(1,3,4)P3 or ADP (Caddick et al. 2008).
 Since  the  synthesis  of  higher  inositol  polyphosphates  are  dissimilar  across 
different  kingdoms  of  life,  analysis  of  crystal  structures  of  StIPMK and  StIPKα may 
provide helpful insight into the synthesis of higher IPs in plants. Considering that phytate 
is an anti-nutrient, and knockout studies has shown homologues of IPMK and ITPK1 are 
responsible  for  phytate  accumulation  in  plant  seeds  (AtIPK2β from  Arabidopsis 
(Stevenson-Paulik et al. 2005) and ZmIPK from Zea mays (Shi et al. 2003) respectively), 
structural insights may prove useful in decreasing the level of phytate in food crops when 
genetic modifications are not viable. However, no crystal structures of plants IPMK and 
IPKα are available in the PDB.
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In this chapter, recombinant StIPMK and StIPKα were produced and attempts were 
made to crystallize the proteins. Attempts to improve the quality of the diffraction from 
crystals involved removing the His-tags from the recombinant proteins.  Human ITPK1 
failed to  crystallize in  its  full-length form, but  a  construct  with the C-terminal  region 
truncated proved amenable to crystallization (Chamberlain et al. 2007). Designing a new 
StIPKα construct truncated from the C-terminus is another method employed in attempts 
to crystallize the protein.
6.1 Experimental
6.1.1 Cloning of StIPMK and StIPKα Into a pOPINf Vector
cDNAs  of  StIPMK  and  StIPKα  were  provided  by  Hayley  Whitfield  (UEA). 
pOPINf, a ligation-independent vector which adds a polyhistidine-tag to the N-terminus of 
the target sequence was used in these experiments (Berrow et al. 2007). The tag is linked 
to the target polypeptide by a 3C cleavage site, which can be cleaved by rhinoviral 3C 
protease with high specificity (Lohkamp et al. 2006).  The cDNAs were amplified with 
pOPINf ligation independent 'overhangs' using PCR. The list of primers and details of the 
recombinant  reaction  are  recorded  in  Appendix  2.  The  resulting  plasmids  from 
recombination  were  then  transformed  into  Stellar  Competent  cells  and  selected  using 
ampicillin and the blue-white screen. The plasmids were then extracted with Wizard Plus 
Minipreps DNA purification System (Promega Corporation), and transformed into cells of 
E. coli strain Rosetta 2 (DE3). 
6.1.2 Trial Expression of StIPMK and StIPKα
LB medium with ampicillin (100 μg/ml) was used with the following protocols. 
Cells prepared as described in the previous section were inoculated into 10 ml media, and 
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incubated at 37 °C overnight. They were then inoculated into a larger volume of media at a 
1:50 ratio. After the cells were grown to an OD600 of 0.6, IPTG induction was attempted , 
varying concentrations of IPTG and duration; 0.0 mM (control), 0.1 mM 0.25 mM, 0.5 
mM and 1.0 mM IPTG were used. Samples were taken and SDS-PAGE experiments were 
performed to monitor the protein expression.
Further  trials  were  carried  out  by  varying  temperature;  25  °C  without  IPTG 
induction (control), 25 °C and 37 °C. 10ml cultures were first grown in LB with glucose 
(0.01% w/v) and ampicillin at 37°C overnight. From the overnight culture, 2 ml was added 
to 100 ml of LB with ampicillin and incubated for 3 hours. Afterwards, IPTG was added 
to a final concentration of 0.5 mM, and samples were then incubated at 37°C or 25°C for 4 
and 5 hours, respectively. Cells were harvested by spinning at 5000 x g for 15 minutes and 
frozen. Later, these were resuspended in cell lysis buffer (50 mM NaH2PO4 pH 8.0, 300 
mM NaCl, 10 mM imidazole) and lysed by sonication. Cell debris was spun down and 
supernatant was loaded onto a Ni-NTA cartridge at 1 ml/min. The cartridge was washed 
with 10 ml of buffer (50mM NaH2PO4 pH 8.0, 300 mM NaCl, 20 mM imidazole) and 
eluted with high imidazole buffer  (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 250 mM 
imidazole), and 10 ml of eluted was collected.
6.1.3 Large Scale Expression and Purification of StIPMK and 
StIPKα
Cells were grown overnight at 37 °C in LB with ampicillin and glucose (0.01 % 
w/v), and inoculated into 2 litres of LB with ampicillin in a 1:50 ratio. After the cells were 
grown to an OD600 of 0.6, IPTG has been added to a final concentration of 0.5 mM. It was 
then incubated at 25 °C for five hours. The cells were harvested by spinning at 9000 x g 
for 20 minutes and then stored at -80 °C. After thawing, the cells were resuspended and 
lysed by French pressing. The cell debris was spun down, and supernatant was loaded onto 
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a Ni-NTA cartridge at the flow rate of 1 ml/min. The cartridge was washed and eluted 
with a gradient of  increasing imidazole concentration, with the  fractions collected and 
assessed with SDS-PAGE. The fractions containing the target protein with sufficient purity 
were pooled.  The pooled sample was concentrated with a centrifugal spin concentrator 
with a molecular weight cut off (MWCO) of 5 kDa. The concentrated sample was loaded, 
2 ml at a time, onto a HiLoad 16/60 Superdex 75 gel filtration column (GE Healthcare) 
equilibrated with gel filtration buffer (10mM Tris-HCl pH 7.4, 150mM NaCl, 2mM DTT) 
and maintained at 4°C. Elution was performed at 1 ml/min, using an ÄKTAprime™ liquid 
chromatography system (GE Healthcare). The purity of the protein was assessed by SDS-
PAGE. Gel filtration fractions containing pure target protein were selected and pooled.
6.1.4 Degradation Study of StIPKα
Purified StIPKα was left at 4 °C for a week, with samples taken on days 1, 2, 5, 6 
and  7.  These  were  immediately  boiled  in  the  presence  of  SDS and  stored  at  20  °C. 
Degradation of the samples as a function of time was then assessed by SDS-PAGE.
6.1.5. Over-expression and Purification of 3C Protease
Vector that encodes His-tagged 3C protease was transformed into Rosetta 2 (DE3) 
cells.  Over-expression  and purification  of  His-tagged 3C protease  were carried  out  in 
similar fashion to that described in section 6.1.3. 
6.1.6. Trial Cleavage of StIPMK and StIPKα
For the trial cleavage of the His-tag of StIPMK and StIPKα, purified 3C protease 
was added to 20 μg potato kinases in following ratios (w/w) of 1:5, 1:10 and 1:50 (based 
on concentrations calculated by measured UV absorbance). Each was then made up to 50 
μl with cleavage buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.5). Samples were taken at 
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1, 2, 4, 8 and 24 hour time points, boiled immediately in the presence of SDS and stored at 
20 °C. The samples were then assessed by SDS-PAGE to check the extent of cleavage.
6.1.7 Large Scale Purification of De-tagged StIPMK and StIPKα
Large scale expressions and the first stages of purification for StIPMK and StIPKα 
were carried out in the same protocol as described in section 6.1.3. 3C protease was added 
to the partially  purified StIPMK and  StIPKα at 1:20 and 1:10 (w/w) ratios respectively. 
The mixture was then dialysed  against a low imidazole  concentration buffer  (50 mM 
NaH2PO4 pH 8.0, 300 mM NaCl, 10 mM imidazole) overnight, and loaded onto a Ni-NTA 
cartridge for a second time. This time, 3C protease and any cleaved 6xHis-tag were bound, 
leaving the untagged kinases to pass  through the column. A buffer with slightly higher 
imidazole content (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 20 mM imidazole) was added 
to wash the remaining untagged protein off the cartridge, and collected in 3 ml fractions. 
The elute and the first fractions were  collected and purified through gel filtration. SDS-
PAGE was performed to assess the purity of the samples.
6.1.8 Crystallization of StIPMK and StIPKα
The  pooled  gel  filtration  products  from  purification  of  the  kinases  were 
concentrated with centrifugal spin concentrators with molecular weight cut off (MWCO) 
of 5 kDa.  The final concentrations of the samples were estimated by measurement of 
A280nm using  a  Nanodrop  ND-1000  Spectrophotometer  (Thermo  Scientific).  The  His-
tagged  StIPMK,  de-tagged  StIPMK,  and  de-tagged  StIPKα  were  subjected  to 
crystallization  trials  at  concentrations  of  9.8  mg/ml,  9.5  mg/ml  and  6.9  mg/ml, 
respectively. Initial  crystallization screening experiments  using  the  sitting drop vapour 
diffusion technique were carried out at both 4 °C and 16 °C with the Structure Screens™ 1 
and  2  (Jancarik et  al. 1991),  the  JCSG-plus™  Screen  (Page et  al. 2003), the  Stura 
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FootPrint Screens  (Stura et al. 1992), the PACT  premier screen  (Newman et al. 2005) 
from  Molecular  Dimensions  and  the  PEG/Ion  Screen  from  Hampton  Research. 
Crystallization  experiments  were  set  using  an  OryxNano  protein  crystallization  robot 
(Douglas Instruments Ltd) employing 0.5-1.0 μl droplets containing concentrated protein 
and screen solution in either 1:1 or 1:2 ratio, with 50 μl of screen solution in each well.  
Single crystals were harvested using litho loop (Molecular Dimensions), and were soaked 
into solutions containing mother liquor with 25 % (v/v) ethylene glycol or mother liquor 
with 30 % (v/v) glycerol prior to storage in liquid nitrogen.
6.1.9 Disorder Prediction and Alignment for StIPKα
The amino acid sequence of native StIPKα was input to FoldIndex (Prilusky et al. 
2005) and  Protein  DisOrder  prediction  System  (PrDOS)  (Ishida et  al. 2007).  For 
FoldIndex, the Kyte & Doolittle hydrophobicity scale  (Kyte et al. 1982) was employed. 
For PrDOS, The prediction false positive rate was set at 5.0 %.
The sequence of native StIPKα was aligned with human ITPK1 (PDB code: 2QB5) 
(Chamberlain et al. 2007) and Entamoeba histolytica ITPK1 (PDB code: 1Z2N) (Miller et  
al. 2005) using T-coffee (Notredame et al. 2000), and displayed using ESPript (Robert et  
al. 2014).
6.1.10 Cloning of a Truncated Form of StIPKα
The procedure followed in the cloning of truncated StIPKα (StIPKαt) is the same 
as that  described for  the full  length protein (section 6.1.1).  A newly designed reverse 
primer was used and its sequence is in Appendix 2.
6.1.11 Expression and Purification of Truncated StIPKα
The methods employed for expression and purification of StIPKαt were similar to 
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that described for the full length protein (see section 6.1.3), except that IPTG was added 
to a final concentration 0.25 mM, and incubated overnight at 30 °C after induction. The 
purified protein was then concentrated to 9.35 mg/ml prior to crystallization experiments.
6.1.12 Crystallization of Truncated StIPKα
The initial crystallization of StIPKαt is the same to that described for the full length 
protein (see section 6.1.8). Initial crystals formed in 0.2 M sodium sulfate, 0.1 M bis-tris 
propane  pH  8.5,  and  20%  (w/v)  PEG  3350.  This  condition  was  then  optimized  by 
systematic  variation  of  the  pH  and  precipitant  concentration.  Single  crystals  in  the 
optimized  conditions  was  harvested  using  a  litho  loop  (Molecular  Dimensions),  and 
soaked in a solution containing the mother liquor and 20% (v/v) ethylene glycol prior to 
storage in liquid nitrogen.
6.1.13 X-ray Diffraction Experiments
Single wavelength X-ray diffraction data collection were carried out on various 
beamlines  at  the  Diamond  Light  Source  (Didcot,  Oxfordshire).  The  X-ray  beam was 
operated at an energy of 12.658 keV (0.979 Å).
6.2 Results and Discussions
6.2.1 Initial Over-expressions of StIPMK and StIPKα
Initial small scale over-expressions trials of StIPMK and StIPKα were successful in 
generating  soluble  recombinant  protein  revealed  by  SDS-PAGE.  Although  leaky 
expression was observed in uninduced samples (data not shown). In an attempt to suppress 
the leaky expression, 0.01 % (w/v) glucose was added to the media in the initial overnight  
culture. Expression was tested at 37 °C, 25 °C and 25 °C without addition of IPTG and the 
protein were found to be over-expressed at all temperatures.  Figure 6.2.1.1 and  figure 
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6.2.1.2 shows the SDS-PAGE results for cells growing at 25 °C with IPTG induction for 
StIPMK and StIPKα, respectively, which is the condition that gave the highest yield of the 
proteins by measurement of A280.
Figure 6.2.1.1. 10  % acrylamide reducing SDS-PAGE for the small-scale expression of 
StIPMK at 25°C with IPTG induction. Lane MW is the molecular weight marker;  lane 3 shows 
the total cell protein; lane 4 shows the pellet after lysis; lane 5 shows the cell free extract after 
lysis; lane 6 shows the flow-through after cell free extract was loaded onto the Ni-NTA column; 
lane 7 shows the wash elute; lane 8 shows the first 5 ml of the elute  by  high  imidazole 
concentration buffer; lane 9 shows the last 5 ml of the elute by high imidazole concentration 
buffer.
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Figure 6.2.1.2. 10  % acrylamide reducing SDS-PAGE for the small-scale expression of 
StIPKα at 25°C with IPTG induction. Lane MW is the molecular weight marker; lane 1 shows 
the overnight culture; lane 2 shows  the culture before the induction; lane 3 shows the total cell 
protein; lane 4 shows the pellet after lysis; lane 5 shows the cell free extract after  lysis; lane 6 
shows the flow-through after cell free extract was loaded onto the Ni-NTA column; lane 7 shows 
the wash elute; lane 8 shows the first 5 ml of the elute by high imidazole concentration buffer; lane 
9 shows the last 5 ml of the elute by high imidazole concentration buffer.
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6.2.2 Large Scale Expression of StIPMK and StIPKα
In the large scale expression,  StIPMK was eluted using a gradient of imidazole, 
and further purified via gel filtration. Figure 6.2.2.1 shows the result of gel filtration for 
StIPMK. The purer fractions were pooled and concentrated prior to crystallization trials. 
Figure 6.2.2.1. 10  % acrylamide reducing SDS-PAGE for the products of gel filtration 
chromatography of  StIPMK. Lane MW is  the molecular weight marker; lane 1 is  the injected 
sample; lane 2 – 7 are the fractions collected.
In the large scale expression, StIPKα was eluted using a gradient of imidazole, and 
further  purified  via  gel  filtration. Figure  6.2.2.2 shows the  result  of  the  gel  filtration 
purification of StIPKα. Impurities of molecular weight lower than that of the target protein 
can be seen in the samples. To further investigate the nature of the impurities, a portion of 
the purified protein was set aside, and left for degradation, as detailed in the next section.
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Figure 6.2.2.2. 10  % acrylamide reducing SDS-PAGE for the products of gel filtration 
chromatography for StIPKα. Lane MW is the molecular weight marker; lane 1 – 9  are the 
fractions collected.
6.2.3 Degradation Study of StIPKα
Multiple bands appeared on SDS-PAGE experiments for StIPKα even after metal 
affinity chromatography and gel filtration chromatography. Therefore, a sample of the 
final product was taken and left at 4°C to see if there is significant degradation. SDS-
PAGE was performed for this experiment, as shown in figure 6.2.3.1. There are  no 
significant changes to the position and the intensities of the bands, suggesting very slow or 
no further degradation. These results bear a number of interpretations: (i) the protein was 
susceptible to proteolysis by proteases native to the E. coli cells, and that the proteases are 
removed during purification; (ii) low molecular weight impurities aggregate to StIPKα via 
disordered polypeptide in the protein structure.  Removing disordered polypeptide from 
StIPKα may reduce the protein susceptibility to proteases or chance for any adventitious 
aggregate (see section 6.2.8).
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Figure 6.2.3.1. Degradation test for StIPKα. Lane 1 is the original product; lane 2 is one day 
after; lane 3 is two days after; lane 4 is five days after; lane 5 is six days after; lane 6 is seven days 
after.
6.2.4 Preparation of 3C Protease
To cleave  the  His-tags from His-tagged proteins  possessing 3C cleavage sites, 
plasmid  encoding  a  recombinant  3C  protease  with  a  non-cleavable  His-tag  was 
transformed into Rosetta 2 (DE3) E. coli cells. The protein was over-expressed via IPTG 
induction,  and  the  cells  were  lysed,  and  was  purified  by  IMAC.  The  IMAC purified 
fractions were pooled, and further purified through gel filtration chromatography. Figure 
6.2.4.1 shows the SDS-PAGE results of fractions generated by gel filtration, and fractions 
with significant quantity and purity of 3C protease were collected.
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Figure 6.2.4.1. 10 % acrylamide reducing SDS-PAGE for the gel filtration of 3C protease. 
Lane 1 is the injected sample; lane MW is the molecular weight marker; lanes 2-9 are the fractions 
collected. Fractions from lanes 5-8 were pooled.
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6.2.5 Trial Cleavage of StIPMK and StIPKα
3C protease prepared as described in the previous section was added to  StIPMK 
and StIPKα. Evidence for cleavage was present at all concentration ratios of 3C protease, 
for StIPMK and StIPKα, as shown in figures 6.2.5.1 and 6.2.5.2, respectively. The 1:10 
3C to target protein concentration ratio is sufficient to generate de-tagged  StIPMK and 
StIPKα in 24 hours at 4 °C.
Figure 6.2.5.1. 15 % acrylamide reducing SDS-PAGE for the small scale cleavage experiment 
of  StIPMK 4 °C. Top gel:  lane MW is the molecular weight marker; lane 1-5 is the negative 
control, at 1, 2, 4, 8 and 24 hours respectively; lane 6-10 is the experiment with 1:5 3C to protein 
ratio, at 1, 2, 4, 8 and 24 hours respectively. Bottom gel: lane 1-5 is the experiment with 1:10 3C to  
protein ratio, at 1, 2, 4, 8 and 24 hours respectively; lane MW is the molecular weight marker; lane  
6-10 is the experiment with 1:50 3C to protein ratio, at 1, 2, 4, 8 and 24 hours respectively.
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Figure 6.2.5.2. 10 % acrylamide reducing SDS-PAGE for the small scale cleavage experiment 
of  StIPKα 4 °C. Top gel:  lane MW is the molecular weight  marker; lane 1-5 is the negative 
control, at 1, 2, 4, 8 and 24 hours, respectively; lane 6-10 is the experiment with 1:5 3C to protein 
ratio,  at  1,  2,  4,  8 and 24 hours,  respectively.  Bottom gel:  lane MW is  the  molecular  weight  
marker;  lane 1-5 is  the experiment  with 1:10 3C to protein ratio,  at  1,  2,  4,  8  and 24 hours,  
respectively; lane 6-10 is the experiment with 1:50 3C to protein ratio, at 1, 2, 4, 8 and 24 hours,  
respectively.
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6.2.6 Large Scale Purification of De-tagged StIPMK and StIPKα
IMAC-purified protein samples were cleaved with 3C protease, and reloaded onto 
Ni-NTA column and  washed with  20  mM imidazole.  Since  the  polyhistidine-tag  was 
removed, the target proteins do not bind to columns. Impurities that previously bound and 
eluted with the protein are removed from this step, giving sample of a greater purity. The 
eluted protein was collected, and further purified by gel filtration chromatography. The 
purity of the final samples were assessed by SDS-PAGE as shown in figures 6.2.6.1 and 
6.2.6.2 for StIPMK and StIPKα respectively. As can be seen, the purity of the final product 
has greatly improved from the previous purifications of the His-tagged protein, both for 
StIPMK and StIPKα. Both products were then subjected to crystallization trials.
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Figure 6.2.6.1. 15 % acrylamide reducing SDS-PAGE showing the gel filtration products for 
cleaved StIPMK. Lane MW is the molecular weight marker; lane 1 is the injected sample, and 
lanes 2 to 10 are the fractions collected. Fractions from lanes 5-8 were pooled.
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Figure  6.2.6.2. 10  %  acrylamide reducing SDS-PAGE for the gel  filtration products for 
cleaved  StIPKα. Lane MW is the molecular weight marker; lane 1 is the injected sample, and 
lanes 2 to 10 are the fractions collected. Fractions from lanes 6-9 were pooled.
6.2.7 Crystallization of StIPMK
His-tagged  StIPMK crystallized in a mother liquor containing  0.1 M Na HEPES 
pH 7.5, 10 % (w/v) PEG 8K and 8 % (v/v) ethylene glycol. The crystals were of space 
group C2221 with a = 168 Å, b = 433 Å, c = 92 Å; α = β = γ = 90 °. An image of the 
crystal used for data collection is shown in figure 6.2.7.1. The X-ray diffraction data had 
an overall Rsymm of 0.13, an overall completeness of 98.6 % at 5 Å resolution. Due to the 
low resolution of the data, the molecular structure cannot be solved from the data. With a 
long cell edge of 433 Å, data collection is possible with the long axis of the crystal parallel 
to the rotation axis, but it would be difficult to obtain a data set with a higher resolution 
from this crystal form.
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Figure 6.2.7.1. Image showing a crystal of His-tagged StIPMK.
De-tagged  StIPMK crystallized  in  a  mother  liquor  containing  0.16  M calcium 
acetate, 0.08 M sodium cacodylate pH 6.5, 14.4 (w/v) % PEG 8K and 20 % (v/v) glycerol. 
It was grown in the hexagonal space group P6222 (or its enantiomorph P6422), with a = b 
= 94.34 Å, c = 338.45 Å;  α = β = 90°, γ = 120°. A picture of the crystals is shown in 
figure 6.2.7.2. The data collected had an overall Rsymm of 0.21, completeness of 100% 
for data in the resolution resolution range  84.61  Å – 4.52 Å. Although not being in the 
same space group, the length of the longest cell edge is lower compared to the crystal for 
the His-tagged protein. The resolution has improved from that for the His-tagged crystal. 
However, the improvement is insufficient for the structure to be solved. Attempts were 
made to stabilize the structure with a ligand by adding ATP to the sample. The resulting 
crystals  are  isomorphous  and  grew over  a  shorter  time  period  but  the  quality  of  the 
diffraction remained unchanged.
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Figure 6.2.7.2. Image showing hexagonal crystals grown from cleaved StIPMK.
6.2.8 Designing a Construct of Truncated StIPKα
StIPKα yielded no positive results from crystallization trials. Failure to crystallize 
is  often thought  to  be due to  disorder  in  the protein.  To test  this  hypothesis,  disorder 
prediction for  StIPKα and alignment between of the sequences between  StIPKα and its 
homologues  on  the  PDB  were  carried  out.  Figure  6.2.8.1 shows  the  results  from 
FoldIndex (Prilusky et al. 2005), indicating five disordered regions, these involve residues 
51-76, 83-89, 213-235, 319-327, 331-365 (numbered based on the sequence of the native 
protein). These can be grouped into residue regions 51-89, 213-235 and 319-365.  Figure 
6.2.8.2 shows the results from Protein DisOrder prediction System (PrDOS) (Ishida et al. 
2007), indicating three disordered regions involving residues 1-9, 210-246 and 320-365.
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Figure 6.2.8.1. Results from the FoldIndex server, showing the predicted foldability of native 
StIPKα. The foldability  of  the  protein was  plotted against  residue number  of  the  amino acid 
sequence,  with regions predicted to  be folded shaded in green,  while  regions predicted to  be  
unfolded shaded in red.
Figure 6.2.8.2.  Results  from the PrDOS server,  showing the predicted disorder of  native 
StIPKα. The disorder probability of the protein was plotted against residue number of the amino 
acid sequence, with regions above the probability threshold shaded in green.
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Figure 6.2.8.3 shows the T-coffee  (Notredame et al. 2000) amino acid sequence 
alignment  of  StIPKα  with  homologues  of  known  structure.  StIPKα  has  C-terminal 
extension compared to the crystallized constructs of other homologues, suggesting that 
truncation of the C-terminal region may render StIPKα more amenable to crystallization. 
To take the compromise between the alignment and the disorder prediction results, and to 
also  taking  a  more  rational  approach  on  making  a  stable  construct,  the  protein  was 
truncated at residue 325, where the last helix of hITPK1 ends in the alignment.
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Figure 6.2.8.3. T-coffee alignment between  StIPKα and homologues with solved structures. 
The top of the alignment shows human ITPK1 (hITPK1) along with its secondary structure. The 
middle shows  StIPKα. The bottom shows ITPK1 from Entamoeba histolytica  (EhITPK1), along 
with its secondary structure. The alignment is numbered based on that of human ITPK1.
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6.2.9 Preparation of Truncated StIPKα
Truncated  StIPKα (referred to as  StIPKαt in the following),  was expressed and 
purified in the same manner of the full length protein, with the His-tag removed by 3C 
protease cleavage. By comparison of figure 6.2.2.2 and 6.2.9.1, it is apparent that purified 
StIPKαt was more pure than the full length protein. The fractions with sufficient purity 
(see figure) were pooled together and concentrated prior to crystallization trials.
Figure  6.2.9.1.  10%  acrylamide reducing SDS-PAGE for the gel  filtration  products  for 
StIPKαt. Lane MW is the molecular weight marker; lanes 1 to 11 are the fractions collected.  
Fractions from lanes 7-11 were pooled.
6.2.10 Crystallization of Truncated StIPKα
StIPKαt crystallized in a mother liquor containing 0.2 M sodium sulfate, 0.1 M bis 
tris  propane  pH 8.3,  and  22  % (w/v)  PEG 3350,  and  cryoprotected  into  20  % (v/v) 
ethylene glycol  before  storing in  liquid  nitrogen.Crystal  in  the  tetragonal  space  group 
P41212 (or its enantiomorph P43212), with a = b = 66.83 Å, c = 192.87 Å;  α = β = c = 90 °. 
A picture of a typical crystal is shown in figure 6.2.10.1. X-ray diffraction data collected 
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had an overall Rsymm of 0.060, with an overall completeness of 100% for data in the 
resolution range 66.83 Å – 3.50 Å. An increased propensity for the protein to crystallize 
had been demonstrated by removing residues  from a disordered region of the protein. 
However, the resolution of the diffraction data is still too low for the structure to be solved 
with enough details for the active site residues.
Figure 6.2.10.1. Image showing a crystal of StIPKαt.
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6.3 Conclusion
Attempts were made to crystallize two inositol polyphosphate kinases from potato. 
Possibly due to intrinsic disorder in the proteins,  crystals  with high diffraction quality 
could not be produced. This chapter has demonstrated the employment of techniques to 
increase the protein's propensity to crystallize and to increase the quality of diffraction by 
supposedly  lowering  the  disorder  in  the  target  proteins.  Although  many  proteins  do 
crystallize and diffract to high quality with a His-tag (see chapter 2 and 3 for examples), 
the  introduced  His-tags  lacks  secondary  structure,  thus  adding  more  disorder  to  the 
protein. Making the His-tag cleavable with a high specificity protease allows the His-tags 
to be removed after the Ni-NTA IMAC step. Not only this allowed the protein to reach 
higher purity, it increased the X-ray diffraction resolution of StIMPK crystals from 5 to 4.5 
Å. Designing a new construct of  StIPKα without the presumptive disordered C-terminal 
has successfully increased the protein's propensity to crystallize and resulted in a crystal 
with X-ray diffraction resolution of  3.5 Å.
High resolution data is required to resolve the atomic position of the amino acid 
side chains,  which would provide insight  to  the enzymes'  catalytic  activity.  Sadly,  the 
resolution of X-ray diffraction data for the potato kinases are insufficient. For  StIPMK, 
further attempts to optimize the crystals has included seeding, co-crystallization with ATP 
ligand  and  varying  cryoprotectants.  However,  none  of  these  strategies  has  yielded 
significant improvements. Further optimization of  StIPKαt crystals had been limited by 
low protein  yield.  If  given more  time and resources, attempts  would  be  made  to  co-
crystallize StIMPK and StIPKαt with different InsP ligands, which hopefully would further 
improve the quality of the crystals.
168
Chapter 7. General Discussion and Future Work
This  thesis presents the results of studies of proteins from human commensal gut 
bacteria with display phytase activity. Phytase is a major commercial animal feed enzyme, 
and the worldwide feed enzyme market is estimated to reach about $1.28 billion by 2019 
(Markets  and  Markets.  http://www.marketsandmarkets.com/PressReleases/feed-
enzyme.asp). Considerable effort has been expended to find new phytases and improve the 
existing ones by research groups around the world. Although activities of phytases are 
often reported in terms of the rate of phosphate release, the actual rate is different for each 
InsP.  Partially-dephosphorylated hydrolytic intermediates of InsP6 may act as inhibitors of 
phytases currently in use as feed additives, producing a bottleneck for the overall rate of 
phosphate release. As a phytase with demonstrable catalytically flexibility, it is possible 
that BtMinpp may be used in synergy with commercial phytases of high activity but low 
catalytic flexibility, to hydrolyze these inhibitory intermediate products. 
Thermostability for the feed pelleting process and protease tolerance for resistance 
to digestive enzymes are considered to be desirable features for any phytase which is to be 
exploited as an animal feed additive. Although the disulfide bridge mutant of  BtMinpp 
reported in this work was not shown to have an increased thermostability over the wild 
type enzyme,  native  BtMinpp did show a high tolerance against proteases.  Given that 
commensal gut bacteria inhabits environments in which they encounter digestive enzymes, 
it is unsurprising that Minpps produced by those bacteria have evolved to possess high 
tolerance against proteases.
The insights gained for Minpp from this work may be used as a starting point to 
develop new phytases with for the animal feed industry. It was demonstrated in chapter 3 
that the catalytic flexibility of Minpp can be reduced by replacing as active site residue 
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with the equivalent from a fungal phytase, it may be the case that the unique catalytic 
flexibility of Minpp may be engineered into existing commercial phytases.
Extending  the  search  for  Minpp  homologues  into  other  members  of  the  gut 
microbiota  may  allow phytases  with  more  attractive  properties  to  be  discovered.  For 
example, it has been shown that Minpp from Bacteroides xylanisolvens possesses higher 
activity relative to  Bacteroides thetaiotaomicron  (Stentz et al. 2014). Cloning  BxMinpp 
and solving its X-ray crystal structure would provide an attractive starting point for this 
research.
The  phosphomolybdate/malachite  green  end  point  assay  used  to  measure 
phosphate release is the standard method to measure phytase activity. However, this assay 
is  inefficient  as  it  requires  manually  stopping  the  reaction,  mixing  the  reagents,  and 
waiting for the colour development before measurements. In addition, since the assay is 
not in real time, the reaction has to be stopped multiple times to ensure the initial rate is  
properly  observed.  Furthermore,  background  phosphates  are  present  in  laboratory 
equipment, interfering with the detection. Ideally, a real-time assay would be developed to 
monitor  phytase  activity  in  real  time  without  relying  on  the  measurement  of  free 
phosphates.
The future work proposed here would allow both fundamental and applied research 
of a new generation of phytases with high catalytic flexibility. With the increase in world 
population and consequent food demand,  improved feed enzymes leading to  enhanced 
feed conversion ratios is one path which may be taken to directly address this pressing 
problem.
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Appendix 1. Crystal structure of the thiol-disulfide 
oxidoreductase ResA from S. coelicolor
ResA is a thioredoxin required for cytochrome c maturation (CCM). It functions by 
reducing the disulfide bonds in apocytochromes before heme insertion (Crow et al. 2005). 
Bacillus subtilis employs type II CCM, which involves the three proteins ResA, ResB and 
ResC, unlike type I CCM which requires eight or nine components to function (Crow et  
al. 2004).  A  homologue  of  Bacillus subtilis ResA  (BsResA)  had  been  found  in 
Streptomyces coelicolor (Bentley et  al. 2002).  This appendix reports  the X-ray crystal 
structure of ScResA and its analysis.
A1.1 Experimental
A1.1.1 Sample of ScResA
Sample of  Streptomyces coelicolor ResA (UniProt ID: Q9F2R7)  (Bentley et  al. 
2002) was provided by Mr Nick Cull (UEA). The insoluble N-terminal of the protein was 
replaced  with  a  soluble  Glutathione  S-transferase  (GST)  tag,  and  cleaved  during  the 
purification process. The final protein has the following sequence:
GSTGSDGIATAKKGERADAPELSGETVDGGQVDVADYKGKVVVLNVWGSWCPP
CRAEAKNFEKVYQDVKDQGVQFVGINTRDTSTGPARAFEKDYGVTYPSLYDPAG
RLMLRFEKGTLNPQAVPSTLIIDREGKVAARTLQALSEEKLRKMLAPYLQPEK
The purified protein was prepared in a buffer consisting of 100 mM Tris HCl pH 8 
and 100 mM NaCl, at a concentration of 11.86 mg/ml.
A1.1.2 Crystallization of ScResA
Crystallization  screening  experiments  using  the  sitting  drop  vapour  diffusion 
technique were carried out at both 4 °C and 16 °C with the JCSG-plus™ Screen (Page et  
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al. 2003) and  the  PACT  premier screen  (Newman et  al. 2005) from  Molecular 
Dimensions. The experiments were set using an OryxNano protein crystallization robot 
(Douglas Instruments Ltd) employing 0.4 μl droplets containing concentrated protein and 
screen solution in either 1:1 ratio, with 50 μl of screen solution in each well. Each single 
crystals was harvested into a LithoLoop™ (Molecular Dimensions), and soaked into a 
solution containing three parts mother liquor and one part ethylene glycol prior to being 
stored in liquid nitrogen.
A1.1.3 Data Collection and Processing
X-ray diffraction experiments were carried out on beamline I04-1 at the Diamond 
Light Source (Didcot, Oxfordshire). The X-ray beam was operated at an energy of 13.477 
keV (0.92 Å).
Indexing and data processing were performed using iMosflm (Battye et al. 2011), 
and the data sets were scaled using SCALA (Evans 2006). Molecular replacement was 
performed  using  Phaser  (McCoy et  al. 2007),  with  a  homology  model  using 
Corynebacterium  glutamicum secreted  thiol-disulfide  isomerase  (PDB  code:  3LWA) 
(Protein Structure Initiative).  AutoBuild  (Terwilliger et  al. 2008) was used to  perform 
automated model building, and the final model was completed using alternate rounds of 
automatic  and  manual  refinement  with  phenix.refine  (Afonine et  al. 2012)  and  Coot 
(Emsley et al. 2010).
A1.2 Results and Discussion
The protein crystallized in a mother liquor containing 0.17 M ammonium sulfate, 
25.5% (w/v) PEG 4000 and 15 (v/v) % glycerol, in space group P212121.  Figure A1.2.1 
shows an image of the orthorhombic crystal. To solve the structure of ScResA. molecular 
replacement  was  carried  out  with  a  homology  model  based  on  Corynebacterium 
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glutamicum secreted  thiol-disulfide  isomerase.  The  final  model  of  the  ScResA crystal 
structure was solved at 1.80 Å, and was refined to R work and R free values of 19.8 % and 
23.0  %  respectively,  with  a  single  residues  (0.3  %)  in  the  disallowed  region  of  the 
Ramachadran plot.
Figure A1.2.1. Image showing a crystal of ScResA in a LithoLoop.
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Table A1.2.1. Data collection and refinement statistics for ScResA crystal structure.
ScResA
Data collection
Wavelength (Å) 0.920
Space group P 21 21 21
Cell parameters
a , b , c (Å) 44.8, 64.6, 113.9
Resolution limit (Å) 37.98 – 1.80 (1.90 – 1.80) 
R merge 0.13 (0.49)
(I)/sd(I) 9.8 (3.8)
Completeness (%) 99.6 (100.0)
Multiplicity 6.7 (6.8)
Overall temperature factor (Å2) 14.6
Refinement Statistics
Protein monomers per asymmetric unit 2
Total atoms 2734
Water molecules 365
R work 19.8%
R free 23.0%
Ramachandran Analysis (%)
Most favoured
Outliers
99.7
0.3
RMS deviations
Bonds (Å)
Angles (°)
Planes (Å)
0.007
1.232
0.006
Mean Atomic B-value (Å2) 13.2
*Statistics for data in the high resolution bin are in brackets.
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Two monomers  were  present  in  the  crystallographic  asymmetric  unit.  Like  the 
structure  of  ResA from  Bacillus  subtilis (Crow et  al. 2004),  the  overall  structure  of 
ScResA adopts a thioredoxin fold consisting a central four-stranded β-sheet surrounded by 
three  α-helices,  as  shown in  figure A1.2.2  (top).  Similar  to  BsResA,  ScResA has  an 
additional N-terminal β-hairpin, and another insertion comprising of an extra α-helix and 
β-strand  compared  to  the  standard  thioredoxin  fold.  Contrasting  BsResA,  the  soluble 
domain of  ScResA had an extended N-terminal that formed an extra strand to the five 
stranded  β-sheet, and an insertion around residues 113-119 which introduced a flexible 
loop between helix  α3 and strand β7 that cannot be resolved in the crystal structure, as 
demonstrated in figure A1.2.2 (bottom).
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Figure A1.2.2. Overall structure of ScResA (top) and its superposition with BsResA (bottom). 
At the top,  the  refined model  of  ScResA was displayed in  cartoon representation,  with loops 
coloured in green,  α-helices coloured in red, and  β-strands coloured in yellow. At the bottom, 
ScResA (green) was aligned with oxidised BsResA (cyan), with the insertions in ScResA labelled.
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The  CXXC motif  of  ScResA revealed  it  to  form a  partially  oxidized/reduced 
dislfide, as shown in the electron density map in figure A1.2.3. In the oxidised form, the 
two sulfur atoms are 2.0 Å apart, with occupancies of 0.57 (Cys51) and 0.32 (Cys54). In 
the reduced form, the two sulfur atoms are 3.9 Å apart, with occupancies of 0.43 (Cys51) 
and 0.68 (Cys54). The refined occupancies suggest that neither redox state is the dominant 
form. In the BsResA structure, the sulfur-sulfur distances were 2.16 Å and 4.5 Å for the 
oxidized and reduced states, respectively. The narrower range of distances could be due to 
the fact that the protein is  neither fully oxidized or fully reduced. However,  it  is also 
possible that the rigidity of the two proline residues (compared to one glutamate and one 
proline in BsResA) had restricted the movement of the cysteine residues in their reduced 
form, thus shortening the distance between them. When aligned to BsResA using DaliLite 
(Hasegawa et al. 2009),  ScResA showed an rmsd of 1.5  Å against the oxidised form of 
BsResA, and an rmsd of 1.6  Å against the reduced form of  BsResA. This might be an 
indication that the ScResA model is more oxidized than it is reduced.
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Figure A1.2.3. Active site of ScResA. At the top, 2Fo – Fc map contoured at 1.2 sigma showed the 
density surrounding the CXXC motif (grey), and the residues shown in stick representation with 
atoms of carbon coloured as green, nitrogen as blue, oxygen as red and sulfur as yellow. At the  
bottom, the oxidised disulfide pair was shown on the left, and the reduced form on the right, both 
shown in sticks representation with the colour scheme as above. 
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A1.3 Conclusion
A  partially  oxidized/reduced  structure  of  ScResA  had  been  reported  in  this 
appendix.  It  had  been  reported  that  the  surface  of  oxidised  BsResA  is  relatively 
hydrophobic, while the surface near the active site of reduced BsResA is relatively basic, 
and  the  reduced  form  produced  an  “opened”  protein  with  a  cavity  lined  with  many 
hydrophobic residues and a few polar/charged ones (Crow et al. 2004). Thus, to properly 
investigate  the  structural  biology  of  a  redox  protein,  both  the  oxidized  and  reduced 
structures are required. The oxidized structure can be obtained by incubating the protein 
with oxidants such as diamide before hand, while the reduced structure can be obtained by 
incubating the protein with reductants such as dithiothreitol before hand. Unfortunately, 
additional protein required to pursue this investigation further could not be obtained.
It is interesting to note that there are two prolines between the cysteines in the 
CXXC motif of ScResA, making the active site rigid compared to BsResA. The distance 
between the Cβ atoms of BsResA increases from 3.6 Å to 4.3 Å from oxidized to reduced 
states,  but the distance between the Cβ atoms of ScResA only changed from 3.7 Å to 4.0 
Å in the different conformations. This may be an artefact of looking at the structure as two 
conformations rather than two fully oxidized and reduced structure, but it may also be an 
indicator of the rigidity of the active site. A CPPC mutant of BsResA had been previously 
reported (Lewin et al. 2008), which exhibited lowered pKa values for active site cysteines 
in both oxidized and reduced form, and an overall destabilizing effect for the oxidized 
form.  It  can  be  proposed  that  a  similar  effect  would  occur  in  ScResA,  but  without 
structures of the fully oxidised and fully reduced forms of ScResA, it is difficult to draw 
any firm conclusions from the available results.
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Appendix 2. Supplement Information
Chapter 3
List of the 5'-phosphorylated primers used in the 'fungalizing' mutagenesis.
Mutation Sense Antisense
A31Y
GAAGTATGCAGGGACGTACATGCCCTATC
CTAATAG TGTATCTTAGTTTGTCCCCA
H59A
ATAAATCATCTGGGAAGAGCTGGAGCCCG
CTTCC ATAAAATGGGGTCATACCATC
R183D
GTGAAGGAAAACAATATAATCATATCCTTG
ATTTTTTTGATCTGAATAAATCTTATGTC TTCGCTGTACCTGTAAAGCTG
A324D
CTTTCGTTTTGCTCATGATGAAACAGTTAT
ACC TTAGCCTGATAATCGGATTTCC
E325N
CGTTTTGCTCATGCAAATACAGTTATACCT
TTTGTG AAAGTTAGCCTGATAATCGG
A324D/
E325N
CTTTCGTTTTGCTCATGATAATACAGTTATA
CCTTTTGTG TTAGCCTGATAATCGGATTTCC
Contents of  the 'fungalizing'  mutagenesis  PCRs using Phusion Site-Directed Mutagenesis 
Kit.
Component Volume (μl) Final concentration
H2O 35.5 N/A
5x Phusion HF buffer 10 1x
10 mM dNTPs 1 200 μM each
25 μM primer mix 1 0.5  μM each
180 pg/μl template DNA 2 360 pg in 50 μl, 7.2 pg/μl
Phusion® Hot  Start  DNA 
polymerase (2 U/μl)
0.5 1 U in 50 μl
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Temperature and times of the 'fungalizing' mutagenesis PCRs using Phusion Site-Directed 
Mutagenesis Kit.
Steps Temperature (°C) Time (m:s) Description
1 98.0 02:00 Initial denaturation
2 98.0 00:20 Denaturation
3 Variable* 00:30 Annealing
4 72.0 05:00 Extension
Repeat steps 2 to 4 twenty-eight times (twenty-nine times total)
5 72.0 10:00 Final extension
6 16.0 Pause
*The annealing temperature is a few degrees above the Tm of the primer with a lower Tm.
List of the primers used in the 'humanizing' mutagenesis.
Mutation Forward Reverse
A31K CAGAAGTATGCAGGGACGAAGATGCCCTATCCTAATAAG 
CCTATTAGGATAGGGCATCTTCGTCCCT
GCATACTTCTG 
V147K GATTGAAGCAATAGCAACCTATAAGCCCCGCAGCATAAATAGTATG 
CATACTATTTATGCTGCGGGGCTTATAG
GTTGCTATTGCTTCAATC 
K195V GAATAAATCTTATGTCAATTATGTAGAGAAAGGTGACTGGCTTCC 
GGAAGCCAGTCACCTTTCTCTACATAA
TTGACATAAGATTTATTC 
S279K GAATTTGCGACAATATATGAAGAAGAGCTCTGCACCTGTCG 
CGACAGGTGCAGAGCTCTTCTTCATAT
ATTGTCGCAAATTC 
Contents of the 'humanizing' mutagenesis PCRs using QuikChange Lightning Site-Directed 
Mutagenesis Kit.
Component Volume (μl)
H2O 14
10x reaction buffer 2
QuikSolution 0.6
dNTP mix 0.4
5 μM forward primer 0.8
5 μM reverse primer 0.8
4.8 ng/μl template DNA 1
QuikChange Lightning Enzyme 0.4
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Temperature and times of the 'humanizing' mutagenesis PCRs using QuikChange Lightning 
Site-Directed Mutagenesis Kit.
Segments Cycles Temperature (°C) Time (m:s) Description
1 1 95.0 02:00 Initial denaturation
2 18 95.0 00:20 Denaturation
18 60.0 00:10 Annealing
18 68.0 03:30 Extension
3 1 68.0 5:00 Final extension
Contents  of  the 'humanizing'  mutagenesis  PCR using  QuikChange Lightning Multi  Site-
Directed Mutagenesis Kit.
Component Volume (μl)
H2O 10.4
10x reaction buffer 2
QuikSolution 0.4
dNTP mix 0.4
5 μM primer mix 1.6
24 ng/μl template DNA 4
QuikChange Lightning Multi Enzyme 0.8
Temperature and times of the 'humanizing' mutagenesis PCRs using QuikChange Lightning 
Multi Site-Directed Mutagenesis Kit.
Segments Cycles Temperature (°C) Time (m:s) Description
1 1 95.0 02:00 Initial denaturation
2 30 95.0 00:20 Denaturation
30 55.0 00:30 Annealing
30 65.0 03:30 Extension
3 1 65.0 5:00 Final extension
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Chapter 4
Sequences  of  the  primers  used  in  cloning  the  truncated  version  of  Minpps  from 
Bifidobacterium.
Gene Forward Reverse
B. longum
Minpp
AAGTTCTGTTTCAGGGCCC
GATGGAGGCTGACGGCCGG 
ATGGTCTAGAAAGCTTTA
GATGCGGGCATCCTGACC 
B. pseudocatenulatum
Minpp
AAGTTCTGTTTCAGGGCCC
GGGGGAAGGAACCGCCCGG 
ATGGTCTAGAAAGCTTTAC
AGTCGGGCATCAACCGT 
Chapter 5
List of primers used for the cysteine free and disulfide bridge mutants.
Mutation Primer sequence
C160S 5'-GCATAAATAGTATGGACGCTTTTCTTTCTAGCATGATAAGGCATAA-3' 
C344S 5'-TAGAAAAAACTGATGTACAGGTTAGCCGGCCCGATT-3' 
C396S 5'-GCTTCCTATATCAACCGCTAGTTTCCCATATTACTCTTG-3' 
Y27C 5'-GGGACAAACTAAGATACAGAAGTGTGCAGGGACGGC-3' 
W269C 5'-CTTGATGAATGGCATCGTTATTGCCAAACCCAGAATTTGC-3' 
A292C 5'-CGGTAAGATGTTACCGGTTTGCATCGCTTGGCCTTTGCTTTC-3'
A416C 5'-CTTTAATCAGCGAATCGAAATGTGTAAAAAAACACTTTCAGTTTTC-3'
Chapter 6
List of the primers used in cloning of IPMK and IPKα from Solanum tuberosum. 
Gene Forward Reverse
StIPMK AAGTTCTGTTTCAGGGCCCGATGGAGGCTGACGGCCGG 
ATGGTCTAGAAAGCTTTAGATGCGGG
CATCCTGACC 
StIPKα AAGTTCTGTTTCAGGGCCCGATGAAAATGGCGGAGCCGATGAG 
ATGGTCTAGAAAGCTTTACACGTGAA
TAGGGTTCT 
StIPKαt - ATGGTCTAGAAAGCTTTACTTTAAACTCCCCAAGCTCTT
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Contents of the recombinant reaction using the Infusion HD cloning kit. The mixture was  
incubated at 50 °C for 15 minutes.
Component Volume (μl) 
5x Infusion HD enzyme premix 2
Linearised pOPINf vector 1.5
Purified PCR product 1
dH2O 5.5
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